,data source,drug name,pubchem id,smile,gene symbol,variant,label
0,pharmgkb,meloxicam,5281106.0,CC1=CN=C(S1)N/C(=C\2/C(=O)C3=CC=CC=C3S(=O)(=O)N2C)/O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13",Metabolism/PK
1,pharmgkb,lornoxicam,5282204.0,CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=C(S1(=O)=O)C=C(S3)Cl,CYP2C9,"CYP2C9*1, CYP2C9*3, CYP2C9*13",Metabolism/PK
2,pharmgkb,siponimod,44599207.0,,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Metabolism/PK
3,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs17376848,Toxicity
4,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs2297595,Toxicity
5,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs1801265,Toxicity
6,pharmgkb,dexlansoprazole,9578005.0,CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Metabolism/PK
7,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11",Toxicity
8,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs1801160,Toxicity
9,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs1801159,Toxicity
10,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],TPMT,"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C",Dosage
11,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs17376848,Toxicity
12,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1801158,Toxicity
13,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1801159,Toxicity
14,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs1801158,Toxicity
15,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1801265,Toxicity
16,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1801160,Toxicity
17,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP4F2,rs2108622,Dosage
18,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,EGFR,rs121434568,Efficacy
19,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,rs3745274,Metabolism/PK
20,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9923231,Dosage
21,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,NUDT15,rs116855232,Dosage
22,pharmgkb,hydrocodone,5284569.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*17, CYP2D6*41",Metabolism/PK
23,pharmgkb,tropisetron,656665.0,,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN",Efficacy
24,pharmgkb,ibuprofen,3672.0,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Metabolism/PK
25,pharmgkb,desipramine,2995.0,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10",Metabolism/PK
26,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs74503330,Efficacy
27,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs267606723,Efficacy
28,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs113993958,Efficacy
29,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121908752,Efficacy
30,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508759,Efficacy
31,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs77834169,Efficacy
32,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508537,Efficacy
33,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs115545701,Efficacy
34,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs368505753,Efficacy
35,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs202179988,Efficacy
36,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs78769542,Efficacy
37,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs141033578,Efficacy
38,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs78060119,Toxicity
39,pharmgkb,rasburicase,,,G6PD,"G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",Toxicity
40,pharmgkb,flurbiprofen,3394.0,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29",Metabolism/PK
41,pharmgkb,trimipramine,5584.0,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",Metabolism/PK
42,pharmgkb,tenoxicam,5312154.0,CN1/C(=C(/NC2=CC=CC=N2)\O)/C(=O)C3=C(S1(=O)=O)C=CS3,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Metabolism/PK
43,pharmgkb,tropisetron,656665.0,,CYP2D6,"CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",Metabolism/PK
44,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs59086055,Other
45,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs115232898,Toxicity
46,pharmgkb,celecoxib,2662.0,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13",Metabolism/PK
47,pharmgkb,piroxicam,5280452.0,CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=CC=CC=C3S1(=O)=O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Metabolism/PK
48,pharmgkb,ivacaftor / lumacaftor,71494926.0,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs113993960,Efficacy
49,pharmgkb,ivacaftor / tezacaftor,72722243.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C.CC(C)(CO)C1=CC2=CC(=C(C=C2N1C[C@H](CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,CFTR,rs113993960,Efficacy
50,pharmgkb,flucloxacillin,21319.0,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,HLA-B,HLA-B*57:01,Toxicity
51,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1801160,Other
52,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs72549306,Other
53,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs72549303,Other
54,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs115232898,Other
55,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs78060119,Other
56,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1801268,Other
57,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1801266,Other
58,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs72549309,Other
59,pharmgkb,hormonal contraceptives for systemic use,,,F5,rs6025,Toxicity
60,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Toxicity
61,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,UGT1A1,"UGT1A1*1, UGT1A1*28",Dosage
62,pharmgkb,desflurane,42113.0,C(C(F)(F)F)(OC(F)F)F,CACNA1S,rs1800559,Toxicity
63,pharmgkb,desflurane,42113.0,C(C(F)(F)F)(OC(F)F)F,CACNA1S,rs772226819,Toxicity
64,pharmgkb,trimipramine,5584.0,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,CYP2C19,"CYP2C19*1, CYP2C19*2",Metabolism/PK
65,pharmgkb,desipramine,2995.0,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",Toxicity
66,pharmgkb,enflurane,3226.0,C(C(OC(F)F)(F)F)(F)Cl,CACNA1S,rs772226819,Toxicity
67,pharmgkb,enflurane,3226.0,C(C(OC(F)F)(F)F)(F)Cl,CACNA1S,rs1800559,Toxicity
68,pharmgkb,halothane,3562.0,C(C(F)(F)F)(Cl)Br,CACNA1S,rs1800559,Toxicity
69,pharmgkb,isoflurane,3763.0,C(C(F)(F)F)(OC(F)F)Cl,CACNA1S,rs1800559,Toxicity
70,pharmgkb,halothane,3562.0,C(C(F)(F)F)(Cl)Br,CACNA1S,rs772226819,Toxicity
71,pharmgkb,isoflurane,3763.0,C(C(F)(F)F)(OC(F)F)Cl,CACNA1S,rs772226819,Toxicity
72,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,CACNA1S,rs1800559,Toxicity
73,pharmgkb,methoxyflurane,4116.0,COC(C(Cl)Cl)(F)F,CACNA1S,rs1800559,Toxicity
74,pharmgkb,methoxyflurane,4116.0,COC(C(Cl)Cl)(F)F,CACNA1S,rs772226819,Toxicity
75,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,CACNA1S,rs772226819,Toxicity
76,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CACNA1S,rs1800559,Toxicity
77,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,CACNA1S,rs772226819,Toxicity
78,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs59086055,Toxicity
79,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],NUDT15,rs116855232,Toxicity
80,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,"CYP2B6*1, CYP2B6*2, CYP2B6*6, CYP2B6*18, CYP2B6*38",Toxicity
81,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*11",Toxicity
82,pharmgkb,abacavir,441300.0,C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO)N,HLA-B,HLA-B*57:01,Toxicity
83,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9923231,Dosage
84,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,rs3745274,Toxicity
85,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-B,HLA-B*58:01,Toxicity
86,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121909041,Efficacy
87,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs80282562,Efficacy
88,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121909013,Efficacy
89,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508256,Efficacy
90,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121908755,Efficacy
91,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs193922525,Efficacy
92,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121908753,Efficacy
93,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs74551128,Efficacy
94,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508288,Efficacy
95,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508442,Efficacy
96,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs150212784,Efficacy
97,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508513,Efficacy
98,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121909020,Efficacy
99,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs75527207,Efficacy
100,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs77932196,Efficacy
101,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs186045772,Efficacy
102,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121909005,Efficacy
103,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs75541969,Efficacy
104,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs11971167,Efficacy
105,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121908757,Efficacy
106,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,"CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9, CYP2B6*18, CYP2B6*28",Metabolism/PK
107,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs78655421,Efficacy
108,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,"CYP2B6*1, CYP2B6*6, CYP2B6*26",Dosage
109,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs2297595,Toxicity
110,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,,rs12777823,Dosage
111,pharmgkb,fluvoxamine,3404.0,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14",Metabolism/PK
112,pharmgkb,amitriptyline,2160.0,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",Toxicity
113,pharmgkb,amitriptyline,2160.0,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",Metabolism/PK
114,pharmgkb,clomipramine,2801.0,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",Toxicity
115,pharmgkb,clomipramine,2801.0,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",Metabolism/PK
116,pharmgkb,imipramine,3696.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",Toxicity
117,pharmgkb,imipramine,3696.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*4, CYP2D6*5",Dosage
118,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN",Toxicity
119,pharmgkb,doxepin,667477.0,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*35, CYP2D6*35xN, CYP2D6*41",Metabolism/PK
120,pharmgkb,imipramine,3696.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5",Metabolism/PK
121,pharmgkb,nortriptyline,4543.0,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",Toxicity
122,pharmgkb,nortriptyline,4543.0,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17",Metabolism/PK
123,pharmgkb,voriconazole,71616.0,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Metabolism/PK
124,pharmgkb,lansoprazole,3883.0,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9, CYP2C19*17",Metabolism/PK
125,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Efficacy
126,pharmgkb,pantoprazole,4679.0,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Metabolism/PK
127,pharmgkb,atomoxetine,54841.0,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6",Toxicity
128,pharmgkb,atomoxetine,54841.0,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*92, CYP2D6*96",Metabolism/PK
129,pharmgkb,flecainide,3356.0,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*21, CYP2D6*36",Metabolism/PK
130,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*10, CYP2D6*14, CYP2D6*41",Metabolism/PK
131,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*10x2, CYP2D6*11, CYP2D6*17, CYP2D6*21, CYP2D6*36, CYP2D6*41",Efficacy
132,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN",Toxicity
133,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,CYP2D6,"CYP2D6*1, CYP2D6*4",Dosage
134,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*31, CYP2D6*35, CYP2D6*41",Metabolism/PK
135,pharmgkb,haloperidol,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17",Metabolism/PK
136,pharmgkb,propafenone,4932.0,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10, CYP2D6*36",Metabolism/PK
137,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*14",Metabolism/PK
138,pharmgkb,clomipramine,2801.0,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Metabolism/PK
139,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Metabolism/PK
140,pharmgkb,imipramine,3696.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Metabolism/PK
141,pharmgkb,omeprazole,4594.0,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Efficacy
142,pharmgkb,omeprazole,4594.0,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*9, CYP2C19*10, CYP2C19*17, CYP2C19*24, CYP2C19*26",Metabolism/PK
143,pharmgkb,lansoprazole,3883.0,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Efficacy
144,pharmgkb,pantoprazole,4679.0,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Efficacy
145,pharmgkb,zuclopenthixol,5311507.0,C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4",Metabolism/PK
146,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*10, CYP2C19*17, CYP2C19*19, CYP2C19*25, CYP2C19*26",Metabolism/PK
147,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs67376798,Other
148,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs67376798,Toxicity
149,pharmgkb,tegafur,5386.0,,DPYD,rs67376798,Toxicity
150,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs67376798,Toxicity
151,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs3918290,Toxicity
152,pharmgkb,tegafur,5386.0,,DPYD,rs3918290,Toxicity
153,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs3918290,Toxicity
154,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs3918290,Other
155,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs55886062,Other
156,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs55886062,Toxicity
157,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs55886062,Toxicity
158,pharmgkb,tegafur,5386.0,,DPYD,rs55886062,Toxicity
159,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs148994843,Other
160,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs56005131,Other
161,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,NUDT15,"NUDT15*1, NUDT15*2, NUDT15*3",Toxicity
162,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,NUDT15,"NUDT15*1, NUDT15*2, NUDT15*3",Dosage
163,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,TPMT,"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*9",Dosage
164,pharmgkb,tobramycin,36294.0,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N,MT-RNR1,rs267606617,Toxicity
165,pharmgkb,amikacin,37768.0,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,MT-RNR1,rs267606617,Toxicity
166,pharmgkb,gentamicin,3467.0,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,"MT-ND1,MT-RNR1",rs267606617,Toxicity
167,pharmgkb,aminoglycoside antibacterials,,,MT-RNR1,rs267606617,Toxicity
168,pharmgkb,streptomycin,19649.0,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,MT-RNR1,rs267606617,Toxicity
169,pharmgkb,kanamycin,6032.0,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,MT-RNR1,rs267606617,Toxicity
170,pharmgkb,kanamycin,6032.0,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,MT-RNR1,rs267606619,Toxicity
171,pharmgkb,streptomycin,19649.0,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,MT-RNR1,rs267606619,Toxicity
172,pharmgkb,gentamicin,3467.0,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,MT-RNR1,rs267606619,Toxicity
173,pharmgkb,tobramycin,36294.0,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N,MT-RNR1,rs267606619,Toxicity
174,pharmgkb,aminoglycoside antibacterials,,,MT-RNR1,rs267606619,Toxicity
175,pharmgkb,aminoglycoside antibacterials,,,MT-RNR1,rs267606618,Toxicity
176,pharmgkb,gentamicin,3467.0,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,MT-RNR1,rs267606618,Toxicity
177,pharmgkb,kanamycin,6032.0,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,MT-RNR1,rs267606618,Toxicity
178,pharmgkb,streptomycin,19649.0,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,MT-RNR1,rs267606618,Toxicity
179,pharmgkb,ondansetron,4595.0,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*35xN",Efficacy
180,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*4, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11",Dosage
181,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*11, CYP2C9*13, CYP2C9*14, CYP2C9*16, CYP2C9*29, CYP2C9*31, CYP2C9*33, CYP2C9*37, CYP2C9*39, CYP2C9*42, CYP2C9*43, CYP2C9*45, CYP2C9*50, CYP2C9*52, CYP2C9*55",Metabolism/PK
182,pharmgkb,aripiprazole,60795.0,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*41",Metabolism/PK
183,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",Dosage
184,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*9, CYP2D6*10, CYP2D6*17, CYP2D6*41",Metabolism/PK
185,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*36, CYP2D6*41",Metabolism/PK
186,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9923231,Dosage
187,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*17, CYP2D6*40",Efficacy
188,pharmgkb,hydrocodone,5284569.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,CYP2D6,"CYP2D6*5, CYP2D6*17",Efficacy
189,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17",Efficacy
190,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*17","Efficacy,Toxicity"
191,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Metabolism/PK
192,pharmgkb,lovastatin,53232.0,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",Toxicity
193,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",Toxicity
194,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,SLCO1B1,rs4149056,Toxicity
195,pharmgkb,lovastatin,53232.0,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,SLCO1B1,rs4149056,Toxicity
196,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,SLCO1B1,rs4149056,Metabolism/PK
197,pharmgkb,pitavastatin,5282452.0,,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37",Metabolism/PK
198,pharmgkb,pitavastatin,5282452.0,,SLCO1B1,rs4149056,Metabolism/PK
199,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,SLCO1B1,rs4149056,Toxicity
200,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,SLCO1B1,rs4149056,Metabolism/PK
201,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,SLCO1B1,rs4149056,Toxicity
202,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",Toxicity
203,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Toxicity
204,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37",Metabolism/PK
205,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,SLCO1B1,rs4149056,Toxicity
206,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,ABCG2,rs2231142,Metabolism/PK
207,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,SLCO1B1,rs4149056,Toxicity
208,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",Toxicity
209,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,SLCO1B1,rs4149056,Metabolism/PK
210,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37",Metabolism/PK
211,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",Metabolism/PK
212,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",Metabolism/PK
213,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",Toxicity
214,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*15:02,Toxicity
215,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-A,HLA-A*31:01,Toxicity
216,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",Metabolism/PK
217,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Metabolism/PK
218,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4",Toxicity
219,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,CYP3A4,"CYP3A4*1, CYP3A4*20, CYP3A4*22",Metabolism/PK
220,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,TPMT,"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*4, TPMT*6, TPMT*9, TPMT*12",Toxicity
221,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,HLA-B,HLA-B*15:02,Toxicity
222,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-B,"HLA-B*15:02, HLA-B*15:11",Toxicity
223,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,HLA-B,HLA-B*15:02,Toxicity
224,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15",Toxicity
225,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs56038477,Toxicity
226,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs56038477,Toxicity
227,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs75017182,Other
228,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs75017182,Toxicity
229,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs75017182,Toxicity
230,pharmgkb,vortioxetine,9966051.0,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*10",Metabolism/PK
231,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Metabolism/PK
232,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,CYP2B6,"CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*9",Metabolism/PK
233,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",Metabolism/PK
234,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*81",Toxicity
235,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17, CYP2D6*29, CYP2D6*35, CYP2D6*41",Metabolism/PK
236,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],TPMT,"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C, TPMT*6",Toxicity
237,pharmgkb,doxepin,667477.0,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31,CYP2C19,"CYP2C19*1, CYP2C19*2",Metabolism/PK
238,pharmgkb,amitriptyline,2160.0,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Metabolism/PK
239,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,SLCO1B1,rs4149056,Metabolism/PK
240,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9923231,Toxicity
241,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
242,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
243,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Toxicity
244,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Dosage
245,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs8050894,Dosage
246,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9934438,Dosage
247,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs2359612,Dosage
248,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs7294,Dosage
249,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,"CYP2A6*1, CYP2A6*1x2, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*12, CYP2A6*13, CYP2A6*14, CYP2A6*15, CYP2A6*17, CYP2A6*19, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*38, CYP2A6*46",Metabolism/PK
250,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9923231,Efficacy
251,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9923231,Efficacy
252,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC19A1,rs1051266,Efficacy
253,pharmgkb,dapsone,2955.0,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,HLA-B,HLA-B*13:01,Toxicity
254,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2B6,rs3745274,Metabolism/PK
255,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,UGT1A1,"UGT1A1*1, UGT1A1*6, UGT1A1*28",Metabolism/PK
256,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,ABCG2,rs2231142,Efficacy
257,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,UGT1A1,rs10929302,Toxicity
258,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A4,rs4646437,Metabolism/PK
259,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Dosage
260,pharmgkb,methazolamide,4100.0,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,HLA-B,HLA-B*59:01,Toxicity
261,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*13, CYP2C9*14",Efficacy
262,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9934438,Dosage
263,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9923231,Toxicity
264,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9934438,Dosage
265,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",Dosage
266,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs2884737,Dosage
267,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,CYP4F2,rs2108622,Dosage
268,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Dosage
269,pharmgkb,salmeterol,5152.0,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,ADRB2,rs1042713,Efficacy
270,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2B6,rs28399499,Toxicity
271,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9923231,Toxicity
272,pharmgkb,hmg coa reductase inhibitors,,,SLCO1B1,rs4149056,Toxicity
273,pharmgkb,captopril,44093.0,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,ACE,rs1799752,Efficacy
274,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,CYP2B6,"CYP2B6*1, CYP2B6*2, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*18, CYP2B6*22, CYP2B6*30",Metabolism/PK
275,pharmgkb,mirtazapine,4205.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",Metabolism/PK
276,pharmgkb,rabeprazole,5029.0,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Metabolism/PK
277,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,"CYP2B6*1, CYP2B6*4, CYP2B6*6, CYP2B6*18",Metabolism/PK
278,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Toxicity
279,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A4,"CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22",Dosage
280,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs61742245,Dosage
281,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-B,HLA-B*40:01,Toxicity
282,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7",Metabolism/PK
283,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801133,Toxicity
284,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801133,Toxicity
285,pharmgkb,sulfamethoxazole / trimethoprim,358641.0,,HLA-B,"HLA-B*13:01, HLA-B*15:02, HLA-B*38:02",Toxicity
286,pharmgkb,isoniazid,3767.0,C1=CN=CC=C1C(=O)NN,NAT2,"NAT2*4, NAT2*5A, NAT2*5B, NAT2*5C, NAT2*6A, NAT2*6B, NAT2*6J, NAT2*6O, NAT2*7A, NAT2*7B, NAT2*7G, NAT2*12A, NAT2*13A, NAT2*14A",Metabolism/PK
287,pharmgkb,antiepileptics,,,HLA-B,HLA-B*15:02,Toxicity
288,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,rs2242480,Dosage
289,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A4,"CYP3A4*1, CYP3A4*18, CYP3A4*20, CYP3A4*22",Metabolism/PK
290,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A4,rs2242480,Metabolism/PK
291,pharmgkb,methazolamide,4100.0,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,HLA-C,HLA-C*01:02,Toxicity
292,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CES1,rs71647871,Efficacy
293,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CES1,rs71647871,Metabolism/PK
294,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,SCN1A,rs3812718,Dosage
295,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-C,HLA-C*03:02,Toxicity
296,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ATIC,rs4673993,Efficacy
297,pharmgkb,etanercept,,,TNF,rs1800629,Efficacy
298,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-DRB1,HLA-DRB1*01:01,Toxicity
299,pharmgkb,Platinum compounds,,,XRCC1,rs25487,Efficacy
300,pharmgkb,erlotinib,176870.0,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,EGFR,rs121434569,Efficacy
301,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA5,rs16969968,Toxicity
302,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-C,HLA-C*04:01,Toxicity
303,pharmgkb,ethanol,702.0,CCO,ALDH2,rs671,Toxicity
304,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,HLA-DPB1,HLA-DPB1*03:01,Toxicity
305,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,APOE,rs7412,Efficacy
306,pharmgkb,"Ace Inhibitors, Plain",,,XPNPEP2,rs3788853,Toxicity
307,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,ADD1,rs4961,Efficacy
308,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,EGFR,rs121434569,Efficacy
309,pharmgkb,rituximab,,,FCGR3A,rs396991,Efficacy
310,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,KIF6,rs20455,Efficacy
311,pharmgkb,sulfamethoxazole / trimethoprim,358641.0,,HLA-C,"HLA-C*06:02, HLA-C*07:27, HLA-C*08:01",Toxicity
312,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-A,HLA-A*33:03,Toxicity
313,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,EPAS1,rs7557402,Toxicity
314,pharmgkb,etoposide,36462.0,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,,rs6539870,Toxicity
315,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,CSRP3,rs983332,Efficacy
316,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,ARAP2,rs437943,Efficacy
317,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,CST5,rs6138150,Efficacy
318,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,MAFB,rs6028945,Efficacy
319,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,MAFB,rs6071980,Efficacy
320,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,rs11188072,Dosage
321,pharmgkb,diuretics,,,ADD1,rs4961,Efficacy
322,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,DRD3,rs6280,Efficacy
323,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,"UGT1A10,UGT1A6,UGT1A7,UGT1A8,UGT1A9",rs6759892,Dosage
324,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC19A1,rs9977268,Efficacy
325,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,PTGS2,rs20417,Efficacy
326,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,ABCB1,rs1045642,Dosage
327,pharmgkb,dicloxacillin,18381.0,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,ABCB1,rs1045642,Other
328,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,ABCB1,rs1045642,Toxicity
329,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC2,rs17222723,Toxicity
330,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,ABCB1,rs1128503,Other
331,pharmgkb,doxorubicin,31703.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,ABCB1,rs2032582,Other
332,pharmgkb,digoxin,30322.0,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,ABCB1,rs2032582,Other
333,pharmgkb,"Ace Inhibitors, Plain",,,PTGER3,rs11209716,Toxicity
334,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,SLCO1B3,rs11045585,Toxicity
335,pharmgkb,"Ace Inhibitors, Plain",,,MME,rs2016848,Toxicity
336,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,DRD2,rs1799978,Toxicity
337,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,ESR2,rs4986938,Toxicity
338,pharmgkb,"Ace Inhibitors, Plain",,,BDKRB2,rs8012552,Toxicity
339,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,STX4,rs10871454,Dosage
340,pharmgkb,trastuzumab,,,ERBB2,rs1136201,Toxicity
341,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs104894539,Dosage
342,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs104894540,Dosage
343,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs104894541,Dosage
344,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs104894542,Dosage
345,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,ABCB1,rs2229109,Other
346,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-C,rs9461684,Toxicity
347,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,SLCO1B1,rs11045819,Efficacy
348,pharmgkb,troglitazone,5591.0,CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O,,rs10811661,Efficacy
349,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,ESR1,rs9340799,Toxicity
350,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,rs9345389,Toxicity
351,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,rs4888024,Toxicity
352,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,"ADORA2A,SPECC1L",rs5760410,Toxicity
353,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,MOB3B,rs868856,Efficacy
354,pharmgkb,topoisomerase I inhibitors,,,EGFR,rs712829,Efficacy
355,pharmgkb,geldanamycin,46936377.0,C[C@@H]1C[C@H]([C@@H]([C@@H](/C=C(\[C@H]([C@@H](/C=C\C=C(/C(=O)NC2=CC(=O)C(=C(C1)C2=O)OC)\C)OC)OC(=O)N)/C)C)O)OC,EGFR,rs712829,Efficacy
356,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,DTNBP1,rs2619538,Toxicity
357,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,ALOX5,rs2115819,Efficacy
358,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,LTA4H,rs2660845,Efficacy
359,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,ADRB3,rs4994,Toxicity
360,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,RGS4,rs2842030,Efficacy
361,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,LEP,rs4731426,Toxicity
362,pharmgkb,cetuximab,,,CCND1,rs9344,Efficacy
363,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,DTNBP1,rs742105,Efficacy
364,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,ABCB1,rs2032582,Efficacy
365,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,ABCB1,rs1128503,Efficacy
366,pharmgkb,amiodarone,2157.0,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,KCNH2,rs12720441,Toxicity
367,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,GGH,rs11545078,Toxicity
368,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,C9orf72,rs774359,Efficacy
369,pharmgkb,doxorubicin,31703.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,CBR3,rs8133052,"Efficacy,Toxicity"
370,pharmgkb,daunorubicin,30323.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O,NRP2,rs10932125,Other
371,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,"CYP3A,CYP3A4",rs12721627,Dosage
372,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,RGS4,rs951439,Efficacy
373,pharmgkb,propofol,4943.0,CC(C)C1=C(C(=CC=C1)C(C)C)O,UGT1A9,rs58597806,Toxicity
374,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,"BAG6,PRRC2A",rs750332,Toxicity
375,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,C9orf72,rs3849942,Efficacy
376,pharmgkb,erlotinib,176870.0,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,EGFR,rs712829,Efficacy
377,pharmgkb,rofecoxib,5090.0,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,PTGS2,rs20417,Efficacy
378,pharmgkb,sildenafil,5212.0,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,ACE,rs4343,Efficacy
379,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,rs4086116,Dosage
380,pharmgkb,Beta Blocking Agents,,,PPARA,rs4253778,Efficacy
381,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,MOB3B,rs2814707,Efficacy
382,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,GBP6,rs928655,Efficacy
383,pharmgkb,anthracyclines and related substances,,,CAT,rs10836235,Toxicity
384,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,SLCO1B1,rs2306283,Other
385,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP2C8,rs11572080,Other
386,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP2C8,rs10509681,Other
387,pharmgkb,haloperidol,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,DTNBP1,rs909706,Efficacy
388,pharmgkb,iloperidone,71360.0,,NRG3,rs4933824,Toxicity
389,pharmgkb,iloperidone,71360.0,,NUBPL,rs7142881,Toxicity
390,pharmgkb,iloperidone,71360.0,,CELF4,rs4799915,Toxicity
391,pharmgkb,iloperidone,71360.0,,CERKL,rs993648,Toxicity
392,pharmgkb,verapamil,2520.0,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,NOS1AP,rs10918594,Toxicity
393,pharmgkb,verapamil,2520.0,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,NOS1AP,rs10494366,Toxicity
394,pharmgkb,Measles vaccines,,,TLR3,rs3775291,Efficacy
395,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,PICK1,rs2076369,Toxicity
396,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,DTNBP1,rs3213207,Toxicity
397,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,PIK3CA,rs870995,Dosage
398,pharmgkb,antipsychotics,,,"CLCN6,MTHFR",rs1801133,Toxicity
399,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,CYP2B6,rs2279343,Toxicity
400,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,DRD3,rs6280,Efficacy
401,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HTR2A,rs6311,Efficacy
402,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,TYMS,rs2853539,Efficacy
403,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,DRD3,rs167771,Toxicity
404,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,GSTP1,rs1695,Toxicity
405,pharmgkb,doxorubicin,31703.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,ABCC2,rs8187710,Toxicity
406,pharmgkb,Platinum compounds,,,"CD3EAP,ERCC1,PPP1R13L",rs3212986,Efficacy
407,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,CYP3A4,rs2740574,Toxicity
408,pharmgkb,pramipexole,59868.0,CCCN[C@@H]1CCC2=C(C1)SC(=N2)N,DRD3,rs6280,Efficacy
409,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,NR1I2,rs2472677,Other
410,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,COMT,rs165599,Efficacy
411,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,GRM3,rs724226,Efficacy
412,pharmgkb,ritonavir,392622.0,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,APOC3,rs5128,Toxicity
413,pharmgkb,rosiglitazone,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,LPIN1,rs10192566,Efficacy
414,pharmgkb,"sulfonamides, urea derivatives",,,TCF7L2,rs12255372,Efficacy
415,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,ABCC1,rs119774,Efficacy
416,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC1,rs28364006,Efficacy
417,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC1,rs2238476,"Efficacy,Toxicity"
418,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCG2,rs17731538,Efficacy
419,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC1,rs246240,Toxicity
420,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCG2,rs13120400,Efficacy
421,pharmgkb,irbesartan,3749.0,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,APOB,rs1367117,Efficacy
422,pharmgkb,caffeine,2519.0,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,CYP1A2,rs762551,Toxicity
423,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,rs12248560,Dosage
424,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,FPGS,rs1544105,Efficacy
425,pharmgkb,nitrous oxide,,,MTHFR,rs1801133,Toxicity
426,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP2C8,rs1113129,Toxicity
427,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,NALCN,rs7992226,Other
428,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ARID5B,rs10821936,Other
429,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs4846051,Toxicity
430,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,GGH,rs1800909,Efficacy
431,pharmgkb,Antihypertensives And Diuretics In Combination,,,NOS3,rs2070744,Efficacy
432,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,TCF7L2,rs290487,Efficacy
433,pharmgkb,doxorubicin,31703.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,ABCC2,rs17222723,Toxicity
434,pharmgkb,doxorubicin,31703.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,ABCC1,rs45511401,Toxicity
435,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,EPHX1,rs1051740,Toxicity
436,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,EPHX1,rs2234922,Toxicity
437,pharmgkb,etoposide,36462.0,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,SLIT1,rs2784917,Toxicity
438,pharmgkb,fexofenadine,3348.0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,ABCB1,rs1045642,Dosage
439,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,PRDX4,rs518329,Dosage
440,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,EPHX1,rs2234922,Dosage
441,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,XRCC4,rs1382368,Dosage
442,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,ADM,rs11042725,Efficacy
443,pharmgkb,clodronate,25419.0,C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl,VDR,rs731236,Efficacy
444,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ADORA2A,rs3761422,Toxicity
445,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ADORA2A,rs2267076,Toxicity
446,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,CYP2B6,rs8192709,Toxicity
447,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],"DDRGK1,ITPA",rs1127354,Efficacy
448,pharmgkb,erlotinib,176870.0,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,EGFR,rs712829,Toxicity
449,pharmgkb,verapamil,2520.0,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,"KCNIP1,KCNMB1",rs11739136,Efficacy
450,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,DRD3,rs963468,Efficacy
451,pharmgkb,leflunomide,3899.0,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,ESR1,rs9340799,Efficacy
452,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,GRK4,rs1024323,Efficacy
453,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC10,rs9349256,Toxicity
454,pharmgkb,"Antiinflammatory agents, non-steroids",,,AGT,rs943580,Toxicity
455,pharmgkb,coumarin,,,CYP2A6,rs1801272,Other
456,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs28399433,Other
457,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,"UGT1A10,UGT1A6,UGT1A7,UGT1A8,UGT1A9",rs2070959,Dosage
458,pharmgkb,antipsychotics,,,COMT,rs4680,Toxicity
459,pharmgkb,coumarin,,,CYP2A6,rs28399433,Other
460,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs28399468,Other
461,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,CYP2B6,rs3745274,Toxicity
462,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,GGH,rs3758149,Efficacy
463,pharmgkb,antipsychotics,,,COMT,rs4680,Other
464,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,"CYP3A,CYP3A4",rs2740574,Other
465,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,CYP2C8,rs10509681,Other
466,pharmgkb,cerivastatin,446156.0,CC(C)C1=C(C(=C(C(=N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)COC,RYR2,rs2819742,Toxicity
467,pharmgkb,amiodarone,2157.0,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,NOS1AP,rs10919035,Toxicity
468,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SHMT1,rs1979277,Toxicity
469,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,CYP2C8,rs11572080,Dosage
470,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,GABRQ,rs3810651,Efficacy
471,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,CYP2D6,rs5030655,Efficacy
472,pharmgkb,lithium,28486.0,[Li+],CACNG2,rs2284017,Efficacy
473,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,CYP2D6,rs3892097,Efficacy
474,pharmgkb,antidepressants,,,FKBP5,rs3800373,Efficacy
475,pharmgkb,zoledronate,68740.0,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,FDPS,rs2297480,Toxicity
476,pharmgkb,cangrelor,9854012.0,CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F,P2RY12,rs9859552,Efficacy
477,pharmgkb,hydroxyurea,3657.0,C(=O)(N)NO,MAP3K5,rs9376230,Efficacy
478,pharmgkb,hydroxyurea,3657.0,C(=O)(N)NO,MAP3K5,rs9483947,Efficacy
479,pharmgkb,lithium,28486.0,[Li+],CRY1,rs8192440,Efficacy
480,pharmgkb,lithium,28486.0,[Li+],DRD1,rs4532,Efficacy
481,pharmgkb,lithium,28486.0,[Li+],GSK3B,rs334558,Efficacy
482,pharmgkb,lithium,28486.0,[Li+],,rs2826494,Efficacy
483,pharmgkb,lithium,28486.0,[Li+],"OR52J2P,OR52J3",rs2499984,Efficacy
484,pharmgkb,lithium,28486.0,[Li+],CACNG2,rs2284018,Efficacy
485,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,IL12A,rs568408,Toxicity
486,pharmgkb,pitrakinra,,,IL4R,rs8832,Efficacy
487,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,BDNF,rs7934165,Dosage
488,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,BDNF,rs1491850,Dosage
489,pharmgkb,lithium,28486.0,[Li+],"NR1D1,THRA",rs2314339,Efficacy
490,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,IMPDH1,rs2278294,Efficacy
491,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NTRK2,rs2120266,Dosage
492,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NTRK2,rs2289658,Dosage
493,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,IMPDH1,rs2278294,Toxicity
494,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NTRK2,rs4358872,Dosage
495,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NTRK2,rs1948308,Dosage
496,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NTRK2,rs2378676,Dosage
497,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NTRK2,rs4877900,Dosage
498,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,ANKK1,rs7118900,Dosage
499,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,DRD2,rs2283265,Dosage
500,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NGF,rs2239622,Dosage
501,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,BDNF,rs10835210,Dosage
502,pharmgkb,lithium,28486.0,[Li+],GSK3B,rs6438552,Efficacy
503,pharmgkb,lithium,28486.0,[Li+],TPH1,rs1800532,Efficacy
504,pharmgkb,cytarabine,6253.0,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,CDA,rs532545,Efficacy
505,pharmgkb,cytarabine,6253.0,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,CDA,rs532545,Toxicity
506,pharmgkb,cytarabine,6253.0,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,CDA,rs602950,Toxicity
507,pharmgkb,cytarabine,6253.0,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,CDA,rs3215400,Toxicity
508,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs2236196,Other
509,pharmgkb,muraglitazar,,,ADRB1,rs1801253,Toxicity
510,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,GNB3,rs5443,Toxicity
511,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,HTR2A,rs6313,Toxicity
512,pharmgkb,nortriptyline,4543.0,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,ABCB1,rs1045642,Toxicity
513,pharmgkb,verapamil,2520.0,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,"KCNIP1,KCNMB1",rs2301149,Efficacy
514,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,DRD3,rs6280,Efficacy
515,pharmgkb,oxaliplatin,6857599.0,C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2],ABCB1,rs1045642,Efficacy
516,pharmgkb,oxaliplatin,6857599.0,C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2],ABCB1,rs1128503,Efficacy
517,pharmgkb,nitroprusside,11963622.0,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.[Fe+4],ACE,rs1799752,Efficacy
518,pharmgkb,acetylcholine,187.0,CC(=O)OCC[N+](C)(C)C,ACE,rs1799752,Efficacy
519,pharmgkb,nifedipine,4485.0,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,SLC14A2,rs1123617,Efficacy
520,pharmgkb,nifedipine,4485.0,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,SLC14A2,rs3745009,Efficacy
521,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs1044396,Other
522,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,CYP1A2,rs762551,Efficacy
523,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,HTR2A,rs7997012,Toxicity
524,pharmgkb,midazolam,4192.0,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,CYP3A4,rs12721627,Other
525,pharmgkb,nemonapride,,,ANKK1,rs1800497,Toxicity
526,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs17880887,Dosage
527,pharmgkb,nitrous oxide,,,MTHFR,rs1801131,Toxicity
528,pharmgkb,verapamil,2520.0,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,ABCB1,rs1045642,Other
529,pharmgkb,spironolactone,5833.0,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,ACE,rs1799752,Efficacy
530,pharmgkb,spironolactone,5833.0,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,ACE,rs4343,Efficacy
531,pharmgkb,sumatriptan,5358.0,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,GNB3,rs5443,Efficacy
532,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,CYP1A2,rs762551,"Dosage,Toxicity"
533,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,BDNF,rs6265,Efficacy
534,pharmgkb,prasugrel,6918456.0,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,CYP2C19,rs4244285,Efficacy
535,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,WNT5B,rs2010851,Other
536,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,NEUROD1,rs1801262,Efficacy
537,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,PAX4,rs114202595,Efficacy
538,pharmgkb,bucindolol,51045.0,CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O,ADRA2C,rs61767072,Efficacy
539,pharmgkb,sulfamethoxazole,5329.0,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,GCLC,rs761142,Toxicity
540,pharmgkb,Alkylating Agents,,,EGFR,rs712829,Efficacy
541,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,ABCB1,rs9282564,Other
542,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,ABCB1,rs72552784,Other
543,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,LDLR,rs688,Efficacy
544,pharmgkb,tolbutamide,5505.0,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,CYP2C9,rs9332239,Other
545,pharmgkb,verapamil,2520.0,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,ABCB1,rs2032582,Other
546,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,CYP2C9,rs1057910,Efficacy
547,pharmgkb,muraglitazar,,,REN,rs2368564,Toxicity
548,pharmgkb,muraglitazar,,,EDN1,rs5370,Toxicity
549,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,P2RY1,rs1065776,Efficacy
550,pharmgkb,lithium,28486.0,[Li+],"NR1D1,THRA",rs2071427,Efficacy
551,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,FSIP1,rs7179742,Toxicity
552,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,CEP68,rs7572857,Toxicity
553,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,PPARG,rs3856806,Toxicity
554,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,IL4,rs2243250,Toxicity
555,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,ADORA1,rs2228079,Toxicity
556,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,GP6,rs1613662,Efficacy
557,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,FCER1G,rs11587213,Toxicity
558,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,IL1B,rs1143627,Toxicity
559,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,TBXA2R,rs1131882,Toxicity
560,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,ITGA2,rs1062535,Efficacy
561,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,NTRK1,rs2768759,Efficacy
562,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,HNMT,rs1050891,Toxicity
563,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,rs9332096,Dosage
564,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,VEGFA,rs833061,Toxicity
565,pharmgkb,erythromycin,12560.0,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,ABCC2,rs717620,Other
566,pharmgkb,calcium,271.0,[Ca+2],VDR,rs731236,Efficacy
567,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,F13A1,rs5985,Efficacy
568,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP2B6,"CYP2B6*1, CYP2B6*5",Efficacy
569,pharmgkb,desipramine,2995.0,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,MC1R,rs2228479,Efficacy
570,pharmgkb,desipramine,2995.0,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,MC1R,rs2228478,Efficacy
571,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,UGT1A9,rs72551330,Toxicity
572,pharmgkb,doxepin,667477.0,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31,CYP2C9,"CYP2C9*1, CYP2C9*3",Efficacy
573,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PPARA,rs135543,Efficacy
574,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PPARA,rs135550,Efficacy
575,pharmgkb,antidepressants,,,GRIK4,rs12800734,Efficacy
576,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,KCNJ1,rs12795437,Toxicity
577,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,rs12782374,Dosage
578,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CRHR1,rs242941,Efficacy
579,pharmgkb,fluvoxamine,3404.0,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,COMT,rs4680,Efficacy
580,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,SLCO1B3,rs7311358,Other
581,pharmgkb,lovastatin,53232.0,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CETP,rs708272,Efficacy
582,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,ACE,rs1799752,Efficacy
583,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,ACE,rs1799752,Efficacy
584,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,FMO1,rs12720462,Other
585,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,FMO3,rs2266780,Other
586,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,FMO1,rs7877,Other
587,pharmgkb,thalidomide,5426.0,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,ERCC1,rs735482,Efficacy
588,pharmgkb,thalidomide,5426.0,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,XRCC5,rs1051685,Efficacy
589,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,rs10509680,Dosage
590,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,"PRSS53,VKORC1",rs17886199,Dosage
591,pharmgkb,thalidomide,5426.0,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,GSTT1,rs4630,Toxicity
592,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,rs4918758,Dosage
593,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs61162043,Dosage
594,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,SREBF1,rs60282872,Efficacy
595,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,SCAP,rs12487736,Efficacy
596,pharmgkb,ABT-751,,,UGT1A4,rs6755571,Other
597,pharmgkb,"Ace Inhibitors, Plain",,,BDKRB2,rs8016905,Toxicity
598,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,TLR4,rs4986790,Efficacy
599,pharmgkb,"Ace Inhibitors, Plain",,,AGTR1,rs5186,"Efficacy,Toxicity"
600,pharmgkb,pitavastatin,5282452.0,,SLCO1B1,rs2306283,Other
601,pharmgkb,"Ace Inhibitors, Plain",,,ABO,rs495828,Toxicity
602,pharmgkb,"Ace Inhibitors, Plain",,,,rs4459610,Toxicity
603,pharmgkb,"Ace Inhibitors, Plain",,,,rs4267385,Toxicity
604,pharmgkb,amphetamine,3007.0,C[C@@H](CC1=CC=CC=C1)N,OPRM1,rs510769,Efficacy
605,pharmgkb,amphetamine,3007.0,C[C@@H](CC1=CC=CC=C1)N,OPRM1,rs2281617,Other
606,pharmgkb,antipsychotics,,,CYP2D6,rs5030655,Toxicity
607,pharmgkb,antipsychotics,,,RGS2,rs4606,Toxicity
608,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,UGT1A3,"UGT1A3*1, UGT1A3*2",Efficacy
609,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],AOX1,rs55754655,Efficacy
610,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,MTTP,rs1800591,Efficacy
611,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,MTTP,rs1800591,Efficacy
612,pharmgkb,nortriptyline,4543.0,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,UST,rs2500535,Efficacy
613,pharmgkb,zidovudine,35370.0,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],UGT2B7,rs28365062,Other
614,pharmgkb,zidovudine,35370.0,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],ABCC4,rs11568695,Other
615,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,ABCB1,rs1045642,Toxicity
616,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,ABCB1,rs1045642,Toxicity
617,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,AGTR1,rs12721226,Efficacy
618,pharmgkb,corticosteroids,,,DCAF4,rs7160796,Efficacy
619,pharmgkb,corticosteroids,,,FKBP5,rs4713916,Efficacy
620,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,ABCB1,rs2032582,Toxicity
621,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,CYP1A2,rs72547517,Other
622,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,CYP1A2,rs72547516,Other
623,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,HTR3A,rs1150226,Efficacy
624,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,SLCO1B1,rs4149081,Efficacy
625,pharmgkb,dexmedetomidine,68602.0,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,PRKCB,rs9922316,Other
626,pharmgkb,dexmedetomidine,68602.0,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,ADRA2A,rs1800544,Other
627,pharmgkb,disulfiram,3117.0,CCN(CC)C(=S)SSC(=S)N(CC)CC,DRD2,rs2283265,Efficacy
628,pharmgkb,disulfiram,3117.0,CCN(CC)C(=S)SSC(=S)N(CC)CC,ANKK1,rs1800497,Efficacy
629,pharmgkb,diuretics,,,PDE4D,rs702553,Efficacy
630,pharmgkb,lopinavir,92727.0,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,ABCC2,rs8187710,Efficacy
631,pharmgkb,mitotane,4211.0,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,CYP2B6,rs3745274,Other
632,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,ABCG8,rs11887534,Efficacy
633,pharmgkb,midazolam,4192.0,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,POR,rs1057868,Other
634,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP3A5,"CYP3A5*1, CYP3A5*3","Efficacy,Toxicity"
635,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CYP3A4,"CYP3A4*1, CYP3A4*4",Efficacy
636,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CYBA,rs4673,Other
637,pharmgkb,haloperidol,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,SLC6A5,rs2298826,Toxicity
638,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,CETP,rs4783961,Efficacy
639,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,ABCB1,rs1922242,Efficacy
640,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,CETP,rs5882,Efficacy
641,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CETP,rs5882,Efficacy
642,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,HMGCR,rs17238540,Efficacy
643,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,HMGCR,rs17238540,Efficacy
644,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,HMGCR,rs17244841,Efficacy
645,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,HMGCR,rs17244841,Efficacy
646,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,MTHFR,rs1801133,Efficacy
647,pharmgkb,hmg coa reductase inhibitors,,,CXCL5,rs352046,Efficacy
648,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,TNF,rs1800629,Other
649,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,F3,rs3917643,Efficacy
650,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,ABCA1,rs2230806,Efficacy
651,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,NPC1L1,rs17655652,Efficacy
652,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,SCARB1,rs5888,Efficacy
653,pharmgkb,hmg coa reductase inhibitors,,,HMGCR,rs12654264,Other
654,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,LPL,rs328,Efficacy
655,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,APOA1,rs964184,Efficacy
656,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,ABCB1,rs7787082,Efficacy
657,pharmgkb,candesartan,2541.0,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,AGTR1,rs5186,Efficacy
658,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,AGT,rs5051,Efficacy
659,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,SCARB1,rs4238001,Efficacy
660,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,SLCO1B1,rs4149015,Toxicity
661,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,ABCC2,rs3740066,Toxicity
662,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,CRP,rs3091244,Efficacy
663,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SACM1L,rs2742435,Toxicity
664,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SACM1L,rs2742423,Toxicity
665,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SACM1L,rs2742421,Toxicity
666,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SACM1L,rs2742417,Toxicity
667,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SACM1L,rs2742390,Toxicity
668,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,DRD2,rs2440390,Toxicity
669,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,GABRA1,rs2290732,Efficacy
670,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SACM1L,rs2251954,Toxicity
671,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SACM1L,rs2245705,Toxicity
672,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,KCNQ1,rs2237895,Efficacy
673,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,KCNQ1,rs2237892,Efficacy
674,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,ABCG2,rs2231137,Toxicity
675,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,ABCA1,rs2230808,Efficacy
676,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,ABCA1,rs2230806,Efficacy
677,pharmgkb,captopril,44093.0,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,ACE2,rs2106809,Efficacy
678,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SACM1L,rs1969624,Toxicity
679,pharmgkb,benazepril,5362124.0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,MTR,rs1805087,Efficacy
680,pharmgkb,irbesartan,3749.0,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,APOB,rs1801701,Efficacy
681,pharmgkb,dobutamine,36811.0,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,ADRB1,rs1801253,Efficacy
682,pharmgkb,disulfiram,3117.0,CCN(CC)C(=S)SSC(=S)N(CC)CC,MTHFR,rs1801133,Efficacy
683,pharmgkb,Enzymes,,,F12,rs1801020,Efficacy
684,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,ADRA2A,rs1800545,Efficacy
685,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,COL26A1,rs17135437,Toxicity
686,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,CRP,rs1417938,Efficacy
687,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,HTR2A,rs6313,Toxicity
688,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,ABCG2,rs2231142,Toxicity
689,pharmgkb,sirolimus,6436030.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,ABCB1,rs1128503,Toxicity
690,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,UGT1A,rs10929303,Other
691,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,UGT1A,rs10929303,Toxicity
692,pharmgkb,iloperidone,71360.0,,CYP2D6,rs1065852,Toxicity
693,pharmgkb,sirolimus,6436030.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,ABCB1,rs1045642,Toxicity
694,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,UGT1A,rs1042640,Other
695,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,UGT1A,rs1042640,Toxicity
696,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,UGT1A,rs8330,Other
697,pharmgkb,mirtazapine,4205.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,CYP2B6,"CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7",Other
698,pharmgkb,mirtazapine,4205.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,CYP2B6,"CYP2B6*1, CYP2B6*4, CYP2B6*5, CYP2B6*6, CYP2B6*7",Efficacy
699,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,HTR2C,rs1414334,Toxicity
700,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,SLCO1B1,rs4149056,Toxicity
701,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,ABCC2,rs2273697,Other
702,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCC4,rs9561765,Efficacy
703,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,NOD2,rs2066844,Efficacy
704,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP2C19,"CYP2C19*1, CYP2C19*2",Efficacy
705,pharmgkb,digoxin,30322.0,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,ABCB1,rs1128503,Other
706,pharmgkb,Enzymes,,,A2M,rs669,Efficacy
707,pharmgkb,benazepril,5362124.0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,PRCP,rs2229437,Efficacy
708,pharmgkb,prasugrel,6918456.0,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,PEAR1,rs12407843,Efficacy
709,pharmgkb,prasugrel,6918456.0,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,PEAR1,rs77235035,Efficacy
710,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,HTR1B,rs130058,Other
711,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,CYP1A2,rs2470890,Efficacy
712,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,CYP1A2,rs2472304,Efficacy
713,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,CYP1A2,rs4646425,Efficacy
714,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,CYP1A2,rs4646427,Efficacy
715,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,SLC22A1,rs34130495,Other
716,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,SLC22A1,rs35167514,Other
717,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,DRD3,rs6280,Efficacy
718,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,,rs13432159,Toxicity
719,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP2C19,"CYP2C19*1, CYP2C19*2",Dosage
720,pharmgkb,trimipramine,5584.0,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,CYP2C9,"CYP2C9*1, CYP2C9*3",Other
721,pharmgkb,prasugrel,6918456.0,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,PEAR1,rs3737224,Efficacy
722,pharmgkb,prasugrel,6918456.0,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,PEAR1,rs41273215,Efficacy
723,pharmgkb,prasugrel,6918456.0,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,PEAR1,rs822441,Efficacy
724,pharmgkb,prasugrel,6918456.0,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,PEAR1,rs822442,Efficacy
725,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,,rs2069521,Toxicity
726,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP1A2,rs2069526,Toxicity
727,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP1A2,rs4646425,Toxicity
728,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP1A2,rs4646427,Toxicity
729,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,DRD3,rs324026,Efficacy
730,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,DRD3,rs324023,Efficacy
731,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,DRD3,rs167770,Efficacy
732,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,GRIN2B,rs1806201,Toxicity
733,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,GRIN2B,rs1806201,Toxicity
734,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HTR2A,rs6313,Toxicity
735,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,GSTM1,"GSTM1 non-null, GSTM1 null",Toxicity
736,pharmgkb,dobutamine,36811.0,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,GNAS,rs62205366,Efficacy
737,pharmgkb,captopril,44093.0,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,AGTR1,rs5186,Efficacy
738,pharmgkb,antidepressants,,,TGFBR3,rs12082710,Efficacy
739,pharmgkb,antipsychotics,,,ZNF804A,rs1344706,Efficacy
740,pharmgkb,enalapril,5362032.0,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,ADRB2,rs1042714,Efficacy
741,pharmgkb,benazepril,5362124.0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,AGT,rs7079,Efficacy
742,pharmgkb,candesartan,2541.0,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,CYP11B2,rs1799998,Efficacy
743,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,,rs16965962,Toxicity
744,pharmgkb,cytarabine,6253.0,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,CDA,rs60369023,Other
745,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,ABCB1,rs10248420,Efficacy
746,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,HTR3A,rs1062613,Efficacy
747,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,HTR3A,rs2276302,Efficacy
748,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PPARA,rs4253778,Efficacy
749,pharmgkb,flunisolide,82153.0,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1C[C@@H]4[C@]2(OC(O4)(C)C)C(=O)CO)C[C@@H](C5=CC(=O)C=C[C@]35C)F)O,TBXT,rs2305089,Efficacy
750,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,DCK,rs66878317,Other
751,pharmgkb,pitrakinra,,,IL4R,rs1110470,Efficacy
752,pharmgkb,pitrakinra,,,IL4R,rs3024530,Efficacy
753,pharmgkb,pitrakinra,,,IL4R,rs1805010,Efficacy
754,pharmgkb,pitrakinra,,,IL4R,rs2239347,Efficacy
755,pharmgkb,pitrakinra,,,IL4R,rs1029489,Efficacy
756,pharmgkb,rituximab,,,TGFB1,rs1800471,Efficacy
757,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,SLCO1B1,rs4149056,Dosage
758,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,SV2C,rs11960832,Efficacy
759,pharmgkb,l-tryptophan,6305.0,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)N,SLC22A2,rs316019,Other
760,pharmgkb,memantine,4054.0,CC12CC3CC(C1)(CC(C3)(C2)N)C,NR1I2,rs1523130,Other
761,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,PPARA,rs4823613,Efficacy
762,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,PPARA,rs4253728,Efficacy
763,pharmgkb,talinolol,,,ABCB1,rs1045642,Other
764,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs9552679,Efficacy
765,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,WNK1,rs880054,Efficacy
766,pharmgkb,antipsychotics,,,HSPG2,rs878949,Toxicity
767,pharmgkb,antipsychotics,,,HSPG2,rs2445142,Toxicity
768,pharmgkb,antipsychotics,,,GABRG3,rs2061051,Toxicity
769,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,ADRB2,rs1042713,Toxicity
770,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,,rs238,Efficacy
771,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,PRKCA,rs4791040,Efficacy
772,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,,rs4815273,Efficacy
773,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,,rs2776546,Efficacy
774,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,UGT1A9,rs17868320,Toxicity
775,pharmgkb,Bisphosphonates,,,MEX3C,rs17751934,Toxicity
776,pharmgkb,antineoplastic agents,,,DPYD,rs1760217,Efficacy
777,pharmgkb,antineoplastic agents,,,SERPINA3,rs17091162,Efficacy
778,pharmgkb,nortriptyline,4543.0,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,SLC39A14,rs17060812,Efficacy
779,pharmgkb,Bisphosphonates,,,RBMS3,rs17024608,Efficacy
780,pharmgkb,Bisphosphonates,,,ABCC4,rs1678387,Toxicity
781,pharmgkb,Bisphosphonates,,,CSRNP3,rs7588295,Toxicity
782,pharmgkb,Bisphosphonates,,,ALDH1A2,rs12903202,Efficacy
783,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,CLOCK,rs1522113,Efficacy
784,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs1423515,Efficacy
785,pharmgkb,"Thiazides, plain",,,SLC12A3,rs13306673,Efficacy
786,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,SLC30A8,rs13266634,Efficacy
787,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],TPMT,"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C",Toxicity
788,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,PEAR1,rs12041331,Toxicity
789,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs11252394,Efficacy
790,pharmgkb,sirolimus,6436030.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,CYP3A4,rs2740574,Other
791,pharmgkb,timolol,33624.0,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5",Other
792,pharmgkb,didanosine,50599.0,C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O,XDH,rs1594160,Toxicity
793,pharmgkb,didanosine,50599.0,C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O,XDH,rs1429376,Toxicity
794,pharmgkb,didanosine,50599.0,C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O,NT5C2,rs11191561,Toxicity
795,pharmgkb,didanosine,50599.0,C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O,NT5C2,rs11598702,Toxicity
796,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,DRD2,rs1124493,Other
797,pharmgkb,lovastatin,53232.0,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CYP2D6,"CYP2D6*1, CYP2D6*5, CYP2D6*10",Other
798,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,SLC19A1,rs1051266,Efficacy
799,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,SLCO1B1,rs2306283,Efficacy
800,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,CDA,rs602950,Toxicity
801,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,ABCB1,rs1045642,Efficacy
802,pharmgkb,nifedipine,4485.0,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,CYP3A5,rs776746,Other
803,pharmgkb,methacholine,1993.0,CC(C[N+](C)(C)C)OC(=O)C,ADRB2,rs1042713,Efficacy
804,pharmgkb,sipoglitazar,9825652.0,CCOC1=NN(C=C1CCC(=O)O)CC2=CC=C(C=C2)OCC3=CSC(=N3)C4=CC=CC=C4,UGT2B15,"UGT2B15*1, UGT2B15*2",Efficacy
805,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CYP3A4,rs28371759,Other
806,pharmgkb,indinavir,5362440.0,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,UGT1A1,rs4148323,Toxicity
807,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,IL6,rs1800795,Efficacy
808,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLC22A5,rs2631372,Efficacy
809,pharmgkb,carvedilol,2585.0,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,UGT1A1,rs4148323,Other
810,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,ABCC11,rs7194667,Toxicity
811,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PPARA,rs9626730,Efficacy
812,pharmgkb,Drugs used in alcohol dependence,,,GATA4,rs13273672,Efficacy
813,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,KCNJ1,rs11600347,Toxicity
814,pharmgkb,Bisphosphonates,,,SFRP5,rs11189381,Toxicity
815,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,DHFR,rs1105525,Efficacy
816,pharmgkb,amiodarone,2157.0,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,NOS1AP,rs10800397,Toxicity
817,pharmgkb,"Antiinflammatory agents, non-steroids",,,CDKN2B-AS1,rs10757274,Toxicity
818,pharmgkb,debrisoquine,2966.0,C1CN(CC2=CC=CC=C21)C(=N)N,CYP2D6,rs1080985,Other
819,pharmgkb,zonisamide,5734.0,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,HLA-A,HLA-A*02:07,Toxicity
820,pharmgkb,antipsychotics,,,BDNF-AS,rs10501087,Efficacy
821,pharmgkb,antipsychotics,,,BDNF,rs6265,Efficacy
822,pharmgkb,antipsychotics,,,BDNF,rs11030104,Efficacy
823,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,VEGFA,rs2010963,Efficacy
824,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,SLCO2B1,rs12422149,Efficacy
825,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,MOB3B,rs7046653,Efficacy
826,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SLC29A1,rs9394992,Toxicity
827,pharmgkb,Bisphosphonates,,,TBC1D32,rs7740004,Toxicity
828,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,SLCO1B3,rs7311358,Other
829,pharmgkb,sildenafil,5212.0,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,VEGFA,rs699947,Efficacy
830,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,VEGFA,rs699947,Toxicity
831,pharmgkb,"Antiinflammatory agents, non-steroids",,,AGT,rs699,Toxicity
832,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,TNFAIP3,rs6920220,Efficacy
833,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,STK39,rs6749447,Efficacy
834,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,KCNJ1,rs658903,Toxicity
835,pharmgkb,antipsychotics,,,HTR2A,rs6311,Efficacy
836,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,TOP1,rs6072262,Toxicity
837,pharmgkb,eculizumab,,,C5,rs56040400,Efficacy
838,pharmgkb,exemestane,60198.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,,rs934635,Toxicity
839,pharmgkb,exemestane,60198.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,,rs16964189,Toxicity
840,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,,rs9936750,Toxicity
841,pharmgkb,glyburide,3488.0,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,G6PD,"G6PD A- 202A_376G, G6PD B (reference)",Toxicity
842,pharmgkb,glyburide,3488.0,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,G6PD,rs5030868,Toxicity
843,pharmgkb,chloramphenicol,298.0,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],G6PD,"G6PD A- 202A_376G, G6PD B (reference)",Toxicity
844,pharmgkb,phenazopyridine,4756.0,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N,G6PD,"G6PD B (reference), G6PD Mediterranean Haplotype",Toxicity
845,pharmgkb,nitrofurantoin,5353830.0,C1C(=O)NC(=O)N1/N=C\C2=CC=C(O2)[N+](=O)[O-],G6PD,"G6PD A- 202A_376G, G6PD B (reference)",Toxicity
846,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,ABCB1,rs1045642,Efficacy
847,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,CDA,rs60369023,Toxicity
848,pharmgkb,ondansetron,4595.0,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,SLC6A4,rs1042173,Efficacy
849,pharmgkb,clomipramine,2801.0,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Toxicity
850,pharmgkb,ondansetron,4595.0,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Efficacy
851,pharmgkb,enalapril,5362032.0,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,NR3C2,rs5522,Efficacy
852,pharmgkb,opioids,,,COMT,rs4633,Other
853,pharmgkb,opioids,,,COMT,rs6269,Other
854,pharmgkb,opioids,,,COMT,rs4818,Other
855,pharmgkb,platinum,,,ERCC5,rs17655,Efficacy
856,pharmgkb,rhodamine 123,,,ABCB1,rs1045642,Other
857,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,DCK,rs4694362,Toxicity
858,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SLC28A3,rs7867504,Other
859,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,FPGS,rs7856096,Dosage
860,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,BMP5,rs41271330,Efficacy
861,pharmgkb,diltiazem,39186.0,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,PLCD3,rs12946454,Efficacy
862,pharmgkb,radiotherapy,,,TANC1,rs264663,Toxicity
863,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,GRM3,rs274618,Other
864,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,GRM3,rs1990040,Other
865,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,GRM3,rs13242038,Other
866,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,GRM3,rs724226,Other
867,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,GRM3,rs2189814,Other
868,pharmgkb,dimercaprol,3080.0,C(C(CS)S)O,G6PD,"G6PD A- 202A_376G, G6PD B (reference)",Toxicity
869,pharmgkb,ciprofloxacin,2764.0,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,G6PD,"G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",Toxicity
870,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,G6PD,"G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",Toxicity
871,pharmgkb,sulfadoxine,17134.0,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,G6PD,"G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",Toxicity
872,pharmgkb,sulfasalazine,5359476.0,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O,G6PD,"G6PD A- 202A_376G, G6PD B (reference)",Toxicity
873,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-DRB1,HLA-DRB1*14:01,Toxicity
874,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-DRB1,HLA-DRB1*09:01,Toxicity
875,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,MYLIP,rs9370867,Efficacy
876,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1476413,Efficacy
877,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs17421511,Efficacy
878,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ATIC,rs16853826,Toxicity
879,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ATIC,rs10197559,Toxicity
880,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,DHFR,rs1643650,Efficacy
881,pharmgkb,vincristine,5978.0,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,CAPG,rs3770102,Toxicity
882,pharmgkb,vincristine,5978.0,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,ABCB1,rs4728709,Toxicity
883,pharmgkb,vincristine,5978.0,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,ABCB1,rs1045642,Efficacy
884,pharmgkb,vincristine,5978.0,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,ACTG1,rs1135989,Toxicity
885,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-DRB1,HLA-DRB1*03:01,Toxicity
886,pharmgkb,debrisoquine,2966.0,C1CN(CC2=CC=CC=C21)C(=N)N,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*9, CYP2D6*38",Other
887,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-C,HLA-C*03:02,Toxicity
888,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-DRB1,HLA-DRB1*15:02,Toxicity
889,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-DRB1,HLA-DRB1*13:02,Toxicity
890,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,,rs2844665,Toxicity
891,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,PSORS1C3,rs3094188,Toxicity
892,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,POU5F1,rs3130501,Toxicity
893,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,POU5F1,rs3130931,Toxicity
894,pharmgkb,sparteine,,,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*7, CYP2D6*8, CYP2D6*11, CYP2D6*12, CYP2D6*41, CYP2D6*59, CYP2D6*62",Other
895,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,KCNQ5,rs9351963,Toxicity
896,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,BCL2L11,rs724710,Efficacy
897,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,PPARA,rs4823613,Other
898,pharmgkb,Platinum compounds,,,ATP7B,rs9535828,Efficacy
899,pharmgkb,Platinum compounds,,,ATP7B,rs9535826,Efficacy
900,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,NR1I2,rs2276706,Other
901,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,NR1I2,rs3814058,Other
902,pharmgkb,opioids,,,OPRD1,rs2236861,Other
903,pharmgkb,opioids,,,GAL,rs948854,Other
904,pharmgkb,opioids,,,OPRM1,rs9479757,Other
905,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,PTGS2,rs4648287,Toxicity
906,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,PLA2G4A,rs10157410,Toxicity
907,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,GALNT2,rs2144297,Toxicity
908,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,GALNT2,rs2144300,Other
909,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,ABCB1,rs3213619,Toxicity
910,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,ABCB1,rs10267099,Toxicity
911,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,FTO,rs12595985,Toxicity
912,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,FTO,rs9940629,Toxicity
913,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-A,HLA-A*02:01,Toxicity
914,pharmgkb,itopride,,,FMO3,rs2266782,Other
915,pharmgkb,itopride,,,FMO3,rs2266780,Other
916,pharmgkb,hmg coa reductase inhibitors,,,HLA-G,rs1063320,Efficacy
917,pharmgkb,dextromethorphan,5360696.0,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*5, CYP2D6*13, CYP2D6*31, CYP2D6*69, CYP2D6*100, CYP2D6*101",Other
918,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-B,HLA-B*48:01,Toxicity
919,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-C,HLA-C*08:01,Toxicity
920,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,ITGB3,rs5918,Efficacy
921,pharmgkb,trichloroethylene,6575.0,C(=C(Cl)Cl)Cl,HLA-B,HLA-B*13:01,Toxicity
922,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*13:02,Toxicity
923,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-B,HLA-B*15:18,Toxicity
924,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*15:19,Toxicity
925,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*15:27,Toxicity
926,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*27:09,Toxicity
927,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*38:02,Toxicity
928,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*48:04,Toxicity
929,pharmgkb,antiepileptics,,,HLA-B,HLA-B*58:01,Toxicity
930,pharmgkb,acetazolamide,1986.0,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,HLA-B,HLA-B*59:01,Toxicity
931,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-B,HLA-B*59:01,Toxicity
932,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,ABCB1,rs1045642,Other
933,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,ABCC2,rs2273697,Toxicity
934,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs7200749,Dosage
935,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs7200749,Dosage
936,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs61742245,Dosage
937,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs55894764,Dosage
938,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs17878544,Dosage
939,pharmgkb,sulfasalazine,5359476.0,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O,HLA-B,HLA-B*39:01,Toxicity
940,pharmgkb,sulfasalazine,5359476.0,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O,HLA-B,HLA-B*13:01,Toxicity
941,pharmgkb,sulfasalazine,5359476.0,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O,HLA-B,HLA-B*15:05,Toxicity
942,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,PPARA,rs4253728,Dosage
943,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,UGT1A9,rs2003569,Efficacy
944,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,CNR1,rs6454674,Other
945,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,CNR1,rs806368,Other
946,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,NR1I2,rs7643645,Metabolism/PK
947,pharmgkb,bevacizumab,,,CFH,rs1061170,Dosage
948,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,,rs478437,Efficacy
949,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,E2F7,rs310786,Efficacy
950,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,E2F7,rs310786,Toxicity
951,pharmgkb,antidepressants,,,CREB1,rs889895,Efficacy
952,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,GSTM3,rs1799735,Metabolism/PK
953,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,ANKK1,rs1800497,Metabolism/PK
954,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6",Toxicity
955,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,TPMT,"TPMT*1, TPMT*3A, TPMT*3C",Toxicity
956,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,UGT1A1,"UGT1A1*1, UGT1A1*28",Toxicity
957,pharmgkb,galantamine,9651.0,CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*41",Metabolism/PK
958,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC22A1,rs628031,Efficacy
959,pharmgkb,Platinum compounds,,,XBP1,rs2269577,"Efficacy,Toxicity"
960,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2B6,rs58425034,Other
961,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,HTR1A,rs6295,Efficacy
962,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,ABCC2,rs12762549,"Toxicity,Metabolism/PK"
963,pharmgkb,deferiprone,2972.0,CC1=C(C(=O)C=CN1C)O,UGT1A6,rs6759892,"Efficacy,Toxicity"
964,pharmgkb,ethanol,702.0,CCO,ADH1B,rs1229984,Metabolism/PK
965,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC22A1,rs72552763,Metabolism/PK
966,pharmgkb,pemetrexed,60843.0,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,DHFR,rs442767,Toxicity
967,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,SLCO1B1,rs4149056,Toxicity
968,pharmgkb,atomoxetine,54841.0,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,SLC6A2,rs3785143,Efficacy
969,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,ABCB1,rs1045642,Other
970,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,TBXA2R,rs4523,Efficacy
971,pharmgkb,bevacizumab,,,CXCL8,rs4073,Efficacy
972,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,CYP2C8,rs11572076,Toxicity
973,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,DAPK1,rs11141915,Toxicity
974,pharmgkb,rituximab,,,IL2,rs6822844,Efficacy
975,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,CYP2B6,"CYP2B6*1, CYP2B6*6","Efficacy,Toxicity"
976,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,BDNF,rs7124442,Efficacy
977,pharmgkb,doxorubicin,31703.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,GSTA1,rs3957357,Efficacy
978,pharmgkb,ustekinumab,,,HLA-C,HLA-C*06:02,Efficacy
979,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs76387818,Toxicity
980,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs12022243,Toxicity
981,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,ENOSF1,rs2741171,Toxicity
982,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,GRIN1,rs1126442,Toxicity
983,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,IL11,rs1126757,Efficacy
984,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,EGFR,rs2293347,Efficacy
985,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,DRD3,rs6280,Efficacy
986,pharmgkb,egfr inhibitors,,,EGFR,rs2227983,Toxicity
987,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,UGT1A1,UGT1A1*60,Efficacy
988,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,CYP3A5,rs776746,"Dosage,Toxicity"
989,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,HLA-DPB1,HLA-DPB1*04:01,Toxicity
990,pharmgkb,"Antiinflammatory agents, non-steroids",,,HLA-DRB1,HLA-DRB1*11:01,Toxicity
991,pharmgkb,tiotropium,5487426.0,C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C.[Br-],ADRB2,rs1042713,Efficacy
992,pharmgkb,topiramate,5284627.0,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,GRIK1,rs2832407,"Efficacy,Metabolism/PK"
993,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,ORM2,rs2250242,Metabolism/PK
994,pharmgkb,"sulfonamides, urea derivatives",,,KCNJ11,rs5219,Efficacy
995,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,ABCC2,rs2273697,Metabolism/PK
996,pharmgkb,Platinum compounds,,,ERCC3,rs3738948,Efficacy
997,pharmgkb,Platinum compounds,,,XPA,rs1800975,Efficacy
998,pharmgkb,Platinum compounds,,,ERCC4,rs1799801,Efficacy
999,pharmgkb,Platinum compounds,,,APLF,rs3213239,Efficacy
1000,pharmgkb,Platinum compounds,,,ERCC2,rs13181,Toxicity
1001,pharmgkb,Platinum compounds,,,CXXC4,rs4413407,Efficacy
1002,pharmgkb,Platinum compounds,,,WNT5B,rs12819505,Efficacy
1003,pharmgkb,Platinum compounds,,,WIF1,rs10878232,Efficacy
1004,pharmgkb,Platinum compounds,,,AXIN2,rs11868547,Efficacy
1005,pharmgkb,Platinum compounds,,,AXIN2,rs4541111,Efficacy
1006,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTR,rs3768142,Toxicity
1007,pharmgkb,antidepressants,,,CRHR1,rs28364032,Efficacy
1008,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,NEDD4L,rs520210,Efficacy
1009,pharmgkb,rosiglitazone,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,PAX4,rs6467136,Efficacy
1010,pharmgkb,pemetrexed,60843.0,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,DHFR,rs1650697,Toxicity
1011,pharmgkb,pemetrexed,60843.0,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,GGH,rs11545078,Toxicity
1012,pharmgkb,pemetrexed,60843.0,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,FOLR3,rs61734430,Efficacy
1013,pharmgkb,pemetrexed,60843.0,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,SLC19A1,rs3788189,Efficacy
1014,pharmgkb,pemetrexed,60843.0,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,SLC19A1,rs914232,Efficacy
1015,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,ABCB1,rs1045642,Toxicity
1016,pharmgkb,Platinum compounds,,,ERCC2,rs1052555,Efficacy
1017,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-B,HLA-B*51:01,Toxicity
1018,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,CYP2D6,rs28360521,Toxicity
1019,pharmgkb,carvedilol,2585.0,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,ADRB2,rs1042714,Efficacy
1020,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,CHIA,rs3818822,Toxicity
1021,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,"UGT1A,UGT1A9",rs8330,Toxicity
1022,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,SLC30A9,rs1047626,Toxicity
1023,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,HLA-DPB1,rs3097671,Toxicity
1024,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,HLA-DPB1,rs1042136,Toxicity
1025,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,HLA-DPB1,rs1042151,Toxicity
1026,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,HLA-DPB2,rs3129294,Toxicity
1027,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,,rs1074373,Toxicity
1028,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,TSC1,rs7862221,Toxicity
1029,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,THRA,rs11819745,Toxicity
1030,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,CAPN10,rs3792269,Efficacy
1031,pharmgkb,latanoprost,5282380.0,CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O,PTGS1,rs10306114,Efficacy
1032,pharmgkb,latanoprost,5282380.0,CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O,ABCC4,rs11568658,Efficacy
1033,pharmgkb,pioglitazone,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,ADIPOQ,rs2241766,Efficacy
1034,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,SOD2,rs4880,Toxicity
1035,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLC22A4,rs1050152,Efficacy
1036,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,,rs10747673,Efficacy
1037,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SP1,rs2683511,"Efficacy,Metabolism/PK"
1038,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,PPARA,rs149711321,"Efficacy,Metabolism/PK"
1039,pharmgkb,hmg coa reductase inhibitors,,,CELSR2,rs646776,Efficacy
1040,pharmgkb,hmg coa reductase inhibitors,,,SLCO1B1,rs2900478,Efficacy
1041,pharmgkb,hmg coa reductase inhibitors,,,,rs445925,Efficacy
1042,pharmgkb,caffeine,2519.0,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,CYP1A2,"CYP1A2*1A, CYP1A2*1F",Toxicity
1043,pharmgkb,clonidine,2803.0,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,GNB3,rs5443,Efficacy
1044,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,GSTT1,"GSTT1 non-null, GSTT1 null",Efficacy
1045,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2B6,rs2054675,Toxicity
1046,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2B6,rs3786547,Toxicity
1047,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HRH3,rs3787430,Efficacy
1048,pharmgkb,rituximab,,,TGFB1,rs1800470,Efficacy
1049,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNFRSF10A,rs20575,Efficacy
1050,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLC22A5,rs2631367,Efficacy
1051,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,UGT1A6,rs2070959,Toxicity
1052,pharmgkb,haloperidol,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,COMT,rs4680,Toxicity
1053,pharmgkb,eculizumab,,,CR1,rs2274567,Efficacy
1054,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,VEGFA,rs35864111,Efficacy
1055,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,VEGFA,rs13207351,Efficacy
1056,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCG2,rs12505410,Efficacy
1057,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCG2,rs13120400,Efficacy
1058,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCG2,rs2725252,Efficacy
1059,pharmgkb,levodopa,6047.0,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,HOMER1,rs4704559,Toxicity
1060,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,GGCX,rs2592551,Dosage
1061,pharmgkb,busulfan,2478.0,CS(=O)(=O)OCCCCOS(=O)(=O)C,CYP2C19,rs12248560,Metabolism/PK
1062,pharmgkb,busulfan,2478.0,CS(=O)(=O)OCCCCOS(=O)(=O)C,CYP2C9,rs1799853,Metabolism/PK
1063,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP2B6,rs3745274,"Efficacy,Toxicity"
1064,pharmgkb,corticosteroids,,,HDAC1,rs1741981,Efficacy
1065,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,,rs11265572,Metabolism/PK
1066,pharmgkb,sulfasalazine,5359476.0,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O,ABCG2,rs2231142,Efficacy
1067,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLC22A1,rs683369,"Efficacy,Metabolism/PK"
1068,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,UGT1A9,rs3806598,Metabolism/PK
1069,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,UGT1A9,rs2741049,Metabolism/PK
1070,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CYP3A4,rs4646437,"Efficacy,Metabolism/PK"
1071,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,IL1B,rs4848306,Efficacy
1072,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,IL1RN,rs4251961,Efficacy
1073,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TLR9,rs352139,Efficacy
1074,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TLR2,rs4696480,Efficacy
1075,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TLR2,rs1816702,Efficacy
1076,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TLR2,rs3804099,Efficacy
1077,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,CD14,rs2569190,Efficacy
1078,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,IL17A,rs2275913,Efficacy
1079,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNFAIP3,rs6927172,Efficacy
1080,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,IL6,rs10499563,Efficacy
1081,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TLR4,rs5030728,Efficacy
1082,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,CNPY4,rs1554973,Efficacy
1083,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNFRSF1A,rs4149570,Efficacy
1084,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,IFNG,rs2430561,Efficacy
1085,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,KCNQ1,rs2237895,Toxicity
1086,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,IL10,rs1800896,Dosage
1087,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,IL10,rs1800872,Dosage
1088,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,IL10,rs1800871,Dosage
1089,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs1045642,Toxicity
1090,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,CMPK1,rs11211524,Efficacy
1091,pharmgkb,hmg coa reductase inhibitors,,,ABCB1,rs1045642,Other
1092,pharmgkb,methylphenobarbital,8271.0,CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*16",Metabolism/PK
1093,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,CDA,rs1048977,Other
1094,pharmgkb,vitamin e,14985.0,CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O,CYP4F2,rs2108622,Metabolism/PK
1095,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs28933389,Toxicity
1096,pharmgkb,isoproterenol,3779.0,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,ADRB2,rs1042713,Other
1097,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,NTRK2,rs10465180,Efficacy
1098,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,NTRK2,rs1778929,Efficacy
1099,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,FKBP5,rs1360780,Efficacy
1100,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,TRAF3IP2,rs76228616,Toxicity
1101,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,TAPBP,rs1059288,Toxicity
1102,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,TAPBP,rs2071888,Toxicity
1103,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCG2,rs2231142,Metabolism/PK
1104,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,,rs10792367,Efficacy
1105,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,STX4,rs10871454,Dosage
1106,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,rs4086116,Dosage
1107,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,FMO1,rs10912675,Other
1108,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,FMO1,rs7877,Other
1109,pharmgkb,XK469,148183.0,CC(C(=O)O)OC1=CC=C(C=C1)OC2=CN=C3C=CC(=CC3=N2)Cl,AOX1,rs10931910,Metabolism/PK
1110,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,RRAS2,rs11023197,Efficacy
1111,pharmgkb,celecoxib,2662.0,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,ALOX12,rs11078659,"Efficacy,Toxicity"
1112,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,UGT2B10,rs112561475,Metabolism/PK
1113,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,PTGIR,rs1126510,Toxicity
1114,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,OCRL,rs113165732,Other
1115,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,,rs1155463,Toxicity
1116,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR1B,rs11568817,Toxicity
1117,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PAPLN,rs11628713,Toxicity
1118,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,,rs11719165,Toxicity
1119,pharmgkb,verapamil,2520.0,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,NR1H3,rs12221497,Toxicity
1120,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2C19,rs12768009,Metabolism/PK
1121,pharmgkb,hmg coa reductase inhibitors,,,CFAP44,rs13064411,Efficacy
1122,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,PTGER2,rs1353411,Toxicity
1123,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs376817657,Metabolism/PK
1124,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs140471703,Metabolism/PK
1125,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs143690364,Metabolism/PK
1126,pharmgkb,levodopa,6047.0,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,DBH,rs1611115,Efficacy
1127,pharmgkb,timolol,33624.0,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,,rs16947,Toxicity
1128,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC4,rs9516519,Toxicity
1129,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,CYP3A5,rs776746,Metabolism/PK
1130,pharmgkb,"Antiinflammatory agents, non-steroids",,,PTGS1,rs10306135,Toxicity
1131,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,THBD,rs1042580,Toxicity
1132,pharmgkb,radiotherapy,,,CDK1,rs10711,Toxicity
1133,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,FGD4,rs10771973,Toxicity
1134,pharmgkb,radiotherapy,,,PRKCE,rs11125035,Toxicity
1135,pharmgkb,enalapril,5362032.0,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,BDKRB2,rs1799722,Efficacy
1136,pharmgkb,Bisphosphonates,,,KCNT2,rs1886629,Toxicity
1137,pharmgkb,sildenafil,5212.0,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,NOS3,rs2070744,Efficacy
1138,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNF,rs1799964,Efficacy
1139,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,ALDH5A1,rs2760118,Efficacy
1140,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CCL2,rs2857657,Efficacy
1141,pharmgkb,phenobarbital,4763.0,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,ABCB1,rs1045642,Efficacy
1142,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,CYP2C19,rs4244285,Toxicity
1143,pharmgkb,etravirine,193962.0,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,CYP2C19,rs4244285,Metabolism/PK
1144,pharmgkb,atomoxetine,54841.0,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,SLC6A2,rs12708954,Efficacy
1145,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,ALG10,rs1705772,Toxicity
1146,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,FMO3,rs1736557,Efficacy
1147,pharmgkb,"Ace Inhibitors, Plain",,,ACE,rs1799752,Toxicity
1148,pharmgkb,timolol,33624.0,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,ADRB1,rs1801252,Efficacy
1149,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,,rs342293,Efficacy
1150,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,EPHX1,rs1877724,Dosage
1151,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,,rs1901440,Toxicity
1152,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,ABCB1,rs2032582,Efficacy
1153,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,PTGER2,rs2075797,Toxicity
1154,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,GDNF,rs2216711,Efficacy
1155,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC2,rs8187707,Toxicity
1156,pharmgkb,haloperidol,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,,rs7912580,Efficacy
1157,pharmgkb,vardenafil,110634.0,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,CYP3A5,rs776746,Metabolism/PK
1158,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,PTGER3,rs7551789,Toxicity
1159,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,ACE,rs4292,Toxicity
1160,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,ACE,rs4291,Toxicity
1161,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,TLR3,rs3775291,Toxicity
1162,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,AGT,rs5050,Toxicity
1163,pharmgkb,haloperidol,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,EIF2AK4,rs2412459,Efficacy
1164,pharmgkb,celecoxib,2662.0,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,IL23R,rs7518660,Toxicity
1165,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,UGT2B7,rs7438135,Toxicity
1166,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC16A7,rs3763980,Efficacy
1167,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,,rs642990,Toxicity
1168,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,,rs578427,Metabolism/PK
1169,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC47A2,rs34834489,Metabolism/PK
1170,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC22A1,rs36056065,Toxicity
1171,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,FLT4,rs307826,Efficacy
1172,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,FLT4,rs307821,Efficacy
1173,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,SLCO1B1,rs4149081,Efficacy
1174,pharmgkb,enalapril,5362032.0,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,,rs495828,Toxicity
1175,pharmgkb,Selective serotonin reuptake inhibitors,,,DRD2,rs2734833,Efficacy
1176,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,,rs2433320,Efficacy
1177,pharmgkb,verapamil,2520.0,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,NR1H3,rs2279238,Toxicity
1178,pharmgkb,celecoxib,2662.0,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PTGES,rs2302821,Toxicity
1179,pharmgkb,fexofenadine,3348.0,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,SLCO2B1,rs2306168,Metabolism/PK
1180,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,GDNF,rs2973049,Efficacy
1181,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,HNF4A,rs3212198,Dosage
1182,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,AHR,rs4410790,Metabolism/PK
1183,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,TPH2,rs4570625,Efficacy
1184,pharmgkb,thiazolidinediones,,,AQP2,rs296766,Toxicity
1185,pharmgkb,hmg coa reductase inhibitors,,,ADAMTS1,rs402007,Efficacy
1186,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,TCF7L2,rs4132670,Toxicity
1187,pharmgkb,celecoxib,2662.0,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PTGER4,rs4133101,Toxicity
1188,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNFRSF1B,rs3397,Efficacy
1189,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNFRSF1B,rs1061631,Efficacy
1190,pharmgkb,etoposide,36462.0,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,,rs446112,Efficacy
1191,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,TCF7L2,rs4506565,Toxicity
1192,pharmgkb,naltrexone,5360515.0,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,OPRD1,rs4654327,Efficacy
1193,pharmgkb,entacapone,5281081.0,CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N,COMT,rs4680,Efficacy
1194,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CACNA1C,rs1006737,Toxicity
1195,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,GRIN3A,rs10121600,Other
1196,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,COL26A1,rs10279545,Toxicity
1197,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,ARRB2,rs1045280,Other
1198,pharmgkb,estradiol,5757.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O,,rs11849538,Other
1199,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs1044397,Other
1200,pharmgkb,etoposide,36462.0,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,ABCB1,rs1045642,Metabolism/PK
1201,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,ABCC2,rs3740066,Metabolism/PK
1202,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLCO1A2,rs3764043,Metabolism/PK
1203,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,GPR83,rs3758785,Efficacy
1204,pharmgkb,candesartan,2541.0,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,GPR83,rs3758785,Efficacy
1205,pharmgkb,"Ace Inhibitors, Plain",,,AGTR1,rs5182,Toxicity
1206,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,RORA,rs809736,Efficacy
1207,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,DTNBP1,rs760761,Efficacy
1208,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CACNA1C,rs10848635,Toxicity
1209,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CRHR2,rs2270007,Efficacy
1210,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,,rs585719,Efficacy
1211,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,,rs6127921,Efficacy
1212,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,,rs6966038,Efficacy
1213,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,IL1B,rs16944,Efficacy
1214,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,rs776746,Toxicity
1215,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,rs776746,Toxicity
1216,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,ABCB1,rs2032582,Efficacy
1217,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,LEPR,rs1137101,Efficacy
1218,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,LEPR,rs1137101,Efficacy
1219,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,ABCB1,rs1045642,Metabolism/PK
1220,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs11045872,Metabolism/PK
1221,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs11045821,Metabolism/PK
1222,pharmgkb,lovastatin,53232.0,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,SLCO1B1,rs2291073,Efficacy
1223,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,SLCO1B1,rs4149032,Metabolism/PK
1224,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,SLCO1B1,rs4149036,Efficacy
1225,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,COMT,rs4680,Efficacy
1226,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,,rs4675690,Toxicity
1227,pharmgkb,Selective serotonin reuptake inhibitors,,,SLC1A1,rs301434,Efficacy
1228,pharmgkb,Selective serotonin reuptake inhibitors,,,SLC1A1,rs301435,Efficacy
1229,pharmgkb,Selective serotonin reuptake inhibitors,,,SLC1A1,rs3087879,Efficacy
1230,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,CHAT,rs1880676,Efficacy
1231,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,DRD2,rs2734841,Toxicity
1232,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,DRD2,rs2734842,Toxicity
1233,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,CHAT,rs3810950,Efficacy
1234,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,CYP3A43,rs472660,Metabolism/PK
1235,pharmgkb,Influenza vaccines,,,HLA-DQB1,HLA-DQB1*06:02,Toxicity
1236,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,HLA-DRB3,HLA-DRB3*02:02,Toxicity
1237,pharmgkb,ticlopidine,5472.0,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,HLA-B,HLA-B*44:03,Toxicity
1238,pharmgkb,methylene blue,6099.0,,G6PD,"G6PD A- 202A_376G, G6PD B (reference)","Efficacy,Toxicity"
1239,pharmgkb,ticlopidine,5472.0,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,HLA-C,HLA-C*14:03,Toxicity
1240,pharmgkb,pazopanib,11525740.0,,UGT1A1,"UGT1A1*1, UGT1A1*6, UGT1A1*28, UGT1A1*37",Toxicity
1241,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC22A11,rs11231809,Efficacy
1242,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC1,rs246240,Efficacy
1243,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC1,rs3784864,Efficacy
1244,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SLC29A1,rs760370,Efficacy
1245,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,TCF7L2,rs7917983,Toxicity
1246,pharmgkb,propofol,4943.0,CC(C)C1=C(C(=CC=C1)C(C)C)O,CYP2B6,rs3745274,Dosage
1247,pharmgkb,antithymocyte globulin,,,FCGR3A,rs396991,Other
1248,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*59",Dosage
1249,pharmgkb,Pertussis vaccines,,,TLR4,rs2770150,Efficacy
1250,pharmgkb,Pertussis vaccines,,,TLR4,rs4986790,Efficacy
1251,pharmgkb,daunorubicin,30323.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O,NOS3,rs1799983,Efficacy
1252,pharmgkb,melphalan,4053.0,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,SLC7A5,rs4240803,Toxicity
1253,pharmgkb,naltrexone,5360515.0,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,DBH,rs1611115,Efficacy
1254,pharmgkb,salvianolic acid b,6441188.0,C1=CC(=C(C=C1C[C@H](C(=O)O)OC(=O)/C=C/C2=C3[C@H]([C@@H](OC3=C(C=C2)O)C4=CC(=C(C=C4)O)O)C(=O)OC(CC5=CC(=C(C=C5)O)O)C(=O)O)O)O,NOS3,rs1799983,Efficacy
1255,pharmgkb,antipsychotics,,,COMT,rs4680,Toxicity
1256,pharmgkb,antipsychotics,,,COMT,rs4680,Toxicity
1257,pharmgkb,cotinine,854019.0,CN1[C@@H](CCC1=O)C2=CN=CC=C2,NAT1,rs13253389,Metabolism/PK
1258,pharmgkb,rocuronium,441290.0,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,SLCO1B1,rs2306283,Efficacy
1259,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,ABCB1,rs9282564,Toxicity
1260,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC4,rs7317112,Toxicity
1261,pharmgkb,adalimumab,,,ATG16L1,rs10210302,Efficacy
1262,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,LEPR,rs1137101,Toxicity
1263,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,ANKK1,rs1800497,Toxicity
1264,pharmgkb,bilirubin,5280352.0,CC1=C(NC(=C1CCC(=O)O)CC2=C(C(=C(N2)/C=C\3/C(=C(C(=O)N3)C)C=C)C)CCC(=O)O)/C=C\4/C(=C(C(=O)N4)C=C)C,UGT1A,rs11563250,Metabolism/PK
1265,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,UGT1A,rs11563250,Toxicity
1266,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,rs1934969,Metabolism/PK
1267,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,SOD2,rs4880,Toxicity
1268,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP2C8,rs1113129,Toxicity
1269,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,ERCC1,rs3212986,Toxicity
1270,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,ERCC1,rs11615,Toxicity
1271,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,POR,rs1057868,Efficacy
1272,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,HTR1A,rs6295,Efficacy
1273,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,COMT,rs4680,Efficacy
1274,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,HSD11B1,rs846908,Metabolism/PK
1275,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,HSD11B1,rs4844880,Metabolism/PK
1276,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,HSD11B1,rs846910,Metabolism/PK
1277,pharmgkb,haloperidol,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,ABCB5,rs17143212,Toxicity
1278,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,GSTP1,rs1138272,Efficacy
1279,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,UGT1A4,rs3732219,Other
1280,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,UGT1A4,rs3732218,Other
1281,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,CYP2C19,"CYP2C19*1, CYP2C19*2",Other
1282,pharmgkb,benazepril,5362124.0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,MTHFR,rs1801133,Efficacy
1283,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,VEGFA,rs1570360,Efficacy
1284,pharmgkb,daptomycin,16129629.0,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,ABCB1,rs1045642,Metabolism/PK
1285,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNFRSF1A,rs767455,Efficacy
1286,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,ILKAP,rs113095083,Efficacy
1287,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,TET2,rs12505746,Efficacy
1288,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,FBXL17,rs7706429,Efficacy
1289,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,FBXL17,rs4431329,Efficacy
1290,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,,rs9285669,Efficacy
1291,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,CSMD1,rs11993031,Efficacy
1292,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,CSMD1,rs7387065,Efficacy
1293,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,SLIT1,rs11189015,Efficacy
1294,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,DIAPH3,rs77876672,Efficacy
1295,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,UGGT2,rs9590353,Efficacy
1296,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,ANKFN1,rs9915451,Efficacy
1297,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC22A3,rs2076828,Efficacy
1298,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,rs11959113,Dosage
1299,pharmgkb,erlotinib,176870.0,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,CYP1A2,rs2472304,Metabolism/PK
1300,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,BDNF,rs6265,Efficacy
1301,pharmgkb,antipsychotics,,,IL1B,rs16944,Toxicity
1302,pharmgkb,antipsychotics,,,IL1B,rs1143634,Toxicity
1303,pharmgkb,antipsychotics,,,BDNF,rs6265,Toxicity
1304,pharmgkb,dextromethorphan,5360696.0,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*36, CYP2D6*40, CYP2D6*42, CYP2D6*56",Other
1305,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,KCNJ6,rs2835859,Dosage
1306,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,POLG,rs3087374,Toxicity
1307,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,,rs1364805,Efficacy
1308,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,GALNT17,rs7794356,Efficacy
1309,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,MLLT3,rs6475448,Efficacy
1310,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,,rs953977,Efficacy
1311,pharmgkb,cytarabine,6253.0,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,ABCB1,rs1128503,Efficacy
1312,pharmgkb,liraglutide,44147092.0,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N,GLP1R,rs10305420,Efficacy
1313,pharmgkb,liraglutide,44147092.0,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N,GLP1R,rs6923761,Efficacy
1314,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC22A2,rs316019,Other
1315,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,CYP2B6,rs3211371,Efficacy
1316,pharmgkb,ketamine,3821.0,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,CYP2B6,"CYP2B6*1, CYP2B6*6",Metabolism/PK
1317,pharmgkb,anthracyclines and related substances,,,ECT2L,rs11155012,Efficacy
1318,pharmgkb,asparaginase,,,HLA-DRB1,rs17885382,Toxicity
1319,pharmgkb,asparaginase,,,NFATC2,rs6021191,Toxicity
1320,pharmgkb,vancomycin,14969.0,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,,rs2789047,Metabolism/PK
1321,pharmgkb,"Ace Inhibitors, Plain",,,KCNIP4,rs6838116,Toxicity
1322,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,CXCL8,rs1126647,Toxicity
1323,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,IL13,rs1800925,Toxicity
1324,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,,rs12346562,Efficacy
1325,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,rs1104514,Efficacy
1326,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,rs10739150,Efficacy
1327,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,UGT2B7,rs7439366,Dosage
1328,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,NR1I2,rs6785049,Toxicity
1329,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,LGR5,rs17109924,Efficacy
1330,pharmgkb,"adrenergics, inhalants",,,,rs34548976,Efficacy
1331,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,,rs12461964,Dosage
1332,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,,rs113288603,Metabolism/PK
1333,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,FMO5,rs7541245,Efficacy
1334,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,ABCC2,rs8187710,Toxicity
1335,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,ABCC2,rs717620,Toxicity
1336,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,FDPS,rs2297480,Other
1337,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,NR1I2,rs4688040,Metabolism/PK
1338,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,GRIA3,rs4825476,Toxicity
1339,pharmgkb,Beta Blocking Agents,,,GNB3,rs5443,Other
1340,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,rs8192709,Metabolism/PK
1341,pharmgkb,calcium channel blockers,,,TANC2,rs2429427,Efficacy
1342,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP3A4,rs2242480,Toxicity
1343,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,ABCB1,rs2032582,Toxicity
1344,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,IL10,rs1800896,Toxicity
1345,pharmgkb,cilostazol,2754.0,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
1346,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,CYP2C19,rs4244285,Toxicity
1347,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,CYP2B6,rs4802101,"Toxicity,Metabolism/PK"
1348,pharmgkb,varenicline,5310966.0,C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23,CHRNA4,rs1044396,Efficacy
1349,pharmgkb,Opium alkaloids and derivatives,,,CHRNA3,rs1051730,Toxicity
1350,pharmgkb,amodiaquine,2165.0,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,CYP2C8,rs11572080,Toxicity
1351,pharmgkb,amodiaquine,2165.0,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O,CYP2C8,rs10509681,Toxicity
1352,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP1A2,rs762551,Efficacy
1353,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,P2RY12,rs6809699,Efficacy
1354,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,P2RY12,rs6787801,Efficacy
1355,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CES1P1,rs3785161,Efficacy
1356,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9934438,Efficacy
1357,pharmgkb,midazolam,4192.0,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,CYP3A4,rs35599367,Other
1358,pharmgkb,antipsychotics,,,,rs9346455,Toxicity
1359,pharmgkb,letrozole,3902.0,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,CYP19A1,rs3759811,Other
1360,pharmgkb,letrozole,3902.0,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,CYP19A1,rs4775936,Other
1361,pharmgkb,letrozole,3902.0,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,CYP19A1,rs749292,Other
1362,pharmgkb,letrozole,3902.0,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,CYP19A1,rs700518,Other
1363,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,NQO1,rs1800566,Dosage
1364,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC4,rs1059751,Toxicity
1365,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,VEGFA,rs1570360,Efficacy
1366,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,KDR,rs2239702,Efficacy
1367,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,VEGFA,rs2010963,Toxicity
1368,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,ABCB1,rs1045642,Toxicity
1369,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,ABCC2,rs717620,Metabolism/PK
1370,pharmgkb,letrozole,3902.0,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,ESR1,rs4870061,Toxicity
1371,pharmgkb,agomelatine,82148.0,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,ABCB1,rs1045642,Efficacy
1372,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,ABCB1,rs1045642,Efficacy
1373,pharmgkb,Selective serotonin reuptake inhibitors,,,ABCB1,rs1045642,Efficacy
1374,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,LRRC15,rs11313667,Efficacy
1375,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,LRRC15,rs11313667,Efficacy
1376,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,LRRC15,rs11313667,Efficacy
1377,pharmgkb,rivastigmine,77991.0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,CHAT,rs2177370,Efficacy
1378,pharmgkb,galantamine,9651.0,CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O,CHAT,rs2177370,Efficacy
1379,pharmgkb,donepezil,3152.0,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,CHAT,rs2177370,Efficacy
1380,pharmgkb,telmisartan,65999.0,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,GNB3,rs5443,Efficacy
1381,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,DRD3,rs6280,Metabolism/PK
1382,pharmgkb,modafinil,4236.0,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,ABCB1,rs1045642,Efficacy
1383,pharmgkb,silibinin,31553.0,COC1=C(C=CC(=C1)[C@@H]2[C@H](OC3=C(O2)C=C(C=C3)[C@@H]4[C@H](C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,ABCB1,rs1045642,Metabolism/PK
1384,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,DRD2,rs1076560,Efficacy
1385,pharmgkb,modafinil,4236.0,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,ABCB1,rs1128503,Efficacy
1386,pharmgkb,amisulpride,2159.0,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,DRD2,rs1079597,Efficacy
1387,pharmgkb,corticosteroids,,,ST13,rs138335,Efficacy
1388,pharmgkb,corticosteroids,,,ST13,rs138337,Efficacy
1389,pharmgkb,fluvoxamine,3404.0,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,FGF2,rs1449683,Efficacy
1390,pharmgkb,antipsychotics,,,ADCY2,rs1544938,Efficacy
1391,pharmgkb,antipsychotics,,,NRG1,rs17716295,Efficacy
1392,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,CYP2B6,"CYP2B6*1, CYP2B6*6",Metabolism/PK
1393,pharmgkb,infliximab,,,FCGR3A,rs396991,Efficacy
1394,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,ABCB1,rs1045642,Toxicity
1395,pharmgkb,Antihypertensives,,,ATP2B1,rs12817819,Efficacy
1396,pharmgkb,antipsychotics,,,GRM3,rs6465084,Efficacy
1397,pharmgkb,antipsychotics,,,GRM3,rs1468412,Toxicity
1398,pharmgkb,antipsychotics,,,NRXN1,rs12467557,Efficacy
1399,pharmgkb,antipsychotics,,,NRXN1,rs10490162,Efficacy
1400,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,HMGCR,rs17671591,Efficacy
1401,pharmgkb,bevacizumab,,,ARMS2,rs10490924,Efficacy
1402,pharmgkb,Drugs For Treatment Of Tuberculosis,,,CYP2E1,"CYP2E1*1A, CYP2E1*5B",Toxicity
1403,pharmgkb,ethanol,702.0,CCO,CAT,rs1001179,Other
1404,pharmgkb,Hepatitis vaccines,,,IL13,rs1295686,Efficacy
1405,pharmgkb,Hepatitis vaccines,,,IL4R,rs1805015,Efficacy
1406,pharmgkb,imiquimod,57469.0,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,TLR7,rs179008,Efficacy
1407,pharmgkb,infliximab,,,TNF,rs361525,Efficacy
1408,pharmgkb,voriconazole,71616.0,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,CYP3A4,rs4646437,Metabolism/PK
1409,pharmgkb,regadenoson,219024.0,CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,AMPD1,rs17602729,Toxicity
1410,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCG2,rs2231135,Toxicity
1411,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,DHFR,rs1650723,Toxicity
1412,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,DHFR,rs1053129,Efficacy
1413,pharmgkb,pegloticase,,,G6PD,G6PD A- 202A_376G,Toxicity
1414,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,rs776746,Toxicity
1415,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP3A5,rs776746,Efficacy
1416,pharmgkb,lovastatin,53232.0,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CYP3A5,rs776746,Efficacy
1417,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,ADAMTS1,rs428785,Efficacy
1418,pharmgkb,peginterferon alfa-2b,71306834.0,,HLA-DPA1,rs3077,Efficacy
1419,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,HLA-B,HLA-B*15:13,Toxicity
1420,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs1045642,Toxicity
1421,pharmgkb,selective beta-2-adrenoreceptor agonists,,,VDR,rs1540339,Efficacy
1422,pharmgkb,selective beta-2-adrenoreceptor agonists,,,VDR,rs2239179,Efficacy
1423,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,GRIN2B,rs1072388,Efficacy
1424,pharmgkb,Selective serotonin reuptake inhibitors,,,PLCB1,rs6108160,Efficacy
1425,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,GIPR,rs10423928,Toxicity
1426,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CCL2,rs4586,Efficacy
1427,pharmgkb,Selective serotonin reuptake inhibitors,,,,rs10514475,Efficacy
1428,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,HTR2A,rs6314,Efficacy
1429,pharmgkb,Platinum compounds,,,HOTAIR,rs7958904,Efficacy
1430,pharmgkb,enalapril,5362032.0,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,SLCO1B1,rs4149056,Toxicity
1431,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,SLCO1B1,rs2306283,Efficacy
1432,pharmgkb,antipsychotics,,,,rs2513265,Efficacy
1433,pharmgkb,Platinum compounds,,,MALAT1,rs619586,Efficacy
1434,pharmgkb,Platinum compounds,,,H19,rs2839698,Efficacy
1435,pharmgkb,milnacipran,65833.0,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2,ADRA2A,rs1800544,Efficacy
1436,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP7A1,rs3808607,Efficacy
1437,pharmgkb,Platinum compounds,,,,rs6983267,Efficacy
1438,pharmgkb,modafinil,4236.0,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,ABCB1,rs2032582,Efficacy
1439,pharmgkb,exemestane,60198.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,ESR1,rs2813543,Toxicity
1440,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,REV3L,rs462779,Efficacy
1441,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,GSTA1,rs3957356,Efficacy
1442,pharmgkb,milnacipran,65833.0,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2,HTR1A,rs6295,Efficacy
1443,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,GRID2,rs1875705,Efficacy
1444,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,GRM7,rs2069062,Efficacy
1445,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,REV1,rs3087403,Efficacy
1446,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,IRS1,rs13431554,Efficacy
1447,pharmgkb,asparaginase,,,SOD2,rs4880,Toxicity
1448,pharmgkb,terbutaline,5403.0,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,ADRB2,rs1042714,Efficacy
1449,pharmgkb,Platinum compounds,,,ABCB1,rs1045642,Efficacy
1450,pharmgkb,voriconazole,71616.0,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,ABCB1,rs1045642,Metabolism/PK
1451,pharmgkb,nifedipine,4485.0,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,ADRA1A,rs1048101,Efficacy
1452,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,EPHX1,rs1051740,Efficacy
1453,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SLC28A2,rs1060896,"Efficacy,Toxicity"
1454,pharmgkb,infliximab,,,IL1B,rs1143634,Efficacy
1455,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,PROC,rs1799808,Dosage
1456,pharmgkb,catecholamines,,,ADRB1,rs1801253,Dosage
1457,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,,rs1805054,Toxicity
1458,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,RRM1,rs183484,Efficacy
1459,pharmgkb,enalapril,5362032.0,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,NOS3,rs2070744,Efficacy
1460,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SLC28A1,rs2242046,Toxicity
1461,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,ABCC2,rs3740065,Efficacy
1462,pharmgkb,ramipril,5362129.0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,ACE,rs4344,Efficacy
1463,pharmgkb,ramipril,5362129.0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,ACE,rs4359,Efficacy
1464,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,GGH,rs719235,Toxicity
1465,pharmgkb,nitrendipine,4507.0,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,AGTR1,rs5186,Efficacy
1466,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,AGTR1,rs5186,Efficacy
1467,pharmgkb,angiotensin II,65143.0,CC[C@H](C)C(C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N,AGTR1,rs5186,Efficacy
1468,pharmgkb,perindopril,107807.0,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,AGTR1,rs5186,Efficacy
1469,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,AGTR1,rs5186,Efficacy
1470,pharmgkb,quinapril,54892.0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O,AGT,rs699,Efficacy
1471,pharmgkb,icotinib,22024915.0,C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Other
1472,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,ABCC10,rs2125739,Metabolism/PK
1473,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CCHCR1,rs1265112,Toxicity
1474,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CCHCR1,rs130072,Toxicity
1475,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,TCF19,rs2073724,Toxicity
1476,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,POLR3G,rs2562519,Toxicity
1477,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,,rs6545803,Toxicity
1478,pharmgkb,pemetrexed,60843.0,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,SLC19A1,rs1051298,Efficacy
1479,pharmgkb,tipifarnib,,,ABCB1,rs1128503,Metabolism/PK
1480,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,DRD2,rs1799732,Efficacy
1481,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,DRD2,rs1799732,Efficacy
1482,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,GRIN2B,rs1019385,Dosage
1483,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs17701271,Efficacy
1484,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs17495520,Efficacy
1485,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs1419555,Efficacy
1486,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs1663330,Efficacy
1487,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs1663332,Efficacy
1488,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs518350,Efficacy
1489,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs6002674,Efficacy
1490,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,EGFR,rs2293347,Efficacy
1491,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,rs8192719,Metabolism/PK
1492,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,EGFR,rs712829,Efficacy
1493,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,DAOA,rs778293,Toxicity
1494,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,DUSP1,rs881152,Efficacy
1495,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,HTR1A,rs878567,Toxicity
1496,pharmgkb,ethanol,702.0,CCO,TAS2R16,rs846664,Toxicity
1497,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,,rs2056527,Efficacy
1498,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,POR,rs1057868,Metabolism/PK
1499,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,PROX1,rs340874,Toxicity
1500,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,UGT1A9,rs11692021,Toxicity
1501,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,UGT1A9,rs72551344,Metabolism/PK
1502,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,UGT1A9,rs34993780,Metabolism/PK
1503,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,UGT1A9,rs35350960,Metabolism/PK
1504,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,CYP3A4,rs4986910,Efficacy
1505,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,LIPC,rs1800588,Efficacy
1506,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,ACE,rs4341,Efficacy
1507,pharmgkb,lovastatin,53232.0,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,LDLR,rs688,Efficacy
1508,pharmgkb,lovastatin,53232.0,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,LDLR,rs5925,Efficacy
1509,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,ABCB1,rs1128503,Efficacy
1510,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,ABCB1,rs1128503,Toxicity
1511,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,ABCC2,rs113646094,Metabolism/PK
1512,pharmgkb,nelfinavir,64143.0,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O,CYP2C19,rs4244285,Metabolism/PK
1513,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,"CYP2B6*27, CYP2B6*28",Other
1514,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,LEPR,rs1805094,Efficacy
1515,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,FKBP5,rs73748206,Other
1516,pharmgkb,cefotaxime,456256.0,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O,SLC22A8,rs11568482,Metabolism/PK
1517,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,NEDD4L,rs292449,Efficacy
1518,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,DRD2,rs2283265,Toxicity
1519,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*5, CYP2C19*6, CYP2C19*7, CYP2C19*8",Metabolism/PK
1520,pharmgkb,"Ace Inhibitors, Plain",,,AGT,rs699,Efficacy
1521,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ULK3,rs2290573,Efficacy
1522,pharmgkb,corticosteroids,,,TBX21,rs2240017,Efficacy
1523,pharmgkb,flupirtine,53276.0,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N,HLA-DRB1,HLA-DRB1*16:01,Toxicity
1524,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-DQB1,HLA-DQB1*05:02,Toxicity
1525,pharmgkb,flupirtine,53276.0,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N,HLA-DQB1,HLA-DQB1*05:02,Toxicity
1526,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,DDC,rs12718541,Toxicity
1527,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,DRD1,rs265976,Efficacy
1528,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,ARRB2,rs2036657,Toxicity
1529,pharmgkb,cannabinoids,,,FAAH,rs324420,Toxicity
1530,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,CYP3A4,rs2740574,Toxicity
1531,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,RRM1,rs9937,"Efficacy,Toxicity"
1532,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,ABCB1,rs2032582,Dosage
1533,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,ABCB1,rs1128503,Dosage
1534,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,GRK4,rs1801058,Efficacy
1535,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,APOA1,rs2727786,Efficacy
1536,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,LPL,rs320,Efficacy
1537,pharmgkb,"Thiazides, plain",,,ACE,rs4341,Toxicity
1538,pharmgkb,"Thiazides, plain",,,AGTR1,rs5186,Toxicity
1539,pharmgkb,"Thiazides, plain",,,GNB3,rs5443,Toxicity
1540,pharmgkb,antiepileptics,,,ABCB1,rs3789243,Efficacy
1541,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,PPARG,rs1801282,Toxicity
1542,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,rs36118214,Metabolism/PK
1543,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,PON1,rs705379,Efficacy
1544,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ADGRL3,rs1947275,Efficacy
1545,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ADGRL3,rs6813183,Efficacy
1546,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ADGRL3,rs1355368,Efficacy
1547,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ADGRL3,rs734644,Efficacy
1548,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,NAT2,rs4271002,Toxicity
1549,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,IGFBP3,rs2854744,Efficacy
1550,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,,rs2960436,Efficacy
1551,pharmgkb,perindopril,107807.0,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,AGTR1,rs275651,Efficacy
1552,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*17","Efficacy,Metabolism/PK"
1553,pharmgkb,perindopril,107807.0,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,BDKRB1,rs12050217,Efficacy
1554,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,ABCB1,rs1128503,Toxicity
1555,pharmgkb,leflunomide,3899.0,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,ESR1,rs2234693,Efficacy
1556,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,TBXAS1,rs6962291,Toxicity
1557,pharmgkb,antipsychotics,,,LEPR,rs1137101,Toxicity
1558,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,VEGFA,rs2010963,Efficacy
1559,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,,rs4604006,Efficacy
1560,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,NOS3,rs2070744,Efficacy
1561,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,NOS3,rs1799983,Efficacy
1562,pharmgkb,tegafur,5386.0,,CYP2A6,rs8192725,Other
1563,pharmgkb,tegafur,5386.0,,CYP2A6,rs28399433,Other
1564,pharmgkb,tegafur,5386.0,,CYP2A6,rs8192720,Other
1565,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,DRD2,rs1799978,Dosage
1566,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP3A4,rs3735451,Toxicity
1567,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP3A4,rs4646440,Toxicity
1568,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP3A4,rs4646437,Toxicity
1569,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP3A4,rs2246709,Toxicity
1570,pharmgkb,lithium,28486.0,[Li+],OR52E2,rs16909440,Efficacy
1571,pharmgkb,lithium,28486.0,[Li+],ASIC2,rs11869731,Efficacy
1572,pharmgkb,lithium,28486.0,[Li+],,rs16973410,Efficacy
1573,pharmgkb,somatropin recombinant,,,COL1A1,rs1800012,Dosage
1574,pharmgkb,testosterone,6013.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,UGT1A4,"UGT1A4*1a, UGT1A4*3a",Metabolism/PK
1575,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2D6,rs28371706,Metabolism/PK
1576,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC22A1,rs594709,Efficacy
1577,pharmgkb,bevacizumab,,,CFH,rs800292,Efficacy
1578,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs6600879,"Efficacy,Toxicity"
1579,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs6600880,"Efficacy,Toxicity"
1580,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs4554144,"Efficacy,Toxicity"
1581,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs11940316,"Efficacy,Toxicity"
1582,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs7438135,"Efficacy,Toxicity"
1583,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs7662029,"Efficacy,Toxicity"
1584,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs7439366,"Efficacy,Toxicity"
1585,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs4292394,"Efficacy,Toxicity"
1586,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs6600893,"Efficacy,Toxicity"
1587,pharmgkb,topotecan,60700.0,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O,ABCG2,rs4148157,Metabolism/PK
1588,pharmgkb,difluorodeoxyuridine,,,CDA,rs4655226,Metabolism/PK
1589,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,CMPK1,rs1044457,Efficacy
1590,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,NT5C3A,rs3750117,Metabolism/PK
1591,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SH2D5,rs10916852,Efficacy
1592,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,CMPK1,rs7543016,Efficacy
1593,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,TENT4A,rs274713,Efficacy
1594,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,CMPK1,rs35687416,Efficacy
1595,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,DCTD,rs12507552,Efficacy
1596,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,TENT4A,rs274717,Efficacy
1597,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,CDC5L,rs992160,Efficacy
1598,pharmgkb,exemestane,60198.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,AKR1C3,rs62621365,Metabolism/PK
1599,pharmgkb,exemestane,60198.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,AKR1C4,rs11253043,Metabolism/PK
1600,pharmgkb,corticosteroids,,,TAAR6,rs7772821,Efficacy
1601,pharmgkb,dimethyl fumarate,637568.0,COC(=O)/C=C/C(=O)OC,GSTP1,rs1695,Efficacy
1602,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,COL1A1,rs1800012,Toxicity
1603,pharmgkb,ranibizumab,,,NRP1,rs2070296,Efficacy
1604,pharmgkb,topiramate,5284627.0,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,INSR,rs2396185,Efficacy
1605,pharmgkb,asparaginase,,,CPA2,rs199695765,Toxicity
1606,pharmgkb,antipsychotics,,,ABCB1,rs1045642,Dosage
1607,pharmgkb,tolperisone,5511.0,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*5",Metabolism/PK
1608,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP1A2,rs762551,Metabolism/PK
1609,pharmgkb,cotinine,854019.0,CN1[C@@H](CCC1=O)C2=CN=CC=C2,,rs77107237,Metabolism/PK
1610,pharmgkb,antipsychotics,,,ABCB1,rs2032582,Dosage
1611,pharmgkb,phenobarbital,4763.0,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,HLA-B,HLA-B*51:01,Toxicity
1612,pharmgkb,cotinine,854019.0,CN1[C@@H](CCC1=O)C2=CN=CC=C2,PSMA4,rs57064725,Metabolism/PK
1613,pharmgkb,cotinine,854019.0,CN1[C@@H](CCC1=O)C2=CN=CC=C2,CHRNA3,rs7170068,Metabolism/PK
1614,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,PRKCB,rs11649514,Toxicity
1615,pharmgkb,sulfinpyrazone,5342.0,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4,UGT1A9,rs72551330,Metabolism/PK
1616,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,NR1I3,rs2307424,Metabolism/PK
1617,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,NR1I3,rs3003596,Metabolism/PK
1618,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,NR1I2,rs3814055,Metabolism/PK
1619,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,NR1I2,rs2461817,Metabolism/PK
1620,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,NR1I2,rs7643645,Metabolism/PK
1621,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,UGT2B7,rs28365063,Metabolism/PK
1622,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,ABCB1,rs4148740,Metabolism/PK
1623,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,ABCB1,rs4148739,Metabolism/PK
1624,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A4,rs2740574,Metabolism/PK
1625,pharmgkb,Dipeptidyl peptidase 4 (DPP-4) inhibitors,,,CDKAL1,rs7756992,Efficacy
1626,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,VAC14,rs875858,Toxicity
1627,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs12132152,Toxicity
1628,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs115632870,Other
1629,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs72728438,Other
1630,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,TYMS,rs2847153,Efficacy
1631,pharmgkb,rivastigmine,77991.0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,BCHE,rs1803274,Efficacy
1632,pharmgkb,donepezil,3152.0,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6",Other
1633,pharmgkb,irbesartan,3749.0,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,CYP2C9,rs1057910,"Efficacy,Metabolism/PK"
1634,pharmgkb,rivastigmine,77991.0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,ACHE,rs2571598,Efficacy
1635,pharmgkb,ritonavir,392622.0,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,ABCB1,rs2032582,Metabolism/PK
1636,pharmgkb,irbesartan,3749.0,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,CYP2C9,rs72558187,Metabolism/PK
1637,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,GRM3,rs274622,Other
1638,pharmgkb,endoxifen,10090750.0,CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3,,rs4386686,Other
1639,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,UGT1A9,rs3832043,Other
1640,pharmgkb,antineoplastic agents,,,RBFOX1,rs6500843,Efficacy
1641,pharmgkb,enalapril,5362032.0,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,VEGFA,rs699947,Efficacy
1642,pharmgkb,brivaracetam,9837243.0,CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Metabolism/PK
1643,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,ABCC2,rs717620,Efficacy
1644,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,NR1I2,rs10934498,Metabolism/PK
1645,pharmgkb,vitamin e,14985.0,CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O,CYP4F2,rs3093105,Metabolism/PK
1646,pharmgkb,mycophenolic acid,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,UGT1A9,rs3832043,Metabolism/PK
1647,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,NR1I2,rs3732360,Toxicity
1648,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,,rs11185648,Toxicity
1649,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,RXRA,rs62576288,Toxicity
1650,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,RXRA,rs1536475,Toxicity
1651,pharmgkb,antiepileptics,,,,rs16935279,Metabolism/PK
1652,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,ABCC2,rs4148386,Metabolism/PK
1653,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,LRP2,rs2228171,Toxicity
1654,pharmgkb,busulfan,2478.0,CS(=O)(=O)OCCCCOS(=O)(=O)C,GSTA1,rs3957357,Metabolism/PK
1655,pharmgkb,calcium channel blockers,,,NUMA1,rs10898815,Efficacy
1656,pharmgkb,calcium channel blockers,,,PICALM,rs588076,Efficacy
1657,pharmgkb,hmg coa reductase inhibitors,,,SREBF1,rs11868035,Toxicity
1658,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,SLCO1B1,rs11045819,Metabolism/PK
1659,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,SLCO1B1,rs2306283,Metabolism/PK
1660,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,HNF4A,rs2273618,Toxicity
1661,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,HNF4A,rs3746574,Toxicity
1662,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,RXRA,rs6413517,Toxicity
1663,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,HNF4A,rs6130615,Toxicity
1664,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,NR1I3,rs9725457,Toxicity
1665,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,NR1I3,rs2502815,Toxicity
1666,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,NR1I3,rs2501873,Toxicity
1667,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,NR1I3,rs10538494,Toxicity
1668,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,NR1I3,rs75114882,Toxicity
1669,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,NR1I2,rs3732359,Toxicity
1670,pharmgkb,indinavir,5362440.0,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,CYP3A4,rs2740574,Other
1671,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP2C8,rs11572080,Toxicity
1672,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC22A1,rs622342,Efficacy
1673,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,NR1I2,rs3814058,Toxicity
1674,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,RGS4,rs2661319,Efficacy
1675,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,RXRA,rs2234753,Toxicity
1676,pharmgkb,sulfasalazine,5359476.0,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O,ABCG2,rs72552713,Metabolism/PK
1677,pharmgkb,cytarabine,6253.0,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,CDA,rs2072671,Toxicity
1678,pharmgkb,opioids,,,COMT,rs4680,Other
1679,pharmgkb,antipsychotics,,,DRD2,rs1799732,Toxicity
1680,pharmgkb,antidepressants,,,HTR2A,rs6314,Efficacy
1681,pharmgkb,Photodynamic therapy,,,F13A1,rs5985,Efficacy
1682,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,SLCO1B3,rs4149117,"Dosage,Toxicity"
1683,pharmgkb,interferons,,,STAT3,rs4796793,Efficacy
1684,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,PICK1,rs713729,Other
1685,pharmgkb,antidepressants,,,,rs521093,Efficacy
1686,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CTLA4,rs231775,Toxicity
1687,pharmgkb,antidepressants,,,FHIT,rs49411,Efficacy
1688,pharmgkb,antidepressants,,,MTRF1L,rs766127,Efficacy
1689,pharmgkb,antidepressants,,,RGS17,rs672170,Efficacy
1690,pharmgkb,antidepressants,,,PON2,rs2299267,Efficacy
1691,pharmgkb,antidepressants,,,CTNNA3,rs10997242,Efficacy
1692,pharmgkb,antidepressants,,,CACNA1A,rs2112460,Efficacy
1693,pharmgkb,antidepressants,,,,rs2831440,Efficacy
1694,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,DRD1,rs4532,Other
1695,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,DRD1,rs686,Other
1696,pharmgkb,adalimumab,,,HFE,rs2071303,Efficacy
1697,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,LDLR,rs1433099,Efficacy
1698,pharmgkb,adalimumab,,,TF,rs1799852,Efficacy
1699,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,LDLR,rs2738466,Efficacy
1700,pharmgkb,dexamethasone,5743.0,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,SERPINE1,rs6092,Toxicity
1701,pharmgkb,ticagrelor,9871419.0,CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO,UGT2B7,rs61361928,Metabolism/PK
1702,pharmgkb,ticagrelor,9871419.0,CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO,CYP3A4,rs56324128,Metabolism/PK
1703,pharmgkb,ticagrelor,9871419.0,CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO,SLCO1B1,rs4149056,Metabolism/PK
1704,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,TPMT,rs12201199,Other
1705,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,TPMT,rs17839843,Other
1706,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,TPMT,rs3931660,Other
1707,pharmgkb,adalimumab,,,CRP,rs1130864,Efficacy
1708,pharmgkb,adalimumab,,,ATG5,rs510432,Efficacy
1709,pharmgkb,rasagiline,3052776.0,C#CCN[C@@H]1CCC2=CC=CC=C12,DRD2,rs1076560,Efficacy
1710,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,,rs10945919,Efficacy
1711,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,CERS6,rs13393173,Efficacy
1712,pharmgkb,rasagiline,3052776.0,C#CCN[C@@H]1CCC2=CC=CC=C12,DRD2,rs2283265,Efficacy
1713,pharmgkb,telaprevir,3010818.0,CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5,CYP24A1,rs2585428,Metabolism/PK
1714,pharmgkb,bisoprolol,2405.0,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,ACY3,rs2514036,Efficacy
1715,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,NPHS1,rs3814995,Efficacy
1716,pharmgkb,mycophenolic acid,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,ABCC2,rs3740066,Metabolism/PK
1717,pharmgkb,mycophenolic acid,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,SLCO1B1,rs2306283,Metabolism/PK
1718,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,NCOA1,rs1804645,Toxicity
1719,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,LRMDA,rs10509373,Efficacy
1720,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,GALR1,rs2717162,Efficacy
1721,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,GALR1,rs2717162,Efficacy
1722,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,ABCB1,rs1128503,Toxicity
1723,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,DOT1L,rs2269879,Efficacy
1724,pharmgkb,midazolam,4192.0,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,VDR,rs1544410,Metabolism/PK
1725,pharmgkb,midazolam,4192.0,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,VDR,rs4516035,Metabolism/PK
1726,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRM2,rs324650,Other
1727,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ARID5B,rs10994982,Metabolism/PK
1728,pharmgkb,dabigatran,,,ABCB1,rs4148738,Metabolism/PK
1729,pharmgkb,dabigatran,,,CES1,rs2244613,Toxicity
1730,pharmgkb,dabigatran,,,CES1,rs8192935,Metabolism/PK
1731,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,SLC6A12,rs557881,Toxicity
1732,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,IMPDH1,rs2228075,Toxicity
1733,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,APOB,rs676210,Efficacy
1734,pharmgkb,cotinine,854019.0,CN1[C@@H](CCC1=O)C2=CN=CC=C2,CHRNA5,rs16969968,Metabolism/PK
1735,pharmgkb,Opium alkaloids and derivatives,,,CHRNA5,rs16969968,Toxicity
1736,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNB2,rs2072660,Toxicity
1737,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNB2,rs2072658,Other
1738,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs2229959,Other
1739,pharmgkb,stavudine,18283.0,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO,TNF,rs1799964,Toxicity
1740,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNB4,rs3813567,Toxicity
1741,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA3,rs3743078,Toxicity
1742,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA5,rs637137,Toxicity
1743,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA5,rs684513,Toxicity
1744,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,CYP1A2,rs2470890,Metabolism/PK
1745,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,CYP1A1,rs2606345,Metabolism/PK
1746,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,CYP1A2,rs762551,Metabolism/PK
1747,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,DRD3,rs6280,Toxicity
1748,pharmgkb,Dihydropyridine derivatives,,,NOS1AP,rs10494366,Toxicity
1749,pharmgkb,ethanol,702.0,CCO,CHRNA3,rs1051730,Other
1750,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,GNB3,rs5443,Toxicity
1751,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,ESR1,rs2234693,Toxicity
1752,pharmgkb,amphetamine,3007.0,C[C@@H](CC1=CC=CC=C1)N,DRD2,rs12364283,Other
1753,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,GRIN3A,rs11788456,Other
1754,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,KCNJ6,rs2070995,Other
1755,pharmgkb,Analgesics,,,KCNJ6,rs2070995,Efficacy
1756,pharmgkb,flucloxacillin,21319.0,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,NR1I2,rs3814055,Toxicity
1757,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,NOS1AP,rs10494366,Efficacy
1758,pharmgkb,ethanol,702.0,CCO,CHRNA3,rs578776,Other
1759,pharmgkb,ethanol,702.0,CCO,CHRNA5,rs615470,Other
1760,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,CHRNA5,rs684513,Other
1761,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,IGF2BP2,rs4402960,Efficacy
1762,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,IGF2BP2,rs1470579,Efficacy
1763,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,SLC6A3,rs2975226,Efficacy
1764,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,CRP,rs1205,Efficacy
1765,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,,rs2808630,Efficacy
1766,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,DRD2,rs1125394,Other
1767,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,DRD2,rs6279,Other
1768,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,DRD2,rs6275,Other
1769,pharmgkb,ritonavir,392622.0,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,APOC3,rs2854116,Toxicity
1770,pharmgkb,ritonavir,392622.0,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,APOC3,rs2854117,Toxicity
1771,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,ABCB1,rs2032582,Toxicity
1772,pharmgkb,doxorubicin,31703.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,CBR1,rs9024,"Dosage,Metabolism/PK"
1773,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,"HSPA1A,HSPA1L",rs1043620,Toxicity
1774,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,rs71486745,Dosage
1775,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,ESR2,rs944050,Efficacy
1776,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,ABCG2,rs2199939,Efficacy
1777,pharmgkb,perindopril,107807.0,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,AGTR1,rs5182,Efficacy
1778,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,KCNJ11,rs5219,Efficacy
1779,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CAPN10,rs5030952,Toxicity
1780,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CCL2,rs4795893,Efficacy
1781,pharmgkb,alendronate,2088.0,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,MVK,rs10161126,Efficacy
1782,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,ERCC1,rs3212986,Toxicity
1783,pharmgkb,antipsychotics,,,IL1B,rs4849127,Toxicity
1784,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,ZBTB22,rs3130100,Toxicity
1785,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,CYP2B6,rs7254579,Metabolism/PK
1786,pharmgkb,cotinine,854019.0,CN1[C@@H](CCC1=O)C2=CN=CC=C2,CHRNB4,rs10851907,Metabolism/PK
1787,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,RXRA,rs11185647,Toxicity
1788,pharmgkb,letrozole,3902.0,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,ESR2,rs10140457,Toxicity
1789,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,HNF4A,rs1884613,Metabolism/PK
1790,pharmgkb,Platinum compounds,,,EIF3A,rs7091672,Toxicity
1791,pharmgkb,Platinum compounds,,,EIF3A,rs4752219,Toxicity
1792,pharmgkb,Platinum compounds,,,EIF3A,rs4752220,Toxicity
1793,pharmgkb,Platinum compounds,,,EIF3A,rs1409314,Toxicity
1794,pharmgkb,Platinum compounds,,,EIF3A,rs10510050,Toxicity
1795,pharmgkb,antidepressants,,,RAPGEF5,rs16873129,Efficacy
1796,pharmgkb,antidepressants,,,CRH,rs4737771,Efficacy
1797,pharmgkb,antidepressants,,,PARP11,rs2532560,Efficacy
1798,pharmgkb,antidepressants,,,NBEA,rs9315310,Efficacy
1799,pharmgkb,ticagrelor,9871419.0,CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO,CYP3A43,rs62471956,Metabolism/PK
1800,pharmgkb,ticagrelor,9871419.0,CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO,SLCO1B1,rs113681054,Metabolism/PK
1801,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNB4,rs2869950,Toxicity
1802,pharmgkb,busulfan,2478.0,CS(=O)(=O)OCCCCOS(=O)(=O)C,GSTM1,rs3754446,Metabolism/PK
1803,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,ARRB2,rs4790694,Toxicity
1804,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,PMCH,rs7973796,Toxicity
1805,pharmgkb,exemestane,60198.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,CYP19A1,rs7176005,Toxicity
1806,pharmgkb,antipsychotics,,,INSIG2,rs17587100,Toxicity
1807,pharmgkb,midazolam,4192.0,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,VDR,rs11568820,Metabolism/PK
1808,pharmgkb,asparaginase,,,GRIA1,rs4958381,Toxicity
1809,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,PTGS2,rs12042763,Efficacy
1810,pharmgkb,ethanol,702.0,CCO,CHRNA5,rs16969968,Other
1811,pharmgkb,aripiprazole,60795.0,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,TAAR6,rs4305746,Efficacy
1812,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,ADORA1,rs16851030,Toxicity
1813,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2B6,rs12721646,Other
1814,pharmgkb,triamcinolone,31307.0,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,HCG22,rs3873352,Toxicity
1815,pharmgkb,Selective serotonin reuptake inhibitors,,,DRD2,rs4460839,Efficacy
1816,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,TGFB1,rs1800469,Toxicity
1817,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC2,rs7917432,Toxicity
1818,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,OCRL,rs757639,Toxicity
1819,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,CYP1A1,rs2472297,Metabolism/PK
1820,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,IL1A,rs11677416,Efficacy
1821,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,LTC4S,rs730012,Efficacy
1822,pharmgkb,triamcinolone,31307.0,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,HCG22,rs2523864,Toxicity
1823,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,UGT1A6,rs1105879,Dosage
1824,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,CYP3A5,rs776746,Efficacy
1825,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,"LTA,TNF",rs1800629,Toxicity
1826,pharmgkb,leflunomide,3899.0,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,DHODH,rs3213422,Efficacy
1827,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,PON1,rs854547,Efficacy
1828,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,PON1,rs854548,Efficacy
1829,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,PON1,rs854555,Efficacy
1830,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9934438,Efficacy
1831,pharmgkb,erythromycin,12560.0,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,CYP3A4,rs35599367,Other
1832,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801131,Efficacy
1833,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HSPA1L,rs2227956,Toxicity
1834,pharmgkb,selective beta-2-adrenoreceptor agonists,,,ARG1,rs2781659,Efficacy
1835,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,COMT,rs165599,Efficacy
1836,pharmgkb,abacavir,441300.0,C1CC1NC2=NC(=NC3=C2N=CN3[C@@H]4C[C@@H](C=C4)CO)N,"LST1,LTA,LTB",rs3093726,Toxicity
1837,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR1B,rs6296,Toxicity
1838,pharmgkb,latanoprost,5282380.0,CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O,PTGFR,rs3766355,Efficacy
1839,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,UGT1A4,rs2011425,Metabolism/PK
1840,pharmgkb,tocilizumab,,,CD69,rs11052877,Efficacy
1841,pharmgkb,tocilizumab,,,GALNT18,rs4910008,Efficacy
1842,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,"CSNK2A3,GALNT18",rs7937567,Efficacy
1843,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,MLLT3,rs10964552,Efficacy
1844,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,RARS,rs244898,Efficacy
1845,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,CYCSP5,rs9469003,Toxicity
1846,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Dosage
1847,pharmgkb,zafirlukast,5717.0,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,CYP2C9,"CYP2C9*1, CYP2C9*3, CYP2C9*13",Metabolism/PK
1848,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,ITIH3,rs2535629,Efficacy
1849,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,"ADORA2A,ADORA2A-AS1",rs2298383,Toxicity
1850,pharmgkb,valganciclovir,64147.0,CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N,ABCC4,rs11568658,Toxicity
1851,pharmgkb,valganciclovir,64147.0,CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N,ABCB1,rs2229109,Toxicity
1852,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP3A5,rs776746,Metabolism/PK
1853,pharmgkb,dalcetrapib,6918540.0,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,ADCY9,rs1967309,"Efficacy,Toxicity"
1854,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,KDR,rs1870377,Efficacy
1855,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,rs776746,Toxicity
1856,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,GNMT,rs10948059,Toxicity
1857,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC2A2,rs8192675,Efficacy
1858,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,UGT1A9,rs7574296,Toxicity
1859,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,VEGFA,rs3025040,Toxicity
1860,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,,rs17180299,Metabolism/PK
1861,pharmgkb,Platinum compounds,,,ERCC2,rs1799793,Toxicity
1862,pharmgkb,Platinum compounds,,,ERCC2,rs50872,Toxicity
1863,pharmgkb,Platinum compounds,,,IL16,rs7170924,Toxicity
1864,pharmgkb,Platinum compounds,,,ABCB1,rs1128503,Toxicity
1865,pharmgkb,Platinum compounds,,,IL1B,rs12621220,Toxicity
1866,pharmgkb,Platinum compounds,,,IL1B,rs1143623,Toxicity
1867,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,POR,rs41301394,Dosage
1868,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,DDHD1,rs17126068,Dosage
1869,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,NEDD4,rs2288344,Dosage
1870,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,ASPH,rs4379440,Efficacy
1871,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,SLCO1B1,rs2306283,Toxicity
1872,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,SLCO1B1,rs4149056,Toxicity
1873,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,ABCC2,rs717620,Toxicity
1874,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,KDR,rs1870377,Toxicity
1875,pharmgkb,captopril,44093.0,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,ACE,rs4291,Efficacy
1876,pharmgkb,raloxifene,5035.0,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,ESR1,rs11543791,Efficacy
1877,pharmgkb,raloxifene,5035.0,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,UGT1A8,rs1042597,Efficacy
1878,pharmgkb,clindamycin,29029.0,CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl,HLA-B,HLA-B*51:01,Toxicity
1879,pharmgkb,clindamycin,29029.0,CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl,HLA-B,HLA-B*15:27,Toxicity
1880,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,B4GALT2,rs1061781,Efficacy
1881,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP4F2,rs2108622,Efficacy
1882,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,GGCX,rs11676382,Efficacy
1883,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,GGCX,rs699664,Efficacy
1884,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,GGCX,rs11676382,Efficacy
1885,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,CYP3A4,rs2740574,"Toxicity,Metabolism/PK"
1886,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*40:02,Toxicity
1887,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*15:01,Toxicity
1888,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-DRB1,HLA-DRB1*04:03,Toxicity
1889,pharmgkb,Antibiotics,,,LGALS3,rs11125,Toxicity
1890,pharmgkb,etanercept,,,CD84,rs6427528,Efficacy
1891,pharmgkb,ustekinumab,,,IL12B,rs3213094,Efficacy
1892,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,CUX2,rs7958375,Toxicity
1893,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,RIPOR2,rs10946739,Toxicity
1894,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,AGBL4,rs320003,Toxicity
1895,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,AGBL4,rs319952,Toxicity
1896,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,AGBL4,rs393994,Toxicity
1897,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CYP3A4,rs35599367,Metabolism/PK
1898,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,NR1I2,rs1523130,Metabolism/PK
1899,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,NR1I2,rs2276707,Metabolism/PK
1900,pharmgkb,hmg coa reductase inhibitors,,,,rs247616,Efficacy
1901,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A4,rs2242480,Metabolism/PK
1902,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A5,rs776746,"Dosage,Metabolism/PK"
1903,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,CYP3A5,rs15524,Metabolism/PK
1904,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,NQO1,rs10517,Dosage
1905,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,STX1B,rs72800847,Dosage
1906,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP1A1,rs3826041,Dosage
1907,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,DNMT3A,rs2304429,Dosage
1908,pharmgkb,rituximab,,,,rs3759467,Efficacy
1909,pharmgkb,rosiglitazone,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,SLCO1B1,rs4149056,Efficacy
1910,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,TGFB1,rs1800469,Toxicity
1911,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,TGFBR2,rs3087465,Toxicity
1912,pharmgkb,zileuton,60490.0,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,PRORP,rs12436663,Efficacy
1913,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,IL23R,rs11209026,Toxicity
1914,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,CTLA4,rs3087243,Toxicity
1915,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,SLC12A8,rs651630,Toxicity
1916,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,FBXL19,rs10782001,Toxicity
1917,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,COMT,rs5993883,Efficacy
1918,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,COMT,rs6269,Efficacy
1919,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,COMT,rs4818,Efficacy
1920,pharmgkb,furosemide,3440.0,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,ABCC4,rs17268282,Efficacy
1921,pharmgkb,granisetron,3510.0,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
1922,pharmgkb,granisetron,3510.0,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,CYP1A1,"CYP1A1*1, CYP1A1*2A",Metabolism/PK
1923,pharmgkb,interferon beta-1a,,,HLA-DRB1,HLA-DRB1*04:01,Efficacy
1924,pharmgkb,interferon beta-1a,,,HLA-B,HLA-B*15:01,Efficacy
1925,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,ABCB1,rs1128503,Toxicity
1926,pharmgkb,bevacizumab,,,EDN1,rs5370,Efficacy
1927,pharmgkb,bevacizumab,,,VEGFA,rs3025039,Efficacy
1928,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,ABCB1,rs1045642,Toxicity
1929,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,GSTM1,"GSTM1 non-null, GSTM1 null",Toxicity
1930,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,GSTT1,"GSTT1 non-null, GSTT1 null",Toxicity
1931,pharmgkb,antidepressants,,,NTRK2,rs1439050,Toxicity
1932,pharmgkb,antipsychotics,,,GRIK3,rs1334802,Toxicity
1933,pharmgkb,antipsychotics,,,SLC18A2,rs363341,Toxicity
1934,pharmgkb,antipsychotics,,,DRD2,rs1124491,Toxicity
1935,pharmgkb,antipsychotics,,,HTR2A,rs9567733,Toxicity
1936,pharmgkb,bevacizumab,,,CXCR4,rs2228014,Efficacy
1937,pharmgkb,exemestane,60198.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,CYP3A4,"CYP3A4*1, CYP3A4*22",Metabolism/PK
1938,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,PGLYRP4,rs2916205,Efficacy
1939,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,CTNNA2,rs11126740,Efficacy
1940,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,MAP3K1,rs96844,Efficacy
1941,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,IL12B,rs2546890,Efficacy
1942,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,CDKAL1,rs6908425,Efficacy
1943,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,HLA-C,rs12191877,Efficacy
1944,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,ZNF816,rs9304742,Efficacy
1945,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,IL17RA,rs4819554,Efficacy
1946,pharmgkb,levodopa,6047.0,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,DRD2,rs1799732,Toxicity
1947,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,HLA-B,HLA-B*38:01,Toxicity
1948,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-A,HLA-A*11:01,Toxicity
1949,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-C,HLA-C*08:01,Toxicity
1950,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,HLA-C,HLA-C*08:01,Toxicity
1951,pharmgkb,tocilizumab,,,IL6R,rs12083537,Efficacy
1952,pharmgkb,tocilizumab,,,IL6R,rs11265618,Efficacy
1953,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,FOXP3,rs3761548,Toxicity
1954,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,ABCC1,rs6498588,Metabolism/PK
1955,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,ABCC1,rs17501331,Toxicity
1956,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,ABCC1,rs35621,Metabolism/PK
1957,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,ABCC1,rs3743527,Toxicity
1958,pharmgkb,ticagrelor,9871419.0,CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO,PEAR1,rs12041331,Efficacy
1959,pharmgkb,ticagrelor,9871419.0,CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO,PEAR1,rs4661012,Efficacy
1960,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,UGT2B7,rs7438135,Metabolism/PK
1961,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,,rs149104283,Toxicity
1962,pharmgkb,dabigatran,,,ABCB1,rs1045642,Metabolism/PK
1963,pharmgkb,rivaroxaban,9875401.0,,ABCB1,rs1045642,Metabolism/PK
1964,pharmgkb,dabigatran,,,ABCB1,rs2032582,Metabolism/PK
1965,pharmgkb,rivaroxaban,9875401.0,,ABCB1,rs2032582,Metabolism/PK
1966,pharmgkb,sirolimus,6436030.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,POR,rs1057868,Metabolism/PK
1967,pharmgkb,sirolimus,6436030.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,IL10,rs1800896,Metabolism/PK
1968,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,VASP,rs10995,Efficacy
1969,pharmgkb,cetuximab,,,EGFR,rs2227983,Efficacy
1970,pharmgkb,Platinum compounds,,,GSTP1,rs1695,Efficacy
1971,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,ENOSF1,rs2612091,Toxicity
1972,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,STX1B,rs4889606,Efficacy
1973,pharmgkb,"3,4-methylenedioxymethamphetamine",1615.0,CC(CC1=CC2=C(C=C1)OCO2)NC,CYP2B6,rs3745274,Metabolism/PK
1974,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,rs776746,Efficacy
1975,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs1128503,Efficacy
1976,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs2032582,Efficacy
1977,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs1045642,Efficacy
1978,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC22A1,rs2282143,Metabolism/PK
1979,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,SLC26A9,rs7512462,Efficacy
1980,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,P2RY12,rs3732759,Efficacy
1981,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,SLC6A2,rs2242446,Efficacy
1982,pharmgkb,cotinine,854019.0,CN1[C@@H](CCC1=O)C2=CN=CC=C2,UGT2B10,rs2942857,Metabolism/PK
1983,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,HTR1B,rs9361233,Efficacy
1984,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,DPYS,rs2669429,Toxicity
1985,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,CES1,rs3217164,Toxicity
1986,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,CES1,rs2244614,Toxicity
1987,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,CES1P1,rs11861118,Toxicity
1988,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,CES1P1,rs7187684,Toxicity
1989,pharmgkb,opioids,,,FAAH,rs2295632,Toxicity
1990,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,FAAH,rs2295632,Toxicity
1991,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,FAAH,rs4141964,Toxicity
1992,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,FAAH,rs3766246,Toxicity
1993,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,IL18,rs1946518,Metabolism/PK
1994,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,IL18,rs5744247,Metabolism/PK
1995,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,C3,rs2277984,Toxicity
1996,pharmgkb,lithium,28486.0,[Li+],,rs79663003,Efficacy
1997,pharmgkb,lithium,28486.0,[Li+],,rs75222709,Efficacy
1998,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,"UGT1A10,UGT1A7,UGT1A8,UGT1A9",rs2741049,Efficacy
1999,pharmgkb,Antihypertensives,,,CLNK,rs13144136,Efficacy
2000,pharmgkb,Selective serotonin reuptake inhibitors,,,ADRA2A,rs1800544,Efficacy
2001,pharmgkb,sulfasalazine,5359476.0,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O,ABCG2,rs2231142,Metabolism/PK
2002,pharmgkb,amisulpride,2159.0,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,ANKS1B,rs7968606,Efficacy
2003,pharmgkb,sulindac,5352.0,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,FMO3,rs2266782,Metabolism/PK
2004,pharmgkb,sulindac,5352.0,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,FMO3,rs2266780,Metabolism/PK
2005,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CTLA4,rs4553808,Metabolism/PK
2006,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,IL3,rs181781,Metabolism/PK
2007,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PEAR1,rs41273215,Efficacy
2008,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PEAR1,rs57731889,Efficacy
2009,pharmgkb,rocuronium,441290.0,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,SLCO1A2,rs3834939,Metabolism/PK
2010,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,ABCB1,rs1045642,Toxicity
2011,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,ABCB1,rs2032582,Metabolism/PK
2012,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,CYP19A1,rs727479,Efficacy
2013,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C19,rs4986893,Toxicity
2014,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,HLA-B,HLA-B*13:01,Toxicity
2015,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,TPMT,"TPMT*1, TPMT*3A",Toxicity
2016,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,TPMT,rs1800460,Toxicity
2017,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,SLC31A1,rs10981694,Toxicity
2018,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,FOXP3,rs3761548,Efficacy
2019,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,UMPS,rs4678145,Toxicity
2020,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,SLC22A7,rs2270860,Toxicity
2021,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,SLC22A7,rs4149178,Toxicity
2022,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,TYMS,rs2853741,Toxicity
2023,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,CDA,rs1048977,Toxicity
2024,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,DPYD,rs12119882,Toxicity
2025,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,UMPS,rs2279199,Toxicity
2026,pharmgkb,atazanavir,148192.0,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,ABCB1,rs2032582,Toxicity
2027,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,TBXA2R,rs1131882,"Efficacy,Toxicity"
2028,pharmgkb,atazanavir,148192.0,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,"CYP3A,CYP3A4",rs2740574,Metabolism/PK
2029,pharmgkb,gemtuzumab ozogamicin,,,CD33,rs35112940,Efficacy
2030,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP4F2,rs2189784,Dosage
2031,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP4F11,rs1060467,Dosage
2032,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,COMT,rs4646316,Toxicity
2033,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,COMT,rs9332377,Toxicity
2034,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,COMT,rs4646316,Toxicity
2035,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,COMT,rs9332377,Toxicity
2036,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,ABCB1,rs2032582,Toxicity
2037,pharmgkb,Beta Blocking Agents,,,ADRB1,rs1801252,Toxicity
2038,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,UGT1A6,"UGT1A6*1a, UGT1A6*2a, UGT1A6*3a, UGT1A6*4a, UGT1A6*8",Dosage
2039,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,NUDT15,rs766023281,"Dosage,Toxicity"
2040,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,NUDT15,rs746071566,"Dosage,Toxicity"
2041,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,GSTM1,"GSTM1 non-null, GSTM1 null",Toxicity
2042,pharmgkb,heparin,772.0,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,HLA-DRB3,HLA-DRB3*01:01,Toxicity
2043,pharmgkb,everolimus,6442177.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,ABCB1,rs2032582,Toxicity
2044,pharmgkb,everolimus,6442177.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,ABCB1,rs1045642,Toxicity
2045,pharmgkb,everolimus,6442177.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,FGFR4,rs351855,Efficacy
2046,pharmgkb,everolimus,6442177.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,PIK3R1,rs10515074,Toxicity
2047,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,COMT,rs4680,Efficacy
2048,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,TPMT,"TPMT*1, TPMT*3B, TPMT*3C",Efficacy
2049,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,C6,rs9200,Metabolism/PK
2050,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,C6,rs10052999,Metabolism/PK
2051,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCG2,rs2231142,Metabolism/PK
2052,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,rs28399504,Metabolism/PK
2053,pharmgkb,dolutegravir,54726191.0,C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,ABCG2,rs2231142,Metabolism/PK
2054,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3","Dosage,Metabolism/PK"
2055,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,rs35303484,Metabolism/PK
2056,pharmgkb,hormonal contraceptives for systemic use,,,F2,rs1799963,Toxicity
2057,pharmgkb,hmg coa reductase inhibitors,,,SLCO1B1,rs2306283,Toxicity
2058,pharmgkb,Drugs For Treatment Of Tuberculosis,,,NAT2,rs1799929,Toxicity
2059,pharmgkb,oseltamivir,65028.0,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC,CES1,rs200707504,Metabolism/PK
2060,pharmgkb,hormonal contraceptives for systemic use,,,F11,rs2289252,Toxicity
2061,pharmgkb,hormonal contraceptives for systemic use,,,KNG1,rs710446,Toxicity
2062,pharmgkb,glatiramer acetate,3081884.0,C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N,,rs12459996,Toxicity
2063,pharmgkb,glatiramer acetate,3081884.0,C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N,,rs1056854,Toxicity
2064,pharmgkb,glatiramer acetate,3081884.0,C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N,,rs75041078,Toxicity
2065,pharmgkb,hormonal contraceptives for systemic use,,,SUGCT,rs4379368,Toxicity
2066,pharmgkb,hormonal contraceptives for systemic use,,,ABO,rs56392308,Toxicity
2067,pharmgkb,hormonal contraceptives for systemic use,,,ABO,rs8176719,Toxicity
2068,pharmgkb,hormonal contraceptives for systemic use,,,CYP2C9,rs1799853,Toxicity
2069,pharmgkb,ethanol,702.0,CCO,SLC6A3,rs6350,Toxicity
2070,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CDH2,rs8094439,Efficacy
2071,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CDH2,rs17446819,Efficacy
2072,pharmgkb,etanercept,,,STAT4,rs7574865,Efficacy
2073,pharmgkb,etanercept,,,PSORS1C1,rs2233945,Efficacy
2074,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,,rs12459249,Metabolism/PK
2075,pharmgkb,Antithyroid Preparations,,,FOXF2,rs199564443,Toxicity
2076,pharmgkb,Antithyroid Preparations,,,HLA-B,rs1071816,Toxicity
2077,pharmgkb,Antithyroid Preparations,,,EHMT2,rs652888,Toxicity
2078,pharmgkb,Antithyroid Preparations,,,HLA-B,HLA-B*08:01,Toxicity
2079,pharmgkb,Antithyroid Preparations,,,HLA-B,HLA-B*27:05,Toxicity
2080,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,ABCB1,rs1128503,Efficacy
2081,pharmgkb,isoniazid,3767.0,C1=CN=CC=C1C(=O)NN,BACH1,rs2070401,Toxicity
2082,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,ADRB2,rs1800888,Other
2083,pharmgkb,isoniazid,3767.0,C1=CN=CC=C1C(=O)NN,XPO1,rs11125883,Toxicity
2084,pharmgkb,isoniazid,3767.0,C1=CN=CC=C1C(=O)NN,MAFK,rs4720833,Toxicity
2085,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,ABCB1,rs1045642,"Efficacy,Toxicity,Metabolism/PK"
2086,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CES1,rs2307240,Efficacy
2087,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,"UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9",rs28898617,Metabolism/PK
2088,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,UGT2B7,rs7439366,Efficacy
2089,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC19A1,rs2838958,Efficacy
2090,pharmgkb,lumefantrine,6437380.0,CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O,CYP3A5,rs10264272,Metabolism/PK
2091,pharmgkb,lumefantrine,6437380.0,CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O,"CYP3A,CYP3A5,ZSCAN25",rs776746,Metabolism/PK
2092,pharmgkb,lumefantrine,6437380.0,CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O,CYP3A4,rs2740574,"Efficacy,Metabolism/PK"
2093,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1L1,rs4072879,Dosage
2094,pharmgkb,midazolam,4192.0,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
2095,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,CYP2B6,rs2279343,Efficacy
2096,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCB1,rs1045642,Efficacy
2097,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCB1,rs1128503,Efficacy
2098,pharmgkb,"Thiazides, plain",,,SLCO2A1,rs34550074,Toxicity
2099,pharmgkb,lithium,28486.0,[Li+],,rs324899,Efficacy
2100,pharmgkb,lithium,28486.0,[Li+],,rs6942227,Efficacy
2101,pharmgkb,lithium,28486.0,[Li+],,rs1611259,Efficacy
2102,pharmgkb,lithium,28486.0,[Li+],EPHX2,rs59724122,Efficacy
2103,pharmgkb,lithium,28486.0,[Li+],GRAMD1B,rs61123830,Efficacy
2104,pharmgkb,lithium,28486.0,[Li+],MYO1H,rs7959663,Efficacy
2105,pharmgkb,lithium,28486.0,[Li+],,rs66486766,Efficacy
2106,pharmgkb,lithium,28486.0,[Li+],,rs7405404,Efficacy
2107,pharmgkb,lithium,28486.0,[Li+],FAM178B,rs6728642,Efficacy
2108,pharmgkb,lithium,28486.0,[Li+],ZNF804A,rs62200793,Efficacy
2109,pharmgkb,lithium,28486.0,[Li+],,rs7588746,Efficacy
2110,pharmgkb,lithium,28486.0,[Li+],,rs3919583,Efficacy
2111,pharmgkb,lithium,28486.0,[Li+],,rs1611255,Efficacy
2112,pharmgkb,lithium,28486.0,[Li+],,rs209474,Efficacy
2113,pharmgkb,lithium,28486.0,[Li+],ADCY1,rs1521470,Efficacy
2114,pharmgkb,lithium,28486.0,[Li+],FAM177A1,rs79403677,Efficacy
2115,pharmgkb,Platinum compounds,,,XPC,rs2228000,Toxicity
2116,pharmgkb,"sulfonamides, urea derivatives",,,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Toxicity
2117,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC47A1,rs2252281,Efficacy
2118,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC47A2,rs12943590,Metabolism/PK
2119,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC47A1,rs2289669,Efficacy
2120,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC47A2,rs12943590,Efficacy
2121,pharmgkb,atazanavir,148192.0,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,CYP3A5,"CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",Metabolism/PK
2122,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,TYMS,rs699517,Toxicity
2123,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,POR,rs1057868,Efficacy
2124,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,SLCO1B3,rs4149117,Efficacy
2125,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,BCHE,rs1803274,Other
2126,pharmgkb,ustekinumab,,,TIRAP,rs8177374,Efficacy
2127,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TLR2,rs11938228,Efficacy
2128,pharmgkb,ustekinumab,,,TLR5,rs5744174,Efficacy
2129,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TLR9,rs352139,Efficacy
2130,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TLR2,rs4696480,Efficacy
2131,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,LY96,rs11465996,Efficacy
2132,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CYP3A4,"CYP3A4*1, CYP3A4*22",Metabolism/PK
2133,pharmgkb,ritodrine,33572.0,C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O,CACNA1C,rs10774053,Toxicity
2134,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*35:05,Toxicity
2135,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*39:10,Toxicity
2136,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*51:01,Toxicity
2137,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*51:02,Toxicity
2138,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*54:01,Toxicity
2139,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*55:01,Toxicity
2140,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*55:02,Toxicity
2141,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*56:01,Toxicity
2142,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*56:06,Toxicity
2143,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs2236196,Other
2144,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA5,rs55781567,Toxicity
2145,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*78:01,Toxicity
2146,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*13:02,Toxicity
2147,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*38:01,Toxicity
2148,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*39:05,Toxicity
2149,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*39:06,Toxicity
2150,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*39:09,Toxicity
2151,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*15:12,Toxicity
2152,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*15:24,Toxicity
2153,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*15:25,Toxicity
2154,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*15:27,Toxicity
2155,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*15:32,Toxicity
2156,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*15:35,Toxicity
2157,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*52:01,Toxicity
2158,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*35:10,Toxicity
2159,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-C,HLA-C*04:03,Toxicity
2160,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-DRB1,HLA-DRB1*01:02,Toxicity
2161,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-DRB1,HLA-DRB1*10:01,Toxicity
2162,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-DRB1,HLA-DRB1*08:01,Toxicity
2163,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-DRB1,HLA-DRB1*04:04,Toxicity
2164,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-DRB1,HLA-DRB1*01:03,Toxicity
2165,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-C,HLA-C*04:06,Toxicity
2166,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-C,HLA-C*04:07,Toxicity
2167,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-C,HLA-C*05:01,Toxicity
2168,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-C,HLA-C*05:09,Toxicity
2169,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-C,HLA-C*18:01,Toxicity
2170,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,ABCB1,rs1128503,Toxicity
2171,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,ABCG2,rs13120400,"Efficacy,Metabolism/PK"
2172,pharmgkb,"Ace Inhibitors, Plain",,,KCNIP4,rs145489027,Toxicity
2173,pharmgkb,"Ace Inhibitors, Plain",,,KCNIP4,rs1495509,Toxicity
2174,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,ABCB1,rs2032582,Toxicity
2175,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,ABCB1,rs2032582,Efficacy
2176,pharmgkb,atazanavir,148192.0,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,NR1I2,rs2472677,Metabolism/PK
2177,pharmgkb,bevacizumab,,,VEGFA,rs3025039,Efficacy
2178,pharmgkb,pazopanib,11525740.0,,KDR,rs34231037,"Efficacy,Metabolism/PK"
2179,pharmgkb,lithium,28486.0,[Li+],,rs78015114,Efficacy
2180,pharmgkb,lithium,28486.0,[Li+],,rs74795342,Efficacy
2181,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,UGT1A3,rs3806596,"Efficacy,Metabolism/PK"
2182,pharmgkb,opioids,,,DBH,rs1611131,Toxicity
2183,pharmgkb,letrozole,3902.0,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,CYP19A1,rs4646,Other
2184,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CYP3A5,rs776746,"Dosage,Metabolism/PK"
2185,pharmgkb,Platinum compounds,,,XRCC3,rs861539,Efficacy
2186,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,OPRD1,rs529520,Efficacy
2187,pharmgkb,irbesartan,3749.0,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,CYP2C9,rs1799853,Efficacy
2188,pharmgkb,ethanol,702.0,CCO,DRD2,rs1800497,Toxicity
2189,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,NOTCH4,rs367398,Toxicity
2190,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,FMO3,rs2266780,Metabolism/PK
2191,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,CYP24A1,rs927650,Metabolism/PK
2192,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,CYP24A1,rs2585428,Metabolism/PK
2193,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,CYP24A1,rs2248359,Metabolism/PK
2194,pharmgkb,aripiprazole,60795.0,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,DRD2,rs6277,Efficacy
2195,pharmgkb,"Antiinflammatory agents, non-steroids",,,IL10,rs1800896,Toxicity
2196,pharmgkb,"Antiinflammatory agents, non-steroids",,,CTLA4,rs231775,Toxicity
2197,pharmgkb,ketorolac,3826.0,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,,rs2562456,Efficacy
2198,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,ABCB1,rs1128503,Metabolism/PK
2199,pharmgkb,corticosteroids,,,BCL2L11,rs724710,Toxicity
2200,pharmgkb,corticosteroids,,,BCL2L11,rs2241843,Toxicity
2201,pharmgkb,caffeine,2519.0,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,CYP1A2,rs2069514,Metabolism/PK
2202,pharmgkb,caffeine,2519.0,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,CYP1A2,rs762551,Metabolism/PK
2203,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,GATA4,rs2645400,Dosage
2204,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,GATA4,rs4841588,Dosage
2205,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VDR,rs11168292,Dosage
2206,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VDR,rs11168293,Dosage
2207,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VDR,rs4760658,Dosage
2208,pharmgkb,sildenafil,5212.0,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,CYP3A4,"CYP3A4*1, CYP3A4*22",Metabolism/PK
2209,pharmgkb,somatropin recombinant,,,CDK4,rs2069502,Other
2210,pharmgkb,somatropin recombinant,,,CDK4,rs2270777,Other
2211,pharmgkb,idarubicin,42890.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,NCF4,rs1883112,Efficacy
2212,pharmgkb,idarubicin,42890.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,RAC2,rs13058338,Efficacy
2213,pharmgkb,Drugs Used In Diabetes,,,IRS1,rs1801278,Efficacy
2214,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLC22A1,rs683369,Toxicity
2215,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLC22A5,rs274558,Toxicity
2216,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,EGFR,rs10258429,Toxicity
2217,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCB1,rs2235040,Toxicity
2218,pharmgkb,"3,4-methylenedioxymethamphetamine",1615.0,CC(CC1=CC2=C(C=C1)OCO2)NC,SLC6A2,rs2242446,Other
2219,pharmgkb,"3,4-methylenedioxymethamphetamine",1615.0,CC(CC1=CC2=C(C=C1)OCO2)NC,SLC6A2,rs36029,Other
2220,pharmgkb,"3,4-methylenedioxymethamphetamine",1615.0,CC(CC1=CC2=C(C=C1)OCO2)NC,SLC6A2,rs1861647,Other
2221,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCG2,rs2231142,Toxicity
2222,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SLC22A1,rs12208357,Metabolism/PK
2223,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,POR,rs1057868,Metabolism/PK
2224,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CYP3A4,rs35599367,Other
2225,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,SUMO4,rs237025,Metabolism/PK
2226,pharmgkb,omeprazole,4594.0,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,ABCB1,rs1045642,"Efficacy,Metabolism/PK"
2227,pharmgkb,dapoxetine,71353.0,CN(C)[C@@H](CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3,CYP2D6,"CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",Metabolism/PK
2228,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,TLR4,rs1927907,Other
2229,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,PSORS1C1,rs3131003,Toxicity
2230,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,DHFR,rs408626,"Efficacy,Toxicity"
2231,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,DHFR,rs442767,Toxicity
2232,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs4803381,Metabolism/PK
2233,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs56113850,Metabolism/PK
2234,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,SP1,rs784888,"Efficacy,Metabolism/PK"
2235,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,AMHR2,rs784892,"Efficacy,Metabolism/PK"
2236,pharmgkb,opioids,,,"OPRL1,RGS19",rs6090041,Toxicity
2237,pharmgkb,opioids,,,"LKAAEAR1,OPRL1",rs6090043,Toxicity
2238,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,CDA,rs2072671,Toxicity
2239,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PEBP4,rs17685420,Efficacy
2240,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ZDHHC7,rs3210967,Efficacy
2241,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ZNF134,rs10413455,Efficacy
2242,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ARSA,rs2071421,Efficacy
2243,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,SPSB2,rs12302749,Efficacy
2244,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ZNF211,rs10420097,Efficacy
2245,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CORO7,rs3810818,Efficacy
2246,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,FXR2,rs9901675,Efficacy
2247,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ZNF565,rs4805162,Efficacy
2248,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ELP5,rs4562,Efficacy
2249,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CDH23,rs17712523,Efficacy
2250,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ARHGAP12,rs2799018,Efficacy
2251,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PIGM,rs12409352,Efficacy
2252,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CHURC1,rs4902333,Efficacy
2253,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,TRIB3,rs2295490,Efficacy
2254,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CMTM8,rs4627790,Efficacy
2255,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PDIA2,rs1048786,Efficacy
2256,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,OPCML,rs751655,Efficacy
2257,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ETFDH,rs11559290,Efficacy
2258,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,NFIB,rs7858,Efficacy
2259,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ARHGEF28,rs929740,Efficacy
2260,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,SENP3,rs11552708,Efficacy
2261,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ESYT2,rs1061735,Efficacy
2262,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,RRP7A,rs11553441,Efficacy
2263,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,HTT,rs362272,Efficacy
2264,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,FARP2,rs757978,Efficacy
2265,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,GGH,rs17279558,Efficacy
2266,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,,rs3761372,Efficacy
2267,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PURA,rs2013169,Efficacy
2268,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs6700741,Efficacy
2269,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,NRXN1,rs4971678,Efficacy
2270,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs9873889,Efficacy
2271,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs9879065,Efficacy
2272,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs4437856,Efficacy
2273,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs2419128,Efficacy
2274,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs12094644,Efficacy
2275,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs9310658,Efficacy
2276,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs7616119,Efficacy
2277,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs7653345,Efficacy
2278,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs9819548,Efficacy
2279,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs13093500,Efficacy
2280,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs12630569,Efficacy
2281,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs9824595,Efficacy
2282,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs4334661,Efficacy
2283,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs7625956,Efficacy
2284,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs4858478,Efficacy
2285,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs12502866,Efficacy
2286,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs61692318,Efficacy
2287,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs10007051,Efficacy
2288,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs11933890,Efficacy
2289,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs62319299,Efficacy
2290,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs56229625,Efficacy
2291,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs55881666,Efficacy
2292,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,TTC37,rs12657120,Efficacy
2293,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,TTC37,rs4639250,Efficacy
2294,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,TREML4,rs13204353,Efficacy
2295,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,INVS,rs10123866,Efficacy
2296,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,TEX10,rs7472,Efficacy
2297,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,TEX10,rs10124893,Efficacy
2298,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,TEX10,rs6479008,Efficacy
2299,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,TEX10,rs10989064,Efficacy
2300,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,FCN2,rs3124955,Efficacy
2301,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,FCN2,rs3128624,Efficacy
2302,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908402,Efficacy
2303,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908403,Efficacy
2304,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908404,Efficacy
2305,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908405,Efficacy
2306,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs17724452,Efficacy
2307,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs17724464,Efficacy
2308,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs17786394,Efficacy
2309,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs17786400,Efficacy
2310,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908406,Efficacy
2311,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs17786412,Efficacy
2312,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908407,Efficacy
2313,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908408,Efficacy
2314,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908409,Efficacy
2315,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908410,Efficacy
2316,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs78482393,Efficacy
2317,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs78615940,Efficacy
2318,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs17724494,Efficacy
2319,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ANO2,rs61908411,Efficacy
2320,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs7316769,Efficacy
2321,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs7306991,Efficacy
2322,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs10771997,Efficacy
2323,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs10771998,Efficacy
2324,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs10771999,Efficacy
2325,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ATP10A,rs12595802,Efficacy
2326,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,MIEF2,rs3889402,Efficacy
2327,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,MIEF2,rs12603700,Efficacy
2328,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,MIEF2,rs56355515,Efficacy
2329,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs58042962,Efficacy
2330,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,,rs2933304,Efficacy
2331,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs9310657,Efficacy
2332,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,TREML4,rs9369266,Efficacy
2333,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,TEX10,rs7035619,Efficacy
2334,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,UGT2B7,rs7668258,Metabolism/PK
2335,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,UGT2B7,rs12233719,Metabolism/PK
2336,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP2C19,rs11568732,Toxicity
2337,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,AGTR1,rs5186,Metabolism/PK
2338,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,BDKRB2,rs1799722,Metabolism/PK
2339,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,UGT1A6,rs1105879,Efficacy
2340,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,UGT1A6,rs2070959,Efficacy
2341,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,ABCC2,rs717620,Efficacy
2342,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,HLA-A,HLA-A*02:07,Toxicity
2343,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,HLA-A,HLA-A*33:03,Toxicity
2344,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,PSORS1C1,rs9263726,Toxicity
2345,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,CYCSP5,rs3099844,Toxicity
2346,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,,rs2734583,Toxicity
2347,pharmgkb,granisetron,3510.0,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,ABCB1,rs1045642,Efficacy
2348,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,rs8192709,Metabolism/PK
2349,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,rs3211371,Metabolism/PK
2350,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,SOD2,rs5746136,Toxicity
2351,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A7,"CYP3A7*1A, CYP3A7*1C",Metabolism/PK
2352,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP2J2,rs890293,Toxicity
2353,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCC2,rs3740066,Metabolism/PK
2354,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP2C8,"CYP2C8*1, CYP2C8*3",Metabolism/PK
2355,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP2C8,"CYP2C8*1, CYP2C8*3",Toxicity
2356,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,PPARA,rs4253728,Toxicity
2357,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,CALU,rs1043550,Dosage
2358,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs7294,Other
2359,pharmgkb,antineoplastic agents,,,ABCB1,rs1045642,Toxicity
2360,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,ABCB1,rs12720066,Toxicity
2361,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508453,Efficacy
2362,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,ABCB1,rs9282564,Metabolism/PK
2363,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,UGT2B7,rs7439366,Efficacy
2364,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,ABCB1,rs1045642,Toxicity
2365,pharmgkb,apixaban,10182969.0,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,ABCG2,rs2231142,Metabolism/PK
2366,pharmgkb,apixaban,10182969.0,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,CYP3A5,rs776746,Metabolism/PK
2367,pharmgkb,Vitamin K,,,CYP4F2,rs2108622,Metabolism/PK
2368,pharmgkb,ethanol,702.0,CCO,KLB,rs11940694,Dosage
2369,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,UGT2B7,rs7668282,Metabolism/PK
2370,pharmgkb,caffeine,2519.0,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,CYP1A2,rs762551,Toxicity
2371,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,CPA6,rs2162145,Efficacy
2372,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,NBEA,rs57081354,Efficacy
2373,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,PRPF31,rs254271,Efficacy
2374,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
2375,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,,rs12046844,Toxicity
2376,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,TPMT,rs1142345,"Dosage,Toxicity"
2377,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,SLCO1B1,rs4149056,Efficacy
2378,pharmgkb,bevacizumab,,,HSP90AB1,rs3734704,Toxicity
2379,pharmgkb,bevacizumab,,,HSP90AB1,rs6929249,Toxicity
2380,pharmgkb,bevacizumab,,,HSP90AB1,rs834576,Toxicity
2381,pharmgkb,bevacizumab,,,PRKCA,rs9381299,Toxicity
2382,pharmgkb,donepezil,3152.0,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,BCHE,rs1803274,Efficacy
2383,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,ABCG2,rs2231142,"Efficacy,Toxicity"
2384,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,POLR2A,rs2228130,Toxicity
2385,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC1,rs35592,Efficacy
2386,pharmgkb,oxazepam,4616.0,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,,rs1976391,Metabolism/PK
2387,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,,rs887829,Metabolism/PK
2388,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,UGT1A1,rs887829,Dosage
2389,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,rs544027339,Toxicity
2390,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,rs1029359343,Toxicity
2391,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,HLA-A,HLA-A*24:02,Toxicity
2392,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,,rs11065987,Efficacy
2393,pharmgkb,Platinum compounds,,,SLC31A1,rs4979223,"Efficacy,Toxicity"
2394,pharmgkb,Platinum compounds,,,SLC31A1,rs4978536,Toxicity
2395,pharmgkb,Platinum compounds,,,SLC31A1,rs2233914,"Efficacy,Toxicity"
2396,pharmgkb,Platinum compounds,,,SLC31A1,rs10817464,Toxicity
2397,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs188052243,Other
2398,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1335150891,Other
2399,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs748620513,Other
2400,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1184321568,Other
2401,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs143879757,Other
2402,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs1212037891,Other
2403,pharmgkb,pemetrexed,60843.0,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,MTHFR,rs1801133,Efficacy
2404,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,UGT1A3,rs7604115,Metabolism/PK
2405,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,UGT1A3,"UGT1A3*1, UGT1A3*2",Metabolism/PK
2406,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,ABCC9,rs704212,Metabolism/PK
2407,pharmgkb,montelukast,5281040.0,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,CYP2C8,"CYP2C8*1, CYP2C8*3, CYP2C8*4",Metabolism/PK
2408,pharmgkb,"HMG CoA reductase inhibitors, other combinations",,,EYS,rs9342288,Toxicity
2409,pharmgkb,hmg coa reductase inhibitors,,,EYS,rs1337512,Toxicity
2410,pharmgkb,hmg coa reductase inhibitors,,,EYS,rs3857532,Toxicity
2411,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A3,rs767263838,Metabolism/PK
2412,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,SULT1A3,rs767263838,Metabolism/PK
2413,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A3,rs767263838,Metabolism/PK
2414,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,"SULT1A3,SULT1A4",rs757573592,Metabolism/PK
2415,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,"SULT1A3,SULT1A4",rs757573592,Metabolism/PK
2416,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A3,rs757573592,Metabolism/PK
2417,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A3,rs776817009,Metabolism/PK
2418,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A3,rs776817009,Metabolism/PK
2419,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A3,rs762151655,Metabolism/PK
2420,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,SULT1A3,rs762151655,Metabolism/PK
2421,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A3,rs762151655,Metabolism/PK
2422,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A3,rs750575779,Metabolism/PK
2423,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A3,rs750575779,Metabolism/PK
2424,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A3,rs553050853,Metabolism/PK
2425,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,SULT1A3,rs553050853,Metabolism/PK
2426,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A3,rs553050853,Metabolism/PK
2427,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A3,rs751527244,Metabolism/PK
2428,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,SULT1A3,rs751527244,Metabolism/PK
2429,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A3,rs751527244,Metabolism/PK
2430,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A3,rs1293732453,Metabolism/PK
2431,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,SULT1A3,rs1293732453,Metabolism/PK
2432,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A3,rs1293732453,Metabolism/PK
2433,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A3,rs1328799050,Metabolism/PK
2434,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,SULT1A3,rs1328799050,Metabolism/PK
2435,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A3,rs1328799050,Metabolism/PK
2436,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,ABCB1,rs1045642,"Efficacy,Metabolism/PK"
2437,pharmgkb,levetiracetam,441341.0,CC[C@H](C(=O)N)N1CCCC1=O,HLA-A,HLA-A*11:01,Toxicity
2438,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,ANKK1,rs1800497,Efficacy
2439,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,ABCB1,rs1045642,Efficacy
2440,pharmgkb,pioglitazone,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,CYP2C8,"CYP2C8*1, CYP2C8*2, CYP2C8*3",Other
2441,pharmgkb,etanercept,,,TNFRSF1B,rs1061622,Efficacy
2442,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,UGT2B7,rs4587017,Efficacy
2443,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,UGT2B7,rs10028494,Efficacy
2444,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ABCB1,rs1045642,Toxicity
2445,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ABCB1,rs2032582,Toxicity
2446,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ABCB1,rs1128503,Toxicity
2447,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ATF2,rs7583431,Efficacy
2448,pharmgkb,opioids,,,IL17A,rs2275913,Dosage
2449,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,rs13093031,Efficacy
2450,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,rs6961071,Efficacy
2451,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ABCB1,rs2032582,Toxicity
2452,pharmgkb,acetylcysteine,12035.0,CC(=O)N[C@@H](CS)C(=O)O,TOLLIP,rs3750920,Efficacy
2453,pharmgkb,cangrelor,9854012.0,CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F,P2RY12,rs6787801,Efficacy
2454,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,HLA-B,HLA-B*44:03,Toxicity
2455,pharmgkb,stavudine,18283.0,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO,SAMHD1,rs8124728,Toxicity
2456,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,rs15524,Metabolism/PK
2457,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,"CYP3A5,ZSCAN25",rs4646450,Metabolism/PK
2458,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Toxicity
2459,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,KIF6,rs20455,Efficacy
2460,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,KIF6,rs20455,Efficacy
2461,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs9282564,Metabolism/PK
2462,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs2229109,Efficacy
2463,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,NR1I2,rs2276707,Metabolism/PK
2464,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,NR1I2,rs3814055,Metabolism/PK
2465,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,,rs10511905,Efficacy
2466,pharmgkb,cetuximab,,,RASSF1,rs2236947,Efficacy
2467,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,ZNF385D,rs4261893,Efficacy
2468,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,KMT2E,rs117986340,Efficacy
2469,pharmgkb,duloxetine,60835.0,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,NCAM1,rs2303377,Efficacy
2470,pharmgkb,phenazepam,40113.0,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=C3Cl,CYP2C19,rs12248560,Efficacy
2471,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP3A5,rs17161788,Efficacy
2472,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,ABCB1,rs1045642,Toxicity
2473,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,IL6,rs1800795,Efficacy
2474,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ATIC,rs2372536,Efficacy
2475,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ITPA,rs1127354,"Efficacy,Toxicity"
2476,pharmgkb,cetuximab,,,FCGR2A,rs1801274,Efficacy
2477,pharmgkb,cetuximab,,,FCGR3A,rs396991,Efficacy
2478,pharmgkb,Platinum compounds,,,MDM2,rs1690924,Efficacy
2479,pharmgkb,Platinum compounds,,,XRCC1,rs1799782,Efficacy
2480,pharmgkb,Platinum compounds,,,SLC19A1,rs1051266,Efficacy
2481,pharmgkb,oxaliplatin,6857599.0,C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2],PIN1,rs2233678,Efficacy
2482,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,PIN1,rs2233678,Efficacy
2483,pharmgkb,dapsone,2955.0,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,HLA-DRB1,rs701829,Toxicity
2484,pharmgkb,dapsone,2955.0,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,HLA-DRB1,rs201929247,Toxicity
2485,pharmgkb,dapsone,2955.0,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,HLA-DRB1,rs17211071,Toxicity
2486,pharmgkb,dapsone,2955.0,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,HLA-DRB1,"HLA-DRB1*15:01, HLA-DRB1*16:02",Toxicity
2487,pharmgkb,dapsone,2955.0,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,HLA-A,HLA-A*24:02,Toxicity
2488,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,UGT1A1,rs10929302,Toxicity
2489,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,UGT1A1,rs1976391,Toxicity
2490,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,UGT1A1,rs887829,Toxicity
2491,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,NEDD4L,rs4149601,Efficacy
2492,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,XRCC1,rs25487,Efficacy
2493,pharmgkb,clonidine,2803.0,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,ADRA2C,rs11269124,Efficacy
2494,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,VEGFA,rs144854329,Efficacy
2495,pharmgkb,thioridazine,5452.0,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,CYP2D6,rs1080985,Other
2496,pharmgkb,antipsychotics,,,CYP2D6,"CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*10, CYP2D6*14",Toxicity
2497,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,MMP3,rs35068180,Efficacy
2498,pharmgkb,ceftriaxone,5479530.0,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,ABCG2,rs13120400,Metabolism/PK
2499,pharmgkb,ceftriaxone,5479530.0,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,ABCC2,rs2273697,Metabolism/PK
2500,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,"UGT1A1,UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9",rs4148324,Metabolism/PK
2501,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCG2,rs12505410,Metabolism/PK
2502,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCG2,rs13120400,Metabolism/PK
2503,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCG2,rs13137622,Metabolism/PK
2504,pharmgkb,ethanol,702.0,CCO,DRD2,rs1800497,Toxicity
2505,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYCSP5,rs3099844,Toxicity
2506,pharmgkb,ondansetron,4595.0,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,CYP3A5,rs776746,Other
2507,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs2032582,Efficacy
2508,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs1128503,Efficacy
2509,pharmgkb,acamprosate,71158.0,CC(=O)NCCCS(=O)(=O)O,GRIN2B,rs2058878,Efficacy
2510,pharmgkb,tocilizumab,,,FCGR3A,rs396991,Efficacy
2511,pharmgkb,rituximab,,,FCGR2A,rs1801274,Efficacy
2512,pharmgkb,maraviroc,3002977.0,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,CYP3A5,"CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7","Efficacy,Metabolism/PK"
2513,pharmgkb,levodopa,6047.0,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,SLC6A3,rs3836790,Efficacy
2514,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRM1,rs3192723,Efficacy
2515,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,IL1B,rs1143634,"Dosage,Efficacy"
2516,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,IL1B,rs1143634,"Dosage,Efficacy"
2517,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,UGT2A1,rs11249454,Toxicity
2518,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCB4,rs1202283,Efficacy
2519,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCC2,rs2273697,Efficacy
2520,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CHST1,rs9787901,Toxicity
2521,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,NQO1,rs10517,Efficacy
2522,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP2F1,rs305968,Toxicity
2523,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLC19A1,rs12659,Toxicity
2524,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLC19A1,rs1051266,Toxicity
2525,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,CDA,rs471760,Toxicity
2526,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SLC28A1,rs3825876,Toxicity
2527,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SLC28A1,rs12148896,Toxicity
2528,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,KCNJ6,rs6517442,Efficacy
2529,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,TRPV1,rs224534,Efficacy
2530,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,UGT2B15,rs1902023,Efficacy
2531,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ABCB1,rs2032582,Toxicity
2532,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,TH,rs2070762,Efficacy
2533,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,DRD2,rs2283265,Toxicity
2534,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,ABCB1,rs1045642,Metabolism/PK
2535,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,ABCB1,rs2032582,Metabolism/PK
2536,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,NTNG1,rs61816456,Efficacy
2537,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,GREM2,rs77567654,Efficacy
2538,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,GREM2,rs10802887,Efficacy
2539,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,GREM2,rs1934341,Efficacy
2540,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,GREM2,rs4659982,Efficacy
2541,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,MYT1L,rs79663562,Efficacy
2542,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,TRIB2,rs10193126,Efficacy
2543,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,TBL1XR1,rs57449396,Efficacy
2544,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,PKD2,rs2725215,Efficacy
2545,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,ABCG2,rs4148157,Efficacy
2546,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,ABCG2,rs76979899,Efficacy
2547,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,ABCG2,rs4148155,Efficacy
2548,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,HLA-C,rs9366772,Efficacy
2549,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,TAOK3,rs795484,"Dosage,Efficacy"
2550,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,TAOK3,rs1277441,"Dosage,Efficacy"
2551,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,KCNJ11,rs5219,Toxicity
2552,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CFHR4,rs78239784,Toxicity
2553,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,SLC6A2,rs28386840,Efficacy
2554,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,TCF7L2,rs290487,Toxicity
2555,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*57:01,Toxicity
2556,pharmgkb,"sulfonamides, urea derivatives",,,"ABCC8,KCNJ11",rs757110,Efficacy
2557,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs2075572,Toxicity
2558,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,COMT,rs4680,Toxicity
2559,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs9479757,Dosage
2560,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,DRD2,rs1800497,Toxicity
2561,pharmgkb,sibutramine,5210.0,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,GNB3,rs5443,Efficacy
2562,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,OPRM1,rs2075572,Toxicity
2563,pharmgkb,ethanol,702.0,CCO,OPRM1,rs511435,Toxicity
2564,pharmgkb,ethanol,702.0,CCO,OPRM1,rs524731,Toxicity
2565,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,OPRM1,rs524731,Toxicity
2566,pharmgkb,ethanol,702.0,CCO,OPRM1,rs3823010,Toxicity
2567,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,OPRM1,rs3823010,Toxicity
2568,pharmgkb,ethanol,702.0,CCO,OPRM1,rs3778156,Toxicity
2569,pharmgkb,opioids,,,OPRM1,rs3778156,Toxicity
2570,pharmgkb,opioids,,,OPRM1,rs609148,Toxicity
2571,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,OPRM1,rs495491,Toxicity
2572,pharmgkb,opioids,,,OPRM1,rs548646,Toxicity
2573,pharmgkb,opioids,,,OPRM1,rs648893,Toxicity
2574,pharmgkb,disopyramide,3114.0,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,KCNH2,rs104894021,Efficacy
2575,pharmgkb,quinidine,441074.0,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,KCNH2,rs104894021,Efficacy
2576,pharmgkb,ethanol,702.0,CCO,CYP2E1,rs2031920,Toxicity
2577,pharmgkb,ethanol,702.0,CCO,CHRNA4,rs1044394,Toxicity
2578,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,OPRM1,rs1799971,Efficacy
2579,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,CYP2B6,"CYP2B6*1, CYP2B6*6",Efficacy
2580,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRK1,rs1051660,Toxicity
2581,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2B6,rs2279343,Metabolism/PK
2582,pharmgkb,ethanol,702.0,CCO,OPRM1,rs553202,Efficacy
2583,pharmgkb,ethanol,702.0,CCO,OPRM1,rs524731,Efficacy
2584,pharmgkb,ethanol,702.0,CCO,OPRM1,rs548646,Efficacy
2585,pharmgkb,ethanol,702.0,CCO,OPRM1,rs648007,Efficacy
2586,pharmgkb,ethanol,702.0,CCO,OPRM1,rs3778148,Efficacy
2587,pharmgkb,ethanol,702.0,CCO,OPRM1,rs1461773,Efficacy
2588,pharmgkb,ethanol,702.0,CCO,OPRM1,rs2075572,Efficacy
2589,pharmgkb,ethanol,702.0,CCO,OPRM1,rs681243,Efficacy
2590,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,GAL,rs694066,Toxicity
2591,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,HTR3B,rs3758987,Toxicity
2592,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRK1,rs6473797,Toxicity
2593,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,CSNK1E,rs1534891,Toxicity
2594,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,DRD2,rs6277,Efficacy
2595,pharmgkb,nimodipine,4497.0,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
2596,pharmgkb,nimodipine,4497.0,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,CACNA1C,rs2239128,Efficacy
2597,pharmgkb,dextropropoxyphene,441275.0,,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
2598,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA7,rs2337980,Efficacy
2599,pharmgkb,ethanol,702.0,CCO,CRHBP,rs10055255,Toxicity
2600,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Efficacy
2601,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,"ANKK1,DRD2",rs1800497,Toxicity
2602,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A13,rs1709083,Toxicity
2603,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A13,rs72552266,Toxicity
2604,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs28399433,Toxicity
2605,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2B6,"CYP2B6*1, CYP2B6*4",Toxicity
2606,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,HTR3B,rs3758987,Toxicity
2607,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,HTR3B,rs11606194,Toxicity
2608,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,CYP2B6,rs8109525,Efficacy
2609,pharmgkb,varenicline,5310966.0,C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23,HYKK,rs7164594,Efficacy
2610,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,BDNF,rs6265,Toxicity
2611,pharmgkb,modafinil,4236.0,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,COMT,rs4680,Efficacy
2612,pharmgkb,highly active antiretroviral therapy (haart),,,OPRM1,rs671531,Efficacy
2613,pharmgkb,ethanol,702.0,CCO,DRD2,rs1800497,Dosage
2614,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,OPRM1,rs2236256,Toxicity
2615,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,GABRA2,rs11503014,Toxicity
2616,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,ACE,rs8075924,Efficacy
2617,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,HTR2A,rs2770296,Efficacy
2618,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,DBH,rs2873804,Efficacy
2619,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SLC18A2,rs363225,Efficacy
2620,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,SLC18A2,rs363226,Efficacy
2621,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,FKBP5,rs17614642,Efficacy
2622,pharmgkb,pitavastatin,5282452.0,,ABCC2,rs717620,Metabolism/PK
2623,pharmgkb,pioglitazone,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,PPARG,rs1801282,Efficacy
2624,pharmgkb,pioglitazone,4829.0,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,PTPRD,rs17584499,Efficacy
2625,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PPA2,rs2636697,Efficacy
2626,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,TJP1,rs813676,Efficacy
2627,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,ATP1A2,rs6688363,Efficacy
2628,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,,rs8050896,Efficacy
2629,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,SPOPL,rs10170310,Efficacy
2630,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,TNFRSF11A,rs2980976,Efficacy
2631,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,PDE4D,rs17382202,Efficacy
2632,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,"MIR582,PDE4D",rs17742120,Efficacy
2633,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,TJP1,rs711355,Efficacy
2634,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,TJP1,rs785423,Efficacy
2635,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,,rs7395555,Efficacy
2636,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PPA2,rs2636719,Efficacy
2637,pharmgkb,everolimus,6442177.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,RPTOR,rs9906827,"Efficacy,Toxicity"
2638,pharmgkb,prochlorperazine,4917.0,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,"ANKK1,DRD2",rs1800497,Efficacy
2639,pharmgkb,prochlorperazine,4917.0,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,DRD2,rs1079597,Efficacy
2640,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs6090378,Toxicity
2641,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs3787138,Toxicity
2642,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs3787140,Toxicity
2643,pharmgkb,spironolactone,5833.0,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,CYP4A11,rs3890011,Efficacy
2644,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs9479757,Toxicity
2645,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,TYMS,rs11280056,Efficacy
2646,pharmgkb,pemetrexed,60843.0,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,TYMS,rs11280056,Efficacy
2647,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs1799971,Toxicity
2648,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRD1,rs2298897,Toxicity
2649,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRD1,rs2236855,Toxicity
2650,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,OPRD1,rs678849,Toxicity
2651,pharmgkb,rifampin,5381226.0,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,SLCO1B1,"SLCO1B1*1, SLCO1B1*15",Toxicity
2652,pharmgkb,opioids,,,ABCB1,rs1045642,Other
2653,pharmgkb,opioids,,,"ANKK1,DRD2",rs1800497,Toxicity
2654,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,HINT1,rs3852209,Other
2655,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,HINT1,rs3852209,Efficacy
2656,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs3778150,Toxicity
2657,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,,rs9384169,Toxicity
2658,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs562859,Toxicity
2659,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,,rs9478495,Toxicity
2660,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,OPRM1,rs10485057,Toxicity
2661,pharmgkb,ethanol,702.0,CCO,OPRM1,rs10485057,Dosage
2662,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,OPRM1,rs10485057,Dosage
2663,pharmgkb,ethanol,702.0,CCO,OPRM1,rs10485057,Toxicity
2664,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,"CHRNA3,CHRNA5",rs16969968,"Dosage,Efficacy"
2665,pharmgkb,aripiprazole,60795.0,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,DRD2,rs2514218,Toxicity
2666,pharmgkb,cannabinoids,,,OPRM1,rs1799971,Toxicity
2667,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,"ANKK1,DRD2",rs1800497,Toxicity
2668,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,DRD2,rs1800497,Toxicity
2669,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,OPRM1,rs1799971,Toxicity
2670,pharmgkb,ethanol,702.0,CCO,OPRM1,rs3778150,Efficacy
2671,pharmgkb,ethanol,702.0,CCO,OPRM1,rs3778150,Dosage
2672,pharmgkb,oxazepam,4616.0,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,UGT2B15,rs1902023,Metabolism/PK
2673,pharmgkb,lorazepam,3958.0,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,UGT2B15,rs1902023,Metabolism/PK
2674,pharmgkb,ethanol,702.0,CCO,SLC6A3,rs28363170,Other
2675,pharmgkb,ethanol,702.0,CCO,SLC6A3,rs28363170,Other
2676,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ABCB1,rs1128503,"Dosage,Efficacy"
2677,pharmgkb,ethanol,702.0,CCO,ACSS2,rs6088638,Toxicity
2678,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"HTT,MSANTD1",rs362306,Efficacy
2679,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HRH3,rs3787429,Efficacy
2680,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CYP1B1,rs1056827,Efficacy
2681,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"UGT1A10,UGT1A3,UGT1A4,UGT1A5,UGT1A6,UGT1A7,UGT1A8,UGT1A9",rs6706232,Efficacy
2682,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CYP1B1,rs10012,Efficacy
2683,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"HTT,MSANTD1",rs362267,Efficacy
2684,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CYP2E1,rs2515641,Efficacy
2685,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,COMT,rs4818,Efficacy
2686,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,AKT1,rs3803300,Efficacy
2687,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HRH4,rs4483927,Efficacy
2688,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,DRD3,rs6280,Efficacy
2689,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,AKT1,rs2494732,Efficacy
2690,pharmgkb,ethanol,702.0,CCO,OPRM1,rs1799971,Dosage
2691,pharmgkb,varenicline,5310966.0,C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23,CHRNA5,rs2036527,Efficacy
2692,pharmgkb,bupropion,444.0,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,CHRNA5,rs2036527,Efficacy
2693,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA5,rs2036527,Efficacy
2694,pharmgkb,opioids,,,TAOK3,rs1277441,Efficacy
2695,pharmgkb,opioids,,,TAOK3,rs1277441,Dosage
2696,pharmgkb,opioids,,,TAOK3,rs795484,Efficacy
2697,pharmgkb,opioids,,,TAOK3,rs795484,Dosage
2698,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA3,rs1051730,Other
2699,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA3,rs1051730,Toxicity
2700,pharmgkb,opioids,,,ABCB1,rs1045642,Dosage
2701,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,ABCB1,rs1045642,Dosage
2702,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRD1,rs508448,Other
2703,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs3778151,Toxicity
2704,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,"BDNF,BDNF-AS",rs16917234,Other
2705,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRD1,rs4654327,Toxicity
2706,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,XIRP2,rs7606603,Efficacy
2707,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,rs16872401,Efficacy
2708,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,TXNDC11,rs3784921,Efficacy
2709,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,rs7184292,Efficacy
2710,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,,rs7184292,Dosage
2711,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA3,rs3743075,Toxicity
2712,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNB4,rs7178270,Toxicity
2713,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNB4,rs1948,Toxicity
2714,pharmgkb,ethanol,702.0,CCO,PIP5K1C,rs2074957,Toxicity
2715,pharmgkb,ethanol,702.0,CCO,PIP5K1C,rs4807493,Toxicity
2716,pharmgkb,ethanol,702.0,CCO,PIP5K1C,rs10432303,Toxicity
2717,pharmgkb,ethanol,702.0,CCO,PIP5K1C,rs8109485,Toxicity
2718,pharmgkb,ethanol,702.0,CCO,PIP5K1C,rs4432372,Toxicity
2719,pharmgkb,ethanol,702.0,CCO,PIP5K1C,rs10405681,Toxicity
2720,pharmgkb,ethanol,702.0,CCO,PIP5K1C,rs1476592,Toxicity
2721,pharmgkb,ethanol,702.0,CCO,PIP5K1C,rs10419980,Toxicity
2722,pharmgkb,ethanol,702.0,CCO,PNPLA3,rs738409,Toxicity
2723,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ADRB2,rs1042718,Other
2724,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CYP3A5,"CYP3A5*1, CYP3A5*3",Toxicity
2725,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,"GNB3,P3H3",rs5441,Efficacy
2726,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,rs2242480,Efficacy
2727,pharmgkb,ethanol,702.0,CCO,,rs10516440,Toxicity
2728,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,CYP27B1,rs10877012,Efficacy
2729,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,UGT1A1,rs887829,Efficacy
2730,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,GC,rs7041,Efficacy
2731,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,UGT1A3,rs1983023,Efficacy
2732,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,VDR,rs731236,Efficacy
2733,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,VDR,rs1544410,Efficacy
2734,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNFAIP3,rs610604,Efficacy
2735,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,"SH3BP2,TNFAIP3",rs6920220,Efficacy
2736,pharmgkb,ethanol,702.0,CCO,MAP2K4,rs2159140,Toxicity
2737,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,ADGRL3,rs2271339,Toxicity
2738,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,ADGRL3,rs1456862,Toxicity
2739,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,SLC22A1,rs628031,"Efficacy,Toxicity,Metabolism/PK"
2740,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP1A2,rs762551,Dosage
2741,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,ABCG2,rs2231137,Dosage
2742,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,"ABCB1,RUNDC3B",rs28656907,Dosage
2743,pharmgkb,mexiletine,4178.0,CC1=C(C(=CC=C1)C)OCC(C)N,SCN4A,rs1567817380,Efficacy
2744,pharmgkb,mexiletine,4178.0,CC1=C(C(=CC=C1)C)OCC(C)N,SCN4A,rs121908560,Efficacy
2745,pharmgkb,flecainide,3356.0,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,SCN4A,rs1567817380,Efficacy
2746,pharmgkb,mexiletine,4178.0,CC1=C(C(=CC=C1)C)OCC(C)N,SCN4A,rs886043595,Efficacy
2747,pharmgkb,mexiletine,4178.0,CC1=C(C(=CC=C1)C)OCC(C)N,SCN4A,rs121908547,Efficacy
2748,pharmgkb,flecainide,3356.0,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,SCN4A,rs121908547,Efficacy
2749,pharmgkb,rocuronium,441290.0,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,ABCB1,rs1128503,Efficacy
2750,pharmgkb,migalastat,176077.0,,"GLA,HNRNPH2",rs869312136,Efficacy
2751,pharmgkb,migalastat,176077.0,,GLA,rs28935195,Efficacy
2752,pharmgkb,migalastat,176077.0,,GLA,rs1569304898,Efficacy
2753,pharmgkb,migalastat,176077.0,,GLA,rs398123212,Efficacy
2754,pharmgkb,migalastat,176077.0,,GLA,rs104894827,Efficacy
2755,pharmgkb,migalastat,176077.0,,GLA,rs372966991,Efficacy
2756,pharmgkb,migalastat,176077.0,,GLA,rs869312146,Efficacy
2757,pharmgkb,migalastat,176077.0,,GLA,rs397515870,Efficacy
2758,pharmgkb,migalastat,176077.0,,GLA,rs398123223,Efficacy
2759,pharmgkb,migalastat,176077.0,,GLA,rs28935490,Efficacy
2760,pharmgkb,migalastat,176077.0,,"GLA,HNRNPH2",rs869312138,Efficacy
2761,pharmgkb,migalastat,176077.0,,GLA,rs398123217,Efficacy
2762,pharmgkb,migalastat,176077.0,,GLA,rs397515874,Efficacy
2763,pharmgkb,migalastat,176077.0,,GLA,rs727505292,Efficacy
2764,pharmgkb,migalastat,176077.0,,GLA,rs869312399,Efficacy
2765,pharmgkb,migalastat,176077.0,,GLA,rs104894828,Efficacy
2766,pharmgkb,migalastat,176077.0,,GLA,rs398123226,Efficacy
2767,pharmgkb,migalastat,176077.0,,GLA,rs727504348,Efficacy
2768,pharmgkb,migalastat,176077.0,,GLA,rs190347120,Efficacy
2769,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,P2RX7,rs1718125,Dosage
2770,pharmgkb,tianeptine,68870.0,,OPRM1,rs1799971,Toxicity
2771,pharmgkb,ibuprofen,3672.0,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,CYP2C8,"CYP2C8*1, CYP2C8*3",Dosage
2772,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,"CYP2C19*1, CYP2C19*5, CYP2C19*6, CYP2C19*8, CYP2C19*9, CYP2C19*10, CYP2C19*11, CYP2C19*13, CYP2C19*14, CYP2C19*15, CYP2C19*16, CYP2C19*18, CYP2C19*19, CYP2C19*22, CYP2C19*23, CYP2C19*24, CYP2C19*25, CYP2C19*26",Metabolism/PK
2773,pharmgkb,tolbutamide,5505.0,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,CYP2C9,rs762081829,Metabolism/PK
2774,pharmgkb,tolbutamide,5505.0,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,CYP2C9,rs761895497,Metabolism/PK
2775,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,rs61311738,Metabolism/PK
2776,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,rs145119820,Metabolism/PK
2777,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,rs1187513719,Metabolism/PK
2778,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,rs144928727,Metabolism/PK
2779,pharmgkb,Drugs For Treatment Of Tuberculosis,,,XPO1,rs4430924,Toxicity
2780,pharmgkb,desmethylnaproxen,162920.0,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,SULT1A1,rs765399160,Metabolism/PK
2781,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A1,rs765399160,Metabolism/PK
2782,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,"NPIPB8,SULT1A1",rs28374453,Metabolism/PK
2783,pharmgkb,desmethylnaproxen,162920.0,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,"NPIPB8,SULT1A1",rs28374453,Metabolism/PK
2784,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,"NPIPB8,SULT1A1",rs28374453,Metabolism/PK
2785,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A1,rs1042028,Metabolism/PK
2786,pharmgkb,desmethylnaproxen,162920.0,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,SULT1A1,rs1042028,Metabolism/PK
2787,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A1,rs1042028,Metabolism/PK
2788,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A1,rs72547527,Metabolism/PK
2789,pharmgkb,desmethylnaproxen,162920.0,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,SULT1A1,rs72547527,Metabolism/PK
2790,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A1,rs72547527,Metabolism/PK
2791,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A1,rs1042008,Metabolism/PK
2792,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A1,rs1042008,Metabolism/PK
2793,pharmgkb,desmethylnaproxen,162920.0,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,SULT1A1,rs1042008,Metabolism/PK
2794,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A1,rs767487725,Metabolism/PK
2795,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A1,rs767487725,Metabolism/PK
2796,pharmgkb,desmethylnaproxen,162920.0,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,SULT1A1,rs767487725,Metabolism/PK
2797,pharmgkb,desmethylnaproxen,162920.0,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,SULT1A1,rs758145522,Metabolism/PK
2798,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A1,rs758145522,Metabolism/PK
2799,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A1,rs758145522,Metabolism/PK
2800,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A1,rs544820732,Metabolism/PK
2801,pharmgkb,desmethylnaproxen,162920.0,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,SULT1A1,rs544820732,Metabolism/PK
2802,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A1,rs544820732,Metabolism/PK
2803,pharmgkb,tapentadol,9838022.0,CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C,SULT1A1,rs552524124,Metabolism/PK
2804,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A1,rs552524124,Metabolism/PK
2805,pharmgkb,desmethylnaproxen,162920.0,CC(C1=CC2=C(C=C1)C=C(C=C2)O)C(=O)O,SULT1A1,rs552524124,Metabolism/PK
2806,pharmgkb,conjugated estrogens,23667301.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+],SULT1A1,rs1042028,Toxicity
2807,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,SULT1A1,rs1042028,Efficacy
2808,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,AQP1,rs1049305,Toxicity
2809,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,AQP1,rs28362731,Toxicity
2810,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,AQP1,rs1049305,Toxicity
2811,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,AQP1,rs1049305,Toxicity
2812,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,AQP1,rs1049305,Toxicity
2813,pharmgkb,ethanol,702.0,CCO,SRPRB,rs17376019,Metabolism/PK
2814,pharmgkb,acetaldehyde,177.0,,ADH1A,rs1229976,Metabolism/PK
2815,pharmgkb,ABT-751,,,UGT1A8,rs6431558,Other
2816,pharmgkb,Beta Blocking Agents,,,KL,rs36217263,Efficacy
2817,pharmgkb,calcium channel blockers,,,CACNA1C,rs2238032,Efficacy
2818,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,ABCB1,rs1128503,Toxicity
2819,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,ADRB1,rs1801252,Efficacy
2820,pharmgkb,glucocorticoids,,,HSD3B1,rs1047303,Efficacy
2821,pharmgkb,caffeine,2519.0,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,ADORA2A,rs3761422,Toxicity
2822,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,SLC15A2,rs2257212,Efficacy
2823,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,HMGCR,rs3846662,Other
2824,pharmgkb,calcium channel blockers,,,CACNA1C,rs2239128,Efficacy
2825,pharmgkb,calcium channel blockers,,,CACNA1C,rs2239050,Efficacy
2826,pharmgkb,rosiglitazone,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,PLIN1,rs894160,Toxicity
2827,pharmgkb,acetaldehyde,177.0,,ADH1B,rs1229984,Metabolism/PK
2828,pharmgkb,Antithyroid Preparations,,,,rs111618861,Toxicity
2829,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CCL11,rs1129844,Toxicity
2830,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRD1,rs678849,Efficacy
2831,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,MYD88,rs6853,Toxicity
2832,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ALDH1L1,rs2886059,Efficacy
2833,pharmgkb,ethanol,702.0,CCO,DRD2,rs1799732,Toxicity
2834,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CACNA1E,rs3845446,Dosage
2835,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,PDE4D,rs2164660,Efficacy
2836,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,SLC22A2,rs316019,Toxicity
2837,pharmgkb,l-phenylalanine,6140.0,C1=CC=C(C=C1)C[C@@H](C(=O)O)N,PAH,rs5030843,Metabolism/PK
2838,pharmgkb,carbocisteine,193653.0,,PAH,rs75193786,Metabolism/PK
2839,pharmgkb,carbocisteine,193653.0,,PAH,rs5030843,Metabolism/PK
2840,pharmgkb,carbocisteine,193653.0,,PAH,rs76394784,Metabolism/PK
2841,pharmgkb,l-phenylalanine,6140.0,C1=CC=C(C=C1)C[C@@H](C(=O)O)N,PAH,rs138809906,Metabolism/PK
2842,pharmgkb,carbocisteine,193653.0,,PAH,rs138809906,Metabolism/PK
2843,pharmgkb,l-phenylalanine,6140.0,C1=CC=C(C=C1)C[C@@H](C(=O)O)N,PAH,rs5030849,Metabolism/PK
2844,pharmgkb,carbocisteine,193653.0,,PAH,rs5030849,Metabolism/PK
2845,pharmgkb,carbocisteine,193653.0,,PAH,rs62516101,Metabolism/PK
2846,pharmgkb,l-phenylalanine,6140.0,C1=CC=C(C=C1)C[C@@H](C(=O)O)N,PAH,rs62516101,Metabolism/PK
2847,pharmgkb,l-phenylalanine,6140.0,C1=CC=C(C=C1)C[C@@H](C(=O)O)N,PAH,rs5030858,Metabolism/PK
2848,pharmgkb,carbocisteine,193653.0,,PAH,rs5030858,Metabolism/PK
2849,pharmgkb,carbocisteine,193653.0,,PAH,rs5030860,Metabolism/PK
2850,pharmgkb,l-phenylalanine,6140.0,C1=CC=C(C=C1)C[C@@H](C(=O)O)N,PAH,rs5030860,Metabolism/PK
2851,pharmgkb,l-phenylalanine,6140.0,C1=CC=C(C=C1)C[C@@H](C(=O)O)N,PAH,rs76394784,Metabolism/PK
2852,pharmgkb,Platinum compounds,,,ERCC2,rs1799793,Toxicity
2853,pharmgkb,Platinum compounds,,,ERCC2,rs1799793,Toxicity
2854,pharmgkb,antipsychotics,,,NRG1,rs13250975,Efficacy
2855,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,ZMAT4,rs1367094,Efficacy
2856,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ADGRL3,rs6551665,Efficacy
2857,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,,rs6924995,Efficacy
2858,pharmgkb,adalimumab,,,ATG5,rs9373839,Efficacy
2859,pharmgkb,Platinum compounds,,,SLC22A2,rs316019,Toxicity
2860,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CES1,rs8192950,Efficacy
2861,pharmgkb,ticagrelor,9871419.0,CCCSC1=NC2=C(C(=N1)N[C@@H]3C[C@H]3C4=CC(=C(C=C4)F)F)N=NN2[C@@H]5C[C@@H]([C@H]([C@H]5O)O)OCCO,PEAR1,rs12566888,Efficacy
2862,pharmgkb,"3,4-methylenedioxymethamphetamine",1615.0,CC(CC1=CC2=C(C=C1)OCO2)NC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*17",Toxicity
2863,pharmgkb,"3,4-methylenedioxymethamphetamine",1615.0,CC(CC1=CC2=C(C=C1)OCO2)NC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*17",Metabolism/PK
2864,pharmgkb,tolterodine,60774.0,CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,CYP2D6,"CYP2D6*1, CYP2D6*10, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*92, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*96, CYP2D6*97, CYP2D6*98",Metabolism/PK
2865,pharmgkb,hmg coa reductase inhibitors,,,APOE,rs429358,Efficacy
2866,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,APOE,rs7412,Efficacy
2867,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,APOE,rs7412,Efficacy
2868,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,APOE,rs7412,Efficacy
2869,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,APOE,rs7412,Efficacy
2870,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,APOE,rs429358,Efficacy
2871,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,APOE,rs429358,Efficacy
2872,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,ABCB1,rs1045642,Efficacy
2873,pharmgkb,propranolol,4946.0,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,ADRB2,rs1042713,Efficacy
2874,pharmgkb,Antihypertensives,,,PTPRD,rs324498,Efficacy
2875,pharmgkb,Antihypertensives,,,,rs11749255,Efficacy
2876,pharmgkb,Antihypertensives,,,,rs6487504,Efficacy
2877,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CYP2D6,"CYP2D6*1, CYP2D6*9, CYP2D6*29",Metabolism/PK
2878,pharmgkb,acetaldehyde,177.0,,PGM1,rs4643,Metabolism/PK
2879,pharmgkb,mycophenolic acid,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,SLCO1B3,rs4149117,Efficacy
2880,pharmgkb,mycophenolic acid,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,SLCO1B3,rs4149117,Efficacy
2881,pharmgkb,mycophenolic acid,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,SLCO1B3,rs7311358,Efficacy
2882,pharmgkb,mycophenolic acid,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,SLCO1B3,rs4149117,Efficacy
2883,pharmgkb,mycophenolic acid,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,SLCO1B3,rs7311358,Efficacy
2884,pharmgkb,mycophenolic acid,446541.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,SLCO1B3,rs7311358,Efficacy
2885,pharmgkb,ethanol,702.0,CCO,OPRK1,rs6473797,Toxicity
2886,pharmgkb,ethanol,702.0,CCO,OPRM1,rs495491,Toxicity
2887,pharmgkb,botulinum toxin type a,,,TRPV1,rs222749,Efficacy
2888,pharmgkb,botulinum toxin type a,,,CALCA,rs3781719,Efficacy
2889,pharmgkb,letermovir,45138674.0,,SLCO1B1,rs4149032,Metabolism/PK
2890,pharmgkb,letermovir,45138674.0,,SLCO1B1,rs4149056,Metabolism/PK
2891,pharmgkb,letermovir,45138674.0,,UGT1A1,rs4148323,Metabolism/PK
2892,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,DRD2,rs12364283,Toxicity
2893,pharmgkb,opioids,,,DRD2,rs1076560,Other
2894,pharmgkb,adalimumab,,,,rs9828223,Efficacy
2895,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,SYT1,rs2251214,Toxicity
2896,pharmgkb,disulfiram,3117.0,CCN(CC)C(=S)SSC(=S)N(CC)CC,SLC6A3,rs28363170,Efficacy
2897,pharmgkb,ethanol,702.0,CCO,RABGAP1L,rs61826952,Toxicity
2898,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC19A1,rs2838956,Toxicity
2899,pharmgkb,atazanavir,148192.0,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,SORCS2,rs73208473,Metabolism/PK
2900,pharmgkb,Vitamin K1,5284607.0,,CYP4F2,"CYP4F2*1, CYP4F2*3",Metabolism/PK
2901,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,APOB,rs679899,Toxicity
2902,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,APOB,rs1367117,Toxicity
2903,pharmgkb,lopinavir,92727.0,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,"CYP3A,CYP3A5,ZSCAN25",rs776746,Metabolism/PK
2904,pharmgkb,amprenavir,65016.0,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,SLCO1B1,rs4149056,Metabolism/PK
2905,pharmgkb,lopinavir,92727.0,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,CYP3A4,"CYP3A4*1, CYP3A4*22",Metabolism/PK
2906,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,NUCB2,rs757081,Efficacy
2907,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,,rs1446468,Efficacy
2908,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,RRP1B,rs9306160,Efficacy
2909,pharmgkb,candesartan,2541.0,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,SH2B3,rs3184504,Efficacy
2910,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,C5orf56,rs12521868,Efficacy
2911,pharmgkb,candesartan,2541.0,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,KCNK3,rs1275988,Efficacy
2912,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,CSK,rs1378942,Efficacy
2913,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,PDE3A,rs12579720,Efficacy
2914,pharmgkb,candesartan,2541.0,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,SULT1C3,rs6722745,Efficacy
2915,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,STN1,rs4387287,Efficacy
2916,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,TBX2,rs8068318,Efficacy
2917,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,PLCE1,rs932764,Efficacy
2918,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,ADO,rs10995311,Efficacy
2919,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,PRKAG2,rs10224002,Efficacy
2920,pharmgkb,candesartan,2541.0,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,"DOT1L,PLEKHJ1",rs740406,Efficacy
2921,pharmgkb,remifentanil,60815.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,ABCB1,rs1045642,Dosage
2922,pharmgkb,remifentanil,60815.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,ABCB1,rs1045642,Efficacy
2923,pharmgkb,opioids,,,MCOLN1,rs114077267,Toxicity
2924,pharmgkb,opioids,,,MCOLN1,rs115208233,Toxicity
2925,pharmgkb,opioids,,,MCOLN1,rs116181528,Toxicity
2926,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,"CHRNA3,CHRNA5",rs578776,Toxicity
2927,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs1044396,Toxicity
2928,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA4,rs2229959,Toxicity
2929,pharmgkb,antipsychotics,,,,rs7720513,Toxicity
2930,pharmgkb,"Beta blocking agents, selective",,,BST1,rs28404156,Efficacy
2931,pharmgkb,antipsychotics,,,DGKB,rs1525085,Toxicity
2932,pharmgkb,ethanol,702.0,CCO,ANKS1B,rs2133896,Toxicity
2933,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,ANKS1B,rs2133896,Toxicity
2934,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,ANKS1B,rs2133896,Toxicity
2935,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,OPRD1,rs581111,Efficacy
2936,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,,rs6848893,Efficacy
2937,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,ERCC1,rs11615,Toxicity
2938,pharmgkb,opioids,,,PDYN,rs910080,Toxicity
2939,pharmgkb,opioids,,,PDYN,rs1997794,Toxicity
2940,pharmgkb,artemether,9796294.0,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@@](O3)(OO4)C)OC)C,CYP2B6,"CYP2B6*1, CYP2B6*6",Metabolism/PK
2941,pharmgkb,opioids,,,PDYN,rs1022563,Toxicity
2942,pharmgkb,budesonide,63006.0,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,,rs2392165,Efficacy
2943,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CES1,rs778068631,Metabolism/PK
2944,pharmgkb,ethanol,702.0,CCO,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Toxicity
2945,pharmgkb,ethanol,702.0,CCO,SLC6A4,rs2066713,Toxicity
2946,pharmgkb,ethanol,702.0,CCO,SLC6A4,rs25531,Toxicity
2947,pharmgkb,ethanol,702.0,CCO,SLC6A4,rs4251417,Toxicity
2948,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,UGT2B7,rs7439366,Efficacy
2949,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,UGT2B7,rs7439366,Metabolism/PK
2950,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,GALNT14,rs9679162,Efficacy
2951,pharmgkb,thioguanine,2723601.0,C1=NC2=C(N1)C(=S)N=C(N2)N,TPMT,"TPMT*1, TPMT*3A, TPMT*3C",Metabolism/PK
2952,pharmgkb,tenofovir disoproxil fumarate,6398764.0,,SLC28A2,rs11854484,Toxicity
2953,pharmgkb,tenofovir disoproxil fumarate,6398764.0,,CYP24A1,rs2248359,Toxicity
2954,pharmgkb,tenofovir disoproxil fumarate,6398764.0,,CYP27B1,rs4646536,Toxicity
2955,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC2,rs717620,Toxicity
2956,pharmgkb,temozolomide,5394.0,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,ABCB1,rs2229109,Efficacy
2957,pharmgkb,creatine,586.0,CN(CC(=O)O)C(=N)N,MOBP,rs616147,Efficacy
2958,pharmgkb,desloratadine,124087.0,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,HRH1,rs901865,Toxicity
2959,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,OTOS,rs2291767,Toxicity
2960,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,TPMT,rs12201199,Toxicity
2961,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,SLC22A2,rs316019,Toxicity
2962,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,ABCC3,rs1051640,Toxicity
2963,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,SLC16A5,rs4788863,Toxicity
2964,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,ABCB1,rs3842,Other
2965,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,ABCB1,rs1045642,Other
2966,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2A6,rs28399433,Other
2967,pharmgkb,ethanol,702.0,CCO,CACNA1C,rs1034936,Toxicity
2968,pharmgkb,lurasidone,213046.0,C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O,HTR1A,rs6295,Efficacy
2969,pharmgkb,Drugs For Treatment Of Tuberculosis,,,ABCC2,rs3740065,Toxicity
2970,pharmgkb,interferon beta-1a,,,RORA,rs4774388,Efficacy
2971,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,RELA,rs11227247,Toxicity
2972,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,IKBKB,rs2272733,Efficacy
2973,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,IKBKE,rs2151222,Toxicity
2974,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,IKBKE,rs12142086,Toxicity
2975,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,NFKBIA,rs2233406,Toxicity
2976,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,NFKBIA,rs2233407,Toxicity
2977,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,IKBKB,rs9694958,Toxicity
2978,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,IKBKE,rs3748022,Toxicity
2979,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,NFKBIA,rs2233409,Toxicity
2980,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,"NFKBIB,SIRT2",rs2053071,Toxicity
2981,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,NR1H2,rs2695121,Toxicity
2982,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,TAB2,rs577001,Toxicity
2983,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,NFKBIA,rs8904,Toxicity
2984,pharmgkb,progesterone,5994.0,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*17",Metabolism/PK
2985,pharmgkb,ethanol,702.0,CCO,"ANKK1,DRD2",rs1800497,Toxicity
2986,pharmgkb,opioids,,,COMT,rs4633,Toxicity
2987,pharmgkb,opioids,,,COMT,rs4633,Toxicity
2988,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,CYP3A5,"CYP3A5*1, CYP3A5*3",Dosage
2989,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,CYP3A5,"CYP3A5*1, CYP3A5*3",Dosage
2990,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,ABCB1,rs1128503,Dosage
2991,pharmgkb,methamphetamine,10836.0,C[C@@H](CC1=CC=CC=C1)NC,FAAH,rs324420,Other
2992,pharmgkb,opioids,,,ADGRV1,rs2366929,Toxicity
2993,pharmgkb,diclofenac,3033.0,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,CYP2C8,"CYP2C8*1, CYP2C8*3, CYP2C8*4",Metabolism/PK
2994,pharmgkb,opioids,,,OPRM1,rs10457090,Toxicity
2995,pharmgkb,opioids,,,OPRM1,rs589046,Toxicity
2996,pharmgkb,hydralazine / isosorbide dinitrate,9954530.0,,GNB3,rs5443,Efficacy
2997,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,GAD1,rs3749034,Dosage
2998,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,GAD1,rs3762556,Dosage
2999,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,GAD1,rs769404,Dosage
3000,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRD1,rs204047,Dosage
3001,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRD1,rs797397,Metabolism/PK
3002,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRD1,rs204047,Metabolism/PK
3003,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRK1,rs3802279,Dosage
3004,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRK1,rs3802281,Dosage
3005,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRK1,rs963549,Dosage
3006,pharmgkb,dipyrone,522325.0,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+],CYP2C19,"CYP2C19*1, CYP2C19*2",Metabolism/PK
3007,pharmgkb,dipyrone,522325.0,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+],CYP2C9,"CYP2C9*1, CYP2C9*3",Metabolism/PK
3008,pharmgkb,dipyrone,522325.0,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+],NAT2,"NAT2*4, NAT2*5, NAT2*6, NAT2*7, NAT2*14",Metabolism/PK
3009,pharmgkb,opioids,,,CRYBG2,rs36024412,Toxicity
3010,pharmgkb,opioids,,,CLCC1,rs168107,Toxicity
3011,pharmgkb,opioids,,,POM121L2,rs41269255,Toxicity
3012,pharmgkb,opioids,,,ZNF165,rs9393888,Toxicity
3013,pharmgkb,opioids,,,MUC16,rs11882256,Toxicity
3014,pharmgkb,opioids,,,PDE3A,rs12305038,Toxicity
3015,pharmgkb,opioids,,,ZNF568,rs10405238,Toxicity
3016,pharmgkb,cytarabine,6253.0,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,ABCB1,rs1045642,Efficacy
3017,pharmgkb,hydralazine,3637.0,C1=CC=C2C(=C1)C=NN=C2NN,NAT2,"NAT2*5, NAT2*6, NAT2*7, NAT2*14",Toxicity
3018,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,ABCC3,rs4793665,Other
3019,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,ERCC1,rs3212986,Toxicity
3020,pharmgkb,alprazolam,2118.0,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,"CYP3A,CYP3A4",rs35599367,Metabolism/PK
3021,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,CHRNA5,rs588765,Toxicity
3022,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,"CHRNA3,CHRNA5",rs16969968,Toxicity
3023,pharmgkb,opioids,,,TH,rs2070762,Toxicity
3024,pharmgkb,opioids,,,TH,rs10770141,Toxicity
3025,pharmgkb,opioids,,,TH,rs10770140,Toxicity
3026,pharmgkb,dexmedetomidine,68602.0,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,ADRA2A,rs1800035,Efficacy
3027,pharmgkb,dexmedetomidine,68602.0,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,ADRA2A,rs201376588,Efficacy
3028,pharmgkb,dexmedetomidine,68602.0,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,ADRA2A,rs775887911,Efficacy
3029,pharmgkb,imatinib,5291.0,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,CYP3A4,"CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22",Metabolism/PK
3030,pharmgkb,amlodipine,2162.0,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CYP3A5,"CYP3A5*1, CYP3A5*3, CYP3A5*6, CYP3A5*7",Metabolism/PK
3031,pharmgkb,fesoterodine,6918558.0,CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,CYP3A4,"CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22",Metabolism/PK
3032,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,UGT2B7,rs7439366,Efficacy
3033,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,"COMT,TXNRD2",rs933271,Efficacy
3034,pharmgkb,opioids,,,COMT,rs4680,Toxicity
3035,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,rs780801862,Metabolism/PK
3036,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,rs780801862,Metabolism/PK
3037,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*29",Metabolism/PK
3038,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,SLC6A4,rs1042173,Dosage
3039,pharmgkb,vancomycin,14969.0,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9[C@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,HLA-A,HLA-A*32:01,Toxicity
3040,pharmgkb,ethanol,702.0,CCO,PDE4B,rs6421482,Toxicity
3041,pharmgkb,ethanol,702.0,CCO,,rs61767420,Toxicity
3042,pharmgkb,ethanol,702.0,CCO,GCKR,rs1260326,Toxicity
3043,pharmgkb,ethanol,702.0,CCO,,rs494904,Toxicity
3044,pharmgkb,ethanol,702.0,CCO,,rs1402398,Toxicity
3045,pharmgkb,ethanol,702.0,CCO,,rs9679319,Toxicity
3046,pharmgkb,ethanol,702.0,CCO,THSD7B,rs13382553,Toxicity
3047,pharmgkb,ethanol,702.0,CCO,,rs2673136,Toxicity
3048,pharmgkb,ethanol,702.0,CCO,CADM2,rs62250713,Toxicity
3049,pharmgkb,ethanol,702.0,CCO,ADH1B,rs75967634,Toxicity
3050,pharmgkb,ethanol,702.0,CCO,ADH1B,rs1229984,Toxicity
3051,pharmgkb,ethanol,702.0,CCO,,rs13129401,Toxicity
3052,pharmgkb,ethanol,702.0,CCO,ADH1C,rs13125415,Toxicity
3053,pharmgkb,ethanol,702.0,CCO,SLC39A8,rs13135092,Toxicity
3054,pharmgkb,antineoplastic agents,,,TP53,rs1042522,Toxicity
3055,pharmgkb,ethanol,702.0,CCO,DPP6,rs2533200,Toxicity
3056,pharmgkb,ethanol,702.0,CCO,,rs2582405,Toxicity
3057,pharmgkb,ethanol,702.0,CCO,,rs7900002,Toxicity
3058,pharmgkb,ethanol,702.0,CCO,,rs56722963,Toxicity
3059,pharmgkb,ethanol,702.0,CCO,"MED19,TMX2",rs576859,Toxicity
3060,pharmgkb,ethanol,702.0,CCO,,rs1783835,Toxicity
3061,pharmgkb,ethanol,702.0,CCO,SLC4A8,rs12296477,Toxicity
3062,pharmgkb,ethanol,702.0,CCO,,rs6589386,Toxicity
3063,pharmgkb,ethanol,702.0,CCO,ARID4A,rs61974485,Toxicity
3064,pharmgkb,ethanol,702.0,CCO,,rs8008020,Toxicity
3065,pharmgkb,ethanol,702.0,CCO,TNRC6A,rs72768626,Toxicity
3066,pharmgkb,ethanol,702.0,CCO,FTO,rs9937709,Toxicity
3067,pharmgkb,ethanol,702.0,CCO,FUT2,rs492602,Toxicity
3068,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,ABCB1,rs1045642,Efficacy
3069,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HTR2A,rs6313,Efficacy
3070,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,HTR2A,rs6313,Efficacy
3071,pharmgkb,ethylmorphine,5359271.0,,CYP2D6,"CYP2D6*1, CYP2D6*4",Metabolism/PK
3072,pharmgkb,hydrocodone,5284569.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4",Toxicity
3073,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4",Toxicity
3074,pharmgkb,dihydrocodeine,5284543.0,,CYP2D6,"CYP2D6*1, CYP2D6*4",Metabolism/PK
3075,pharmgkb,hydrocodone,5284569.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,CYP2D6,"CYP2D6*1, CYP2D6*2xN",Toxicity
3076,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,GSTM3,rs36120609,Metabolism/PK
3077,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,HLA-G,rs371194629,Efficacy
3078,pharmgkb,ethanol,702.0,CCO,OPRM1,rs1799971,Toxicity
3079,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,UGT1A1,"UGT1A1*1, UGT1A1*28",Metabolism/PK
3080,pharmgkb,raloxifene,5035.0,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,UGT1A1,"UGT1A1*1, UGT1A1*28",Efficacy
3081,pharmgkb,raloxifene,5035.0,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,UGT1A1,"UGT1A1*1, UGT1A1*28",Metabolism/PK
3082,pharmgkb,metronidazole,4173.0,CC1=NC=C(N1CCO)[N+](=O)[O-],CYP2A6,"CYP2A6*1, CYP2A6*2, CYP2A6*9, CYP2A6*17",Metabolism/PK
3083,pharmgkb,tranilast,5282230.0,,UGT1A1,"UGT1A1*1, UGT1A1*28",Toxicity
3084,pharmgkb,nilotinib,644241.0,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,UGT1A1,"UGT1A1*1, UGT1A1*6, UGT1A1*27, UGT1A1*28",Toxicity
3085,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-A,HLA-A*31:01,Toxicity
3086,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,ABCB1,rs1128503,Metabolism/PK
3087,pharmgkb,dabigatran,,,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
3088,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CYP2D6,"CYP2D6*1, CYP2D6*10",Dosage
3089,pharmgkb,opioids,,,ABCB1,rs9282564,Toxicity
3090,pharmgkb,opioids,,,COMT,rs4680,Toxicity
3091,pharmgkb,tafenoquine,115358.0,CC1=CC(=NC2=C1C(=C(C=C2NC(C)CCCN)OC)OC3=CC=CC(=C3)C(F)(F)F)OC,,rs62103056,Efficacy
3092,pharmgkb,indinavir,5362440.0,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,UGT1A1,"UGT1A1*1, UGT1A1*28",Toxicity
3093,pharmgkb,peginterferon alfa-2a,,,"IFNL3,IFNL4",rs12979860,Efficacy
3094,pharmgkb,sofosbuvir,45375808.0,C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,"IFNL3,IFNL4",rs12979860,Efficacy
3095,pharmgkb,interferons,,,"IFNL3,IFNL4",rs12979860,Efficacy
3096,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,rs2279343,Toxicity
3097,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,PNOC,rs351776,Toxicity
3098,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,PNOC,rs351776,Toxicity
3099,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,"CYP2A7P1,CYP2B6",rs3745274,Toxicity
3100,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,COMT,rs4680,Toxicity
3101,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,PNOC,rs4732636,Toxicity
3102,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,PNOC,rs4732636,Toxicity
3103,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,COMT,rs740603,Toxicity
3104,pharmgkb,Platinum compounds,,,SLC31A1,rs10759637,Efficacy
3105,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SLC28A2,rs11854484,Efficacy
3106,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2B6,rs28399499,Metabolism/PK
3107,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,"CYP2B6*1, CYP2B6*6",Toxicity
3108,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,"CYP2B6*1, CYP2B6*6",Efficacy
3109,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6, CYP2C9*8, CYP2C9*13, CYP2C9*59, CYP2C9*62",Metabolism/PK
3110,pharmgkb,atazanavir,148192.0,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,UGT1A1,rs887829,Other
3111,pharmgkb,antidepressants,,,"HTR7,RPP30",rs7905446,Efficacy
3112,pharmgkb,Selective serotonin reuptake inhibitors,,,HTR7,rs7905446,Efficacy
3113,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,"HTR7,RPP30",rs7905446,Efficacy
3114,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,"HTR7,RPP30",rs7905446,Efficacy
3115,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs495491,Toxicity
3116,pharmgkb,opioids,,,OPRM1,rs495491,Toxicity
3117,pharmgkb,Platinum compounds,,,TP53,rs1042522,Efficacy
3118,pharmgkb,corticosteroids,,,CRHR1,rs1876828,Efficacy
3119,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,CDA,rs3215400,Toxicity
3120,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,XPC,rs2228001,Toxicity
3121,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,"TMEM43,XPC",rs2228001,Toxicity
3122,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,"TMEM43,XPC",rs2228001,Toxicity
3123,pharmgkb,dapsone,2955.0,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,HLA-B,HLA-B*15:02,Toxicity
3124,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,ABCG2,rs2231142,Toxicity
3125,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,UGT1A1,"UGT1A1*1, UGT1A1*28",Toxicity
3126,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC3,rs9895420,Efficacy
3127,pharmgkb,omeprazole,4594.0,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CYP2C19,"CYP2C19*1, CYP2C19*23, CYP2C19*29, CYP2C19*30, CYP2C19*31, CYP2C19*33",Metabolism/PK
3128,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs9923231,Toxicity
3129,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,HMGCR,rs17244841,Efficacy
3130,pharmgkb,lovastatin acid,64727.0,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)C,SLCO1B1,rs4149056,Metabolism/PK
3131,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"ANKK1,DRD2",rs1800497,Toxicity
3132,pharmgkb,clobazam,2789.0,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Metabolism/PK
3133,pharmgkb,clobazam,2789.0,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Efficacy
3134,pharmgkb,clobazam,2789.0,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Dosage
3135,pharmgkb,corticosteroids,,,ADRB2,rs1042713,Efficacy
3136,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,LPA,rs10455872,Efficacy
3137,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,COMT,rs4680,Efficacy
3138,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,COMT,rs4680,Toxicity
3139,pharmgkb,enalapril,5362032.0,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,ACE,rs1799752,Efficacy
3140,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,CDA,rs2072671,Toxicity
3141,pharmgkb,caffeine,2519.0,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,ADORA2A,rs5751876,Toxicity
3142,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,EGFR,rs11568315,Efficacy
3143,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,CYP2C19,CYP2C19*2,Metabolism/PK
3144,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,EPHX1,rs1051740,Metabolism/PK
3145,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,EPHX1,rs1051740,Dosage
3146,pharmgkb,lapatinib,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,HLA-DRB1,HLA-DRB1*07:01,Toxicity
3147,pharmgkb,tegafur,5386.0,,UMPS,rs1801019,Toxicity
3148,pharmgkb,lopinavir,92727.0,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O,SLCO1B1,rs4149056,Metabolism/PK
3149,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,ABCG2,rs2231142,Efficacy
3150,pharmgkb,Drugs For Treatment Of Tuberculosis,,,,rs1495741,Toxicity
3151,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,ANKK1,rs1800497,Efficacy
3152,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Toxicity
3153,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,SCN1A,rs3812718,Efficacy
3154,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CALU,rs339097,Dosage
3155,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP4F2,rs2108622,Dosage
3156,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,EPHX1,rs2234922,Dosage
3157,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,"CYP2C9*1, CYP2C9*19, CYP2C9*27, CYP2C9*36, CYP2C9*40, CYP2C9*41, CYP2C9*47, CYP2C9*49, CYP2C9*51, CYP2C9*53, CYP2C9*54, CYP2C9*56",Metabolism/PK
3158,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CCHCR1,rs746647,Toxicity
3159,pharmgkb,antipsychotics,,,,rs6977820,Toxicity
3160,pharmgkb,hmg coa reductase inhibitors,,,CETP,rs1532624,Efficacy
3161,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNB2,rs2072661,"Efficacy,Toxicity"
3162,pharmgkb,digoxin,30322.0,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,ABCB1,rs1045642,Metabolism/PK
3163,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,UGT2B10,rs61750900,Metabolism/PK
3164,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,SOD2,rs4880,Efficacy
3165,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,POR,rs1057868,Metabolism/PK
3166,pharmgkb,rosiglitazone,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CYP2C8,"CYP2C8*1, CYP2C8*3",Metabolism/PK
3167,pharmgkb,rosiglitazone,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CYP2C8,"CYP2C8*1, CYP2C8*3",Toxicity
3168,pharmgkb,sunitinib,5329102.0,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,FLT3,rs1933437,Toxicity
3169,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTRR,rs1801394,Efficacy
3170,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs7196161,Dosage
3171,pharmgkb,Bisphosphonates,,,FDPS,rs2297480,Efficacy
3172,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,CRHR2,rs7793837,Efficacy
3173,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,ACE,rs1799752,Efficacy
3174,pharmgkb,nortriptyline,4543.0,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,GNB3,rs5443,Efficacy
3175,pharmgkb,mirtazapine,4205.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Toxicity
3176,pharmgkb,fluindione,,,VKORC1,rs9934438,Efficacy
3177,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,EPHA7,rs78132896,Toxicity
3178,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,CYP19A1,rs1008805,Toxicity
3179,pharmgkb,radiotherapy,,,TANC1,rs10497203,Toxicity
3180,pharmgkb,anthracyclines and related substances,,,CBR3,rs1056892,Toxicity
3181,pharmgkb,anthracyclines and related substances,,,CBR1,rs9024,Toxicity
3182,pharmgkb,esomeprazole,9568614.0,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,STAT6,rs1059513,Efficacy
3183,pharmgkb,antipsychotics,,,HTR2C,rs3813929,Toxicity
3184,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,HTR2C,rs3813929,Toxicity
3185,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HTR2C,rs3813929,Toxicity
3186,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,HTR2C,rs3813929,Toxicity
3187,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,HTR2C,rs1414334,Toxicity
3188,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HTR2C,rs1414334,Toxicity
3189,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,HTR2C,rs518147,Toxicity
3190,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HTR2C,rs6318,Toxicity
3191,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2C,rs6318,Efficacy
3192,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,HTR2C,rs2497538,Toxicity
3193,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,CYP19A1,rs4646,Efficacy
3194,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,CYP19A1,rs4646,Efficacy
3195,pharmgkb,amitriptyline,2160.0,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,CYP2D6,"CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",Metabolism/PK
3196,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP2C19,"CYP2C19*1, CYP2C19*14, CYP2C19*23",Metabolism/PK
3197,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA3,rs1051730,Toxicity
3198,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA3,rs1051730,Dosage
3199,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,NT5C2,rs11598702,Metabolism/PK
3200,pharmgkb,radiotherapy,,,TANC1,rs7582141,Toxicity
3201,pharmgkb,radiotherapy,,,TANC1,rs6432512,Toxicity
3202,pharmgkb,radiotherapy,,,TANC1,rs264631,Toxicity
3203,pharmgkb,radiotherapy,,,TANC1,rs264588,Toxicity
3204,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,PRKCA,rs16960228,Efficacy
3205,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,COL22A1,rs6988229,Efficacy
3206,pharmgkb,radiotherapy,,,TANC1,rs264651,Toxicity
3207,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,ACYP2,rs1872328,Toxicity
3208,pharmgkb,caffeine,2519.0,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,ADORA2A,rs2298383,Toxicity
3209,pharmgkb,cerivastatin,446156.0,CC(C)C1=C(C(=C(C(=N1)C(C)C)/C=C/[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)COC,SLCO1B1,rs4149056,Toxicity
3210,pharmgkb,clodronate,25419.0,C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl,VDR,rs1544410,Efficacy
3211,pharmgkb,sirolimus,6436030.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
3212,pharmgkb,sirolimus,6436030.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Dosage
3213,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,ADRB1,rs1801253,Efficacy
3214,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,SLCO1C1,rs3794271,Efficacy
3215,pharmgkb,Selective serotonin reuptake inhibitors,,,CYP2D6,"CYP2D6*1, CYP2D6*4",Dosage
3216,pharmgkb,"sulfonamides, urea derivatives",,,TCF7L2,rs7903146,Efficacy
3217,pharmgkb,trastuzumab,,,FCGR3A,rs396991,Efficacy
3218,pharmgkb,anthracyclines and related substances,,,HAS3,rs2232228,Toxicity
3219,pharmgkb,trastuzumab,,,FCGR2A,rs1801274,Efficacy
3220,pharmgkb,Selective serotonin reuptake inhibitors,,,COMT,rs13306278,Efficacy
3221,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,rs7089580,Dosage
3222,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,SLCO1B1,rs4149015,Metabolism/PK
3223,pharmgkb,hmg coa reductase inhibitors,,,,rs1719247,Toxicity
3224,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,,rs1346268,Toxicity
3225,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,GGCX,rs11676382,Dosage
3226,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,ABCB1,rs2032582,Efficacy
3227,pharmgkb,anthracyclines and related substances,,,SLC28A3,rs885004,Toxicity
3228,pharmgkb,anthracyclines and related substances,,,SLC28A3,rs7853758,Toxicity
3229,pharmgkb,ibuprofen,3672.0,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,CYP2C8,"CYP2C8*1, CYP2C8*3",Metabolism/PK
3230,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,SEMA3C,rs7779029,Toxicity
3231,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,SCN1A,rs3812718,Dosage
3232,pharmgkb,sildenafil,5212.0,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,GNB3,rs5443,Efficacy
3233,pharmgkb,rituximab,,,FCGR3A,rs396991,Efficacy
3234,pharmgkb,naloxone,5284596.0,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,OPRM1,rs1799971,Efficacy
3235,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,C8orf34,rs1517114,Toxicity
3236,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,HLA-B,HLA-B*58:01,Toxicity
3237,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C19,rs3814637,Dosage
3238,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C19,rs3814637,Toxicity
3239,pharmgkb,gliclazide,3475.0,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,KCNJ11,rs5219,Efficacy
3240,pharmgkb,"sulfonamides, urea derivatives",,,KCNJ11,rs5219,Efficacy
3241,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,GNB3,rs5443,Efficacy
3242,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,CETP,rs708272,Efficacy
3243,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,rs4803419,Metabolism/PK
3244,pharmgkb,alfentanil,51263.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,OPRM1,rs1799971,Efficacy
3245,pharmgkb,alfentanil,51263.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,OPRM1,rs1799971,Toxicity
3246,pharmgkb,alfentanil,51263.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,OPRM1,rs1799971,Metabolism/PK
3247,pharmgkb,alfentanil,51263.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,OPRM1,rs1799971,Dosage
3248,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,OPRM1,rs1799971,Toxicity
3249,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,OPRM1,rs540825,Toxicity
3250,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,OPRM1,rs9397685,Toxicity
3251,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,OPRM1,rs1799971,Efficacy
3252,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,OPRM1,rs1799971,Dosage
3253,pharmgkb,hydrocodone,5284569.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,OPRM1,rs1799971,Toxicity
3254,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,OPRM1,rs1799971,Toxicity
3255,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,OPRM1,rs1799971,Dosage
3256,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,OPRM1,rs1323040,Dosage
3257,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,COMT,rs4680,Toxicity
3258,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,COMT,rs4680,Toxicity
3259,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,COMT,rs740603,Toxicity
3260,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,COMT,rs4680,Efficacy
3261,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,COMT,rs4680,Toxicity
3262,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,COMT,rs4680,Dosage
3263,pharmgkb,remifentanil,60815.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,COMT,rs4680,Efficacy
3264,pharmgkb,opioids,,,COMT,rs4680,Efficacy
3265,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,COMT,rs4680,Efficacy
3266,pharmgkb,opioids,,,OPRM1,rs1799971,Toxicity
3267,pharmgkb,opioids,,,OPRM1,rs1799971,Efficacy
3268,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,OPRM1,rs1799971,Efficacy
3269,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRM1,rs2075572,Toxicity
3270,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRM1,rs1799971,Toxicity
3271,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRM1,rs558025,Dosage
3272,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRM1,rs1799971,Toxicity
3273,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,COMT,rs4680,Toxicity
3274,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",Efficacy
3275,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",Metabolism/PK
3276,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",Dosage
3277,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,rs4917639,Dosage
3278,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,TYMS,rs45445694,Toxicity
3279,pharmgkb,acetaldehyde,177.0,,ALDH2,rs671,Metabolism/PK
3280,pharmgkb,ethanol,702.0,CCO,ALDH2,rs671,Metabolism/PK
3281,pharmgkb,ivacaftor / lumacaftor,71494926.0,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs113993960,Toxicity
3282,pharmgkb,ivacaftor / lumacaftor,71494926.0,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs74551128,Efficacy
3283,pharmgkb,ivacaftor / lumacaftor,71494926.0,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O.CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121909011,Efficacy
3284,pharmgkb,esomeprazole,9568614.0,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Metabolism/PK
3285,pharmgkb,Platinum compounds,,,NQO1,rs1800566,Efficacy
3286,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CYP3A5,"CYP3A5*1, CYP3A5*3",Dosage
3287,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
3288,pharmgkb,antidepressants,,,GRIK4,rs1954787,Efficacy
3289,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,GP1BA,rs6065,Efficacy
3290,pharmgkb,hmg coa reductase inhibitors,,,LPA,rs10455872,Efficacy
3291,pharmgkb,hmg coa reductase inhibitors,,,LPA,rs10455872,Toxicity
3292,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNF,rs1800629,Efficacy
3293,pharmgkb,lapatinib,208908.0,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,HLA-DQA1,HLA-DQA1*02:01,Toxicity
3294,pharmgkb,cetuximab,,,EGF,rs4444903,Efficacy
3295,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,GSTP1,rs1695,Toxicity
3296,pharmgkb,antipsychotics,,,MC4R,rs17782313,Toxicity
3297,pharmgkb,antipsychotics,,,MC4R,rs489693,Toxicity
3298,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,LTC4S,rs730012,Toxicity
3299,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,PTGS1,rs10306114,Efficacy
3300,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,DRD2,rs1076560,Toxicity
3301,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,GSTP1,rs1695,Efficacy
3302,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,UGT1A1,"UGT1A1*1, UGT1A1*6",Dosage
3303,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ABCB1,rs1045642,Dosage
3304,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRD1,rs2236857,Toxicity
3305,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*35:01,Toxicity
3306,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs510769,Toxicity
3307,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRD1,rs3766951,Toxicity
3308,pharmgkb,tolterodine,60774.0,CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10",Metabolism/PK
3309,pharmgkb,SN-38,104842.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)O,UGT1A9,rs3832043,Metabolism/PK
3310,pharmgkb,ondansetron,4595.0,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,ABCB1,rs1045642,Efficacy
3311,pharmgkb,ondansetron,4595.0,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,ABCB1,rs2032582,Efficacy
3312,pharmgkb,opioids,,,OPRM1,rs1799971,Dosage
3313,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CHRNA3,rs578776,"Efficacy,Toxicity"
3314,pharmgkb,hydrochlorothiazide,3639.0,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,YEATS4,rs7297610,Efficacy
3315,pharmgkb,latanoprost,5282380.0,CC(C)OC(=O)CCC/C=C/C[C@H]1[C@H](C[C@H]([C@@H]1CC[C@H](CCC2=CC=CC=C2)O)O)O,PTGFR,rs3753380,Efficacy
3316,pharmgkb,propafenone,4932.0,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,CYP2D6,"CYP2D6*1, CYP2D6*10",Efficacy
3317,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,UGT1A4,rs2011425,Metabolism/PK
3318,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,HTR1A,rs6295,Efficacy
3319,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,ABCB1,rs1045642,Toxicity
3320,pharmgkb,hydralazine,3637.0,C1=CC=C2C(=C1)C=NN=C2NN,NAT2,"NAT2*4, NAT2*5, NAT2*6, NAT2*7",Metabolism/PK
3321,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,SLC22A1,rs34059508,Metabolism/PK
3322,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,ABCB1,rs3842,Metabolism/PK
3323,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,ABCB1,rs10248420,Toxicity
3324,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,CYP3A5,"CYP3A5*1, CYP3A5*3",Toxicity
3325,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,APOC3,rs5128,Metabolism/PK
3326,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,ABCB1,rs4728709,Toxicity
3327,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,ABCB1,rs3842,Toxicity
3328,pharmgkb,tamoxifen,2733526.0,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,CYP2D6,"CYP2D6*1, CYP2D6*87, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*95, CYP2D6*98",Metabolism/PK
3329,pharmgkb,atomoxetine,54841.0,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,CYP2D6,"CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",Metabolism/PK
3330,pharmgkb,"sulfonamides, urea derivatives",,,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Efficacy
3331,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,KDR,rs2071559,Efficacy
3332,pharmgkb,Platinum compounds,,,GSTP1,rs1695,Toxicity
3333,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,ABCB1,rs2032582,Efficacy
3334,pharmgkb,alendronate,2088.0,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,VDR,rs1544410,Efficacy
3335,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,EPHA5,rs7349683,Toxicity
3336,pharmgkb,Platinum compounds,,,HSPA5,rs430397,Efficacy
3337,pharmgkb,direct acting antivirals,,,IFNL4,rs11322783,Efficacy
3338,pharmgkb,telmisartan,65999.0,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,UGT1A3,"UGT1A3*1, UGT1A3*2, UGT1A3*3",Metabolism/PK
3339,pharmgkb,telmisartan,65999.0,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,SLCO1B3,rs60140950,Metabolism/PK
3340,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,rs2279345,Metabolism/PK
3341,pharmgkb,cysteamine,6058.0,C(CS)N,CFTR,rs113993960,Efficacy
3342,pharmgkb,lumacaftor,16678941.0,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,CFTR,rs113993960,Efficacy
3343,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CES1,rs71647871,Metabolism/PK
3344,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CES1,rs71647871,Dosage
3345,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,"C18orf56,TYMS",rs45445694,Efficacy
3346,pharmgkb,taxanes,,,,rs74497159,Toxicity
3347,pharmgkb,indomethacin,3715.0,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,CYP2C9,"CYP2C9*1, CYP2C9*3",Toxicity
3348,pharmgkb,naproxen,1302.0,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CYP2C9,rs780801862,Metabolism/PK
3349,pharmgkb,cavosonstat,56960912.0,C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O,CFTR,rs113993960,Efficacy
3350,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,ALDH2,rs671,Other
3351,pharmgkb,lumacaftor,16678941.0,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,CFTR,rs121909047,Efficacy
3352,pharmgkb,enalapril,5362032.0,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,CES1,rs71647871,Metabolism/PK
3353,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121909011,Efficacy
3354,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs77010898,Efficacy
3355,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508602,Efficacy
3356,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,CES1,rs71647871,Metabolism/PK
3357,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs1800100,Efficacy
3358,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs1800111,Efficacy
3359,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508328,Efficacy
3360,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121909019,Efficacy
3361,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508510,Efficacy
3362,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121908751,Efficacy
3363,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508139,Efficacy
3364,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs34911792,Efficacy
3365,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs77409459,Efficacy
3366,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs397508435,Efficacy
3367,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs121909047,Efficacy
3368,pharmgkb,hmg coa reductase inhibitors,,,RYR1,rs118192172,Toxicity
3369,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,OPRM1,rs1799971,Toxicity
3370,pharmgkb,opioids,,,COMT,rs4680,Dosage
3371,pharmgkb,opioids,,,OPRM1,rs1799971,Toxicity
3372,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,OPRM1,rs79910351,Efficacy
3373,pharmgkb,remifentanil,60815.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,OPRM1,rs79910351,Efficacy
3374,pharmgkb,sofosbuvir,45375808.0,C[C@@H](C(=O)OC(C)C)N[P@](=O)(OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,IFNL4,rs11322783,Efficacy
3375,pharmgkb,opioids,,,KCNJ6,rs6517442,Dosage
3376,pharmgkb,opioids,,,ABCB1,rs1045642,Toxicity
3377,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,OPRM1,rs1799971,Dosage
3378,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,ABCB1,rs2032582,Dosage
3379,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs72547529,"Dosage,Efficacy"
3380,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CNR1,rs806368,Dosage
3381,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,TPH2,rs1386493,Dosage
3382,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRL1,rs2229205,Dosage
3383,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,rs16974799,Dosage
3384,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,NFIB,rs28379954,Metabolism/PK
3385,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NECTIN4,rs11265549,Toxicity
3386,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NECTIN4,rs11265549,Dosage
3387,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,NECTIN4,rs11265549,Metabolism/PK
3388,pharmgkb,ethanol,702.0,CCO,OPRM1,rs1799971,Toxicity
3389,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,SLCO1B1,rs4149056,Efficacy
3390,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,NFKBIA,rs696,Dosage
3391,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,CSMD1,rs6990851,Efficacy
3392,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,DLG2,rs2449598,Efficacy
3393,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,CSMD1,rs6981827,Efficacy
3394,pharmgkb,anastrozole,2187.0,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,,rs1437153,Efficacy
3395,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,DBH,rs1611114,Toxicity
3396,pharmgkb,propranolol,4946.0,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,COMT,rs4680,Efficacy
3397,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,ABCC4,rs9561778,Toxicity
3398,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,GNB3,rs2301339,Efficacy
3399,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,GNB3,rs11064426,Efficacy
3400,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP2C19,"CYP2C19*1, CYP2C19*17",Toxicity
3401,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,HTR2C,rs3813928,Efficacy
3402,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,STRBP,rs9032,Efficacy
3403,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,PYROXD2,rs1061115,Efficacy
3404,pharmgkb,deferasirox,5493381.0,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,UGT1A1,rs4124874,Toxicity
3405,pharmgkb,pregabalin,5486971.0,CC(C)C[C@@H](CC(=O)O)CN,SLC7A5,rs4240803,Toxicity
3406,pharmgkb,gabapentin,3446.0,C1CCC(CC1)(CC(=O)O)CN,SLC7A5,rs4240803,Toxicity
3407,pharmgkb,gabapentin,3446.0,C1CCC(CC1)(CC(=O)O)CN,SLC7A5,rs4240803,Efficacy
3408,pharmgkb,gabapentin,3446.0,C1CCC(CC1)(CC(=O)O)CN,SLC7A5,rs4240803,Dosage
3409,pharmgkb,pregabalin,5486971.0,CC(C)C[C@@H](CC(=O)O)CN,SLC7A5,rs4240803,Efficacy
3410,pharmgkb,propylthiouracil,657298.0,CCCC1=CC(=O)NC(=S)N1,HLA-B,HLA-B*38:02,Toxicity
3411,pharmgkb,carvedilol,2585.0,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,ADRB1,rs1801252,Efficacy
3412,pharmgkb,carvedilol,2585.0,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,ADRB1,rs1801253,Dosage
3413,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,FKBP5,rs4713916,Efficacy
3414,pharmgkb,mirtazapine,4205.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,FKBP5,rs4713916,Efficacy
3415,pharmgkb,bucindolol,51045.0,CC(C)(CC1=CNC2=CC=CC=C21)NCC(COC3=CC=CC=C3C#N)O,ADRB1,rs1801253,Efficacy
3416,pharmgkb,paliperidone,115237.0,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,MC4R,rs489693,Efficacy
3417,pharmgkb,paliperidone,115237.0,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,MC4R,rs17782313,Toxicity
3418,pharmgkb,haloperidol,3559.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,MC4R,rs489693,Toxicity
3419,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,MC4R,rs489693,Toxicity
3420,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,MC4R,rs17782313,Toxicity
3421,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,MC4R,rs489693,Toxicity
3422,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,MC4R,rs17782313,Toxicity
3423,pharmgkb,amisulpride,2159.0,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,MC4R,rs489693,Toxicity
3424,pharmgkb,amisulpride,2159.0,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,MC4R,rs17782313,Toxicity
3425,pharmgkb,aripiprazole,60795.0,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,MC4R,rs489693,Toxicity
3426,pharmgkb,ataluren,11219835.0,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,CFTR,rs77010898,Other
3427,pharmgkb,ataluren,11219835.0,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,CFTR,rs75039782,Other
3428,pharmgkb,ataluren,11219835.0,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,CFTR,rs113993959,Other
3429,pharmgkb,cetuximab,,,KRAS,rs112445441,Efficacy
3430,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,APOA5,rs3135506,Efficacy
3431,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs4149081,Toxicity
3432,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,ABCB1,rs1045642,Metabolism/PK
3433,pharmgkb,opioids,,,BDNF-AS,rs11030096,Toxicity
3434,pharmgkb,opioids,,,GABRB3,rs4906902,Toxicity
3435,pharmgkb,opioids,,,DRD2,rs1079596,Toxicity
3436,pharmgkb,opioids,,,DRD3,rs2654754,Toxicity
3437,pharmgkb,opioids,,,DRD2,rs1125394,Toxicity
3438,pharmgkb,opioids,,,DRD3,rs9288993,Toxicity
3439,pharmgkb,opioids,,,TACR1,rs735668,Toxicity
3440,pharmgkb,opioids,,,ZNF804A,rs7597593,Toxicity
3441,pharmgkb,opioids,,,CNR1,rs2023239,Toxicity
3442,pharmgkb,opioids,,,OPRM1,rs510769,Toxicity
3443,pharmgkb,opioids,,,CNR1,rs6928499,Toxicity
3444,pharmgkb,opioids,,,"CYP2A7P1,CYP2B6",rs3745274,Toxicity
3445,pharmgkb,opioids,,,DRD3,rs6280,Toxicity
3446,pharmgkb,opioids,,,CYP2D6,rs1065852,Toxicity
3447,pharmgkb,opioids,,,DRD3,rs324029,Toxicity
3448,pharmgkb,opioids,,,EXOC4,rs718656,Toxicity
3449,pharmgkb,opioids,,,TACR3,rs1384401,Toxicity
3450,pharmgkb,opioids,,,,rs4530637,Toxicity
3451,pharmgkb,rocuronium,441290.0,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,SLCO1A2,rs7967354,Dosage
3452,pharmgkb,rocuronium,441290.0,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,"IAPP,SLCO1A2",rs11045995,Dosage
3453,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,ABCB1,rs1045642,Efficacy
3454,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,OPRM1,rs1799971,Efficacy
3455,pharmgkb,ibuprofen,3672.0,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,PTGS2,rs20417,Efficacy
3456,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,ABCB1,rs2032582,Efficacy
3457,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,FTO,rs16952570,Toxicity
3458,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],FTO,rs16952570,Toxicity
3459,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,OPRK1,rs1051660,Dosage
3460,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,COMT,rs4680,Efficacy
3461,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,OPRM1,rs1799971,Efficacy
3462,pharmgkb,butorphanol,5361092.0,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,OPRK1,rs702764,Efficacy
3463,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,COMT,rs6269,Efficacy
3464,pharmgkb,butorphanol,5361092.0,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,COMT,rs4633,Efficacy
3465,pharmgkb,butorphanol,5361092.0,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,COMT,rs6269,Efficacy
3466,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,ABCA1,rs2230806,Efficacy
3467,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,ABCA1,rs2230806,Efficacy
3468,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,ABCA1,rs2230806,Efficacy
3469,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4",Efficacy
3470,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4",Efficacy
3471,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4",Efficacy
3472,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,CYP2D6,"CYP2D6*1, CYP2D6*4",Efficacy
3473,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,CETP,rs708272,Efficacy
3474,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,CETP,rs5882,Efficacy
3475,pharmgkb,cotinine glucuronide,178540.0,,UGT1A9,rs12471326,Metabolism/PK
3476,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs145014075,Metabolism/PK
3477,pharmgkb,everolimus,6442177.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
3478,pharmgkb,everolimus,6442177.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,MTOR,rs2024627,Efficacy
3479,pharmgkb,infliximab,,,HLA-B,"HLA-B*08:01, HLA-B*39:01",Toxicity
3480,pharmgkb,infliximab,,,HLA-C,HLA-C*12:03,Toxicity
3481,pharmgkb,infliximab,,,HLA-DQB1,HLA-DQB1*02:01,Toxicity
3482,pharmgkb,infliximab,,,HLA-DPB1,HLA-DPB1*10:01,Toxicity
3483,pharmgkb,infliximab,,,HLA-DRB1,"HLA-DRB1*03:01, HLA-DRB1*04:04",Toxicity
3484,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,MICA,rs1051792,Efficacy
3485,pharmgkb,"Ace Inhibitors, Plain",,,KCNMA1,rs2253201,Toxicity
3486,pharmgkb,voriconazole,71616.0,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,SLCO2B1,rs3781727,Metabolism/PK
3487,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ADORA2A,rs2236624,Toxicity
3488,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ADORA2A,rs2298383,Toxicity
3489,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ADORA2A-AS1,rs17004921,Efficacy
3490,pharmgkb,glyburide,3488.0,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,NOS1AP,rs10494366,Toxicity
3491,pharmgkb,glimepiride,3476.0,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,NOS1AP,rs10494366,Toxicity
3492,pharmgkb,glipizide,3478.0,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,NOS1AP,rs10494366,Toxicity
3493,pharmgkb,oseltamivir,65028.0,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC,ABCB1,rs1045642,Toxicity
3494,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,ABCG2,rs3114020,Metabolism/PK
3495,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,ABCG2,rs2231142,Metabolism/PK
3496,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,SLC22A1,rs628031,Metabolism/PK
3497,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,UGT1A4,"UGT1A4*1a, UGT1A4*1b, UGT1A4*2",Metabolism/PK
3498,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,UGT2B7,rs7668258,Dosage
3499,pharmgkb,Antithyroid Preparations,,,HLA-DRB1,HLA-DRB1*08:03,Toxicity
3500,pharmgkb,Antithyroid Preparations,,,HLA-B,HLA-B*39:01,Toxicity
3501,pharmgkb,Antithyroid Preparations,,,HLA-DQB1,HLA-DQB1*06:01,Toxicity
3502,pharmgkb,Antithyroid Preparations,,,HLA-DQA1,HLA-DQA1*01:03,Toxicity
3503,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs745364489,Toxicity
3504,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs1799807,Toxicity
3505,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs1803274,Toxicity
3506,pharmgkb,antidepressants,,,HTR2A,rs6313,Toxicity
3507,pharmgkb,antidepressants,,,HTR2A,rs6311,Toxicity
3508,pharmgkb,antidepressants,,,HTR2A,rs7997012,Efficacy
3509,pharmgkb,FOLFIRINOX,,,UGT1A1,"UGT1A1*1, UGT1A1*28",Toxicity
3510,pharmgkb,temozolomide,5394.0,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,ABCB1,rs1128503,Metabolism/PK
3511,pharmgkb,carvedilol,2585.0,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10",Metabolism/PK
3512,pharmgkb,carvedilol,2585.0,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*10",Dosage
3513,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP2D6,"CYP2D6*1, CYP2D6*4, CYP2D6*10",Metabolism/PK
3514,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*2xN",Efficacy
3515,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP2D6,"CYP2D6*1, CYP2D6*4",Dosage
3516,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CYP2D6,"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*10, CYP2D6*17",Metabolism/PK
3517,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*5, CYP2D6*10",Toxicity
3518,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,CYP2D6,"CYP2D6*2, CYP2D6*10",Toxicity
3519,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4",Toxicity
3520,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4",Toxicity
3521,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,CYP2D6,"CYP2D6*1, CYP2D6*4",Dosage
3522,pharmgkb,metoprolol,4171.0,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,CYP2D6,"CYP2D6*1, CYP2D6*45, CYP2D6*46",Metabolism/PK
3523,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CYP2D6,"CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",Metabolism/PK
3524,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,CYP2D6,"CYP2D6*1, CYP2D6*87, CYP2D6*88, CYP2D6*89, CYP2D6*90, CYP2D6*91, CYP2D6*93, CYP2D6*94, CYP2D6*95, CYP2D6*97, CYP2D6*98",Metabolism/PK
3525,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,HLA-B,HLA-B*56:02,Toxicity
3526,pharmgkb,isepamicin,3037209.0,,"MT-ND1,MT-RNR1",rs267606617,Toxicity
3527,pharmgkb,micronomicin,3037206.0,,"MT-ND1,MT-RNR1",rs267606619,Toxicity
3528,pharmgkb,aminoglycoside antibacterials,,,MT-RNR1,rs1556422499,Toxicity
3529,pharmgkb,aminoglycoside antibacterials,,,"MT-ND1,MT-RNR1",rs1603218569,Toxicity
3530,pharmgkb,aminoglycoside antibacterials,,,,rs28358572,Toxicity
3531,pharmgkb,dihydrostreptomycin,439369.0,,MT-RNR1,rs1556422499,Toxicity
3532,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CYP3A4,rs2740574,Metabolism/PK
3533,pharmgkb,streptomycin,19649.0,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,MT-RNR1,rs28358569,Toxicity
3534,pharmgkb,gentamicin,3467.0,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,MT-RNR1,rs28358569,Toxicity
3535,pharmgkb,neomycin,8378.0,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N,"MT-ND1,MT-RNR1",rs267606617,Toxicity
3536,pharmgkb,streptomycin,19649.0,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,MT-RNR1,rs1556422499,Toxicity
3537,pharmgkb,streptomycin,19649.0,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,,rs28358571,Toxicity
3538,pharmgkb,kanamycin,6032.0,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,,rs28358571,Toxicity
3539,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,CYP3A4,rs2740574,Dosage
3540,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,"CYP3A,CYP3A4",rs2740574,Metabolism/PK
3541,pharmgkb,tolbutamide,5505.0,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*62",Metabolism/PK
3542,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,COMT,rs4680,Dosage
3543,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,SLCO2B1,rs12422149,Efficacy
3544,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,PACSIN2,rs2413739,Toxicity
3545,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],PACSIN2,rs2413739,Efficacy
3546,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,NUDT15,"NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6",Toxicity
3547,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,NUDT15,"NUDT15*1, NUDT15*4, NUDT15*5, NUDT15*6",Dosage
3548,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,NUDT15,"NUDT15*1, NUDT15*6",Toxicity
3549,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,SLCO1B1,rs4149056,Efficacy
3550,pharmgkb,hmg coa reductase inhibitors,,,CETP,rs708272,Efficacy
3551,pharmgkb,hmg coa reductase inhibitors,,,ABCB1,rs1128503,Other
3552,pharmgkb,hmg coa reductase inhibitors,,,GNB3,rs5443,Efficacy
3553,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ARID5B,rs4948496,Metabolism/PK
3554,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ARID5B,rs4948496,Toxicity
3555,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs11045879,Metabolism/PK
3556,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC2,rs17222723,Toxicity
3557,pharmgkb,doxorubicin,31703.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,GSTP1,rs1695,Toxicity
3558,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SOD2,rs4880,Other
3559,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRD1,rs2236861,Toxicity
3560,pharmgkb,irbesartan,3749.0,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,AGT,rs4762,Efficacy
3561,pharmgkb,irbesartan,3749.0,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,AGT,rs699,Efficacy
3562,pharmgkb,atenolol,2249.0,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,AGT,rs699,Efficacy
3563,pharmgkb,irbesartan,3749.0,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,AGTR1,rs5186,Efficacy
3564,pharmgkb,irbesartan,3749.0,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,ACE,rs1799752,Efficacy
3565,pharmgkb,diazepam,3016.0,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Metabolism/PK
3566,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,SOD2,rs2758339,Toxicity
3567,pharmgkb,sulfamethoxazole,5329.0,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,G6PD,"G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like",Toxicity
3568,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs774072493,Toxicity
3569,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs568724445,Toxicity
3570,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs764841347,Toxicity
3571,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs1560022535,Toxicity
3572,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs531738678,Toxicity
3573,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs201820739,Toxicity
3574,pharmgkb,succinylcholine,5314.0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,BCHE,rs28933390,Toxicity
3575,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFD1,rs2236225,Efficacy
3576,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,TYMS,rs45445694,Efficacy
3577,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs4149056,Efficacy
3578,pharmgkb,Beta Blocking Agents,,,,rs139945292,Efficacy
3579,pharmgkb,Beta Blocking Agents,,,,rs139945292,Toxicity
3580,pharmgkb,rivaroxaban,9875401.0,,ABCB1,rs1045642,Toxicity
3581,pharmgkb,apixaban,10182969.0,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,ABCB1,rs4148738,Toxicity
3582,pharmgkb,pegaspargase,,,ARHGAP28,rs9958628,Toxicity
3583,pharmgkb,pegaspargase,,,HLA-DQB1,HLA-DQB1*02:02,Toxicity
3584,pharmgkb,pegaspargase,,,HLA-DRB1,HLA-DRB1*07:01,Toxicity
3585,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,GGH,rs3758149,Metabolism/PK
3586,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC19A1,rs1051296,Metabolism/PK
3587,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Dosage
3588,pharmgkb,phenprocoumon,9908.0,CCC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Metabolism/PK
3589,pharmgkb,conjugated estrogens,23667301.0,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[Na+],SLCO1B1,"SLCO1B1*1, SLCO1B1*12, SLCO1B1*13",Metabolism/PK
3590,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,SLCO1B1,"SLCO1B1*1, SLCO1B1*14",Efficacy
3591,pharmgkb,olmesartan,130881.0,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,SLCO1B1,"SLCO1B1*15, SLCO1B1*37",Metabolism/PK
3592,pharmgkb,repaglinide,65981.0,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*15, SLCO1B1*37",Metabolism/PK
3593,pharmgkb,atrasentan,,,SLCO1B1,"SLCO1B1*1, SLCO1B1*5, SLCO1B1*9, SLCO1B1*14, SLCO1B1*15, SLCO1B1*37",Metabolism/PK
3594,pharmgkb,opioids,,,CNIH3,rs10799590,Toxicity
3595,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,FPGS,rs1544105,Efficacy
3596,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,DHFR,rs70991108,Toxicity
3597,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,"ENOSF1,TYMS",rs11280056,Toxicity
3598,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,"ENOSF1,TYMS",rs11280056,Efficacy
3599,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,TLR2,rs3804100,Dosage
3600,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,ERCC1,rs11615,Efficacy
3601,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,ERCC1,rs11615,Efficacy
3602,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,ERCC1,rs2336219,Efficacy
3603,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,GGH,rs3758149,Efficacy
3604,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,GGH,rs11545077,Efficacy
3605,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,GGH,rs11545076,Efficacy
3606,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,"CYP2A7P1,CYP2B6",rs3745274,Metabolism/PK
3607,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,TYMS,rs45445694,Toxicity
3608,pharmgkb,salbutamol,2083.0,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,ADRB2,rs1042713,Efficacy
3609,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,UGT2B7,rs7668258,Efficacy
3610,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,UGT2B7,rs7668258,Metabolism/PK
3611,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,ABCB1,rs2032582,Metabolism/PK
3612,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ASTN2,rs7858836,Dosage
3613,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ASTN2,rs958804,Dosage
3614,pharmgkb,antiepileptics,,,SCN2A,rs2304016,Efficacy
3615,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,SCN2A,rs2304016,Efficacy
3616,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,SCN2A,rs2304016,Efficacy
3617,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,SCN2A,rs2304016,Efficacy
3618,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,SCN2A,rs2304016,Efficacy
3619,pharmgkb,topiramate,5284627.0,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,SCN2A,rs2304016,Efficacy
3620,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*67:01,Toxicity
3621,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,VDR,rs11574077,Metabolism/PK
3622,pharmgkb,interferons,,,"IFNL3,IFNL4",rs12979860,Efficacy
3623,pharmgkb,flurbiprofen,3394.0,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,CYP2C9,rs780801862,Metabolism/PK
3624,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,GAD1,rs3762555,Dosage
3625,pharmgkb,rosiglitazone,77999.0,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,CYP2C8,"CYP2C8*1, CYP2C8*3",Efficacy
3626,pharmgkb,talinolol,,,ABCC2,rs2273697,Metabolism/PK
3627,pharmgkb,thiotepa,,,GSTP1,rs1138272,Metabolism/PK
3628,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,COMT,rs9606186,Efficacy
3629,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs11150606,Dosage
3630,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,CCND1,rs9344,Efficacy
3631,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,ABCB1,rs2032582,Efficacy
3632,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,SLC22A1,rs12208357,Metabolism/PK
3633,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,MC4R,rs11872992,Toxicity
3634,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,MC4R,rs11872992,Toxicity
3635,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,GLP1R,rs2268639,Toxicity
3636,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,GLP1R,rs2268639,Toxicity
3637,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,NQO1,rs1800566,Efficacy
3638,pharmgkb,Dipeptidyl peptidase 4 (DPP-4) inhibitors,,,CDKAL1,rs7754840,Efficacy
3639,pharmgkb,ethanol,702.0,CCO,OPRM1,rs1381376,Toxicity
3640,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,OPRM1,rs3778156,Toxicity
3641,pharmgkb,tolbutamide,5505.0,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,CYP2C9,rs771237265,Metabolism/PK
3642,pharmgkb,antipsychotics,,,,rs62097526,Toxicity
3643,pharmgkb,mephenytoin,4060.0,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CYP2C19,rs183701923,Metabolism/PK
3644,pharmgkb,doxorubicin,31703.0,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,AKR1C3,rs1937840,Other
3645,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,OPRM1,rs1799971,Other
3646,pharmgkb,levodopa,6047.0,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,DRD3,rs6280,Toxicity
3647,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,DRD2,rs6275,Dosage
3648,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCB1,rs1045642,Metabolism/PK
3649,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC2,rs3740065,Toxicity
3650,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs4149056,Metabolism/PK
3651,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs4149081,Metabolism/PK
3652,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs2306283,Metabolism/PK
3653,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1A2,rs4149009,Metabolism/PK
3654,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,FPGS,rs1544105,Metabolism/PK
3655,pharmgkb,Bisphosphonates,,,,rs2736308,Toxicity
3656,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCB1,rs1045642,"Efficacy,Toxicity"
3657,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC19A1,rs1051266,Toxicity
3658,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801131,Toxicity
3659,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCB1,rs1128503,Toxicity
3660,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCB1,rs1045642,Toxicity
3661,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTR,rs1805087,Efficacy
3662,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTR,rs1805087,Toxicity
3663,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC2,rs717620,Toxicity
3664,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,CCND1,rs9344,Toxicity
3665,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,CCND1,rs9344,Efficacy
3666,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFD1,rs2236225,Toxicity
3667,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTRR,rs1801394,Toxicity
3668,pharmgkb,disulfiram,3117.0,CCN(CC)C(=S)SSC(=S)N(CC)CC,OPRD1,rs678849,Efficacy
3669,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,SLCO1B1,rs11045879,Toxicity
3670,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,,rs115346678,Toxicity
3671,pharmgkb,cephalexin,27447.0,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O,,rs34545984,Toxicity
3672,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,WBP2NL,rs9620007,Toxicity
3673,pharmgkb,hydrocodone,5284569.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,OPRM1,rs62436463,Toxicity
3674,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,OPRM1,rs62436463,Toxicity
3675,pharmgkb,meperidine,4058.0,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,FIP1L1,rs113100019,Toxicity
3676,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,OPRM1,rs62436463,Toxicity
3677,pharmgkb,codeine,5284371.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,"SEPTIN3,WBP2NL",rs739296,Toxicity
3678,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,"SEPTIN3,WBP2NL",rs739296,Toxicity
3679,pharmgkb,hydrocodone,5284569.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4,"SEPTIN3,WBP2NL",rs739296,Toxicity
3680,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,"SEPTIN3,WBP2NL",rs739296,Toxicity
3681,pharmgkb,meperidine,4058.0,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,SERINC5,rs185462714,Toxicity
3682,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,,rs76103438,Toxicity
3683,pharmgkb,ketorolac,3826.0,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Efficacy
3684,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,ABCB1,rs1128503,Toxicity
3685,pharmgkb,naltrexone,5360515.0,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,,rs12749274,Efficacy
3686,pharmgkb,acamprosate,71158.0,CC(=O)NCCCS(=O)(=O)O,,rs77583603,Efficacy
3687,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-B,HLA-B*46:01,Toxicity
3688,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-B,HLA-B*15:21,Toxicity
3689,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-A,HLA-A*24:02,Toxicity
3690,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,rs2279343,Dosage
3691,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,ABCB1,rs1045642,Dosage
3692,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,DRD1,rs5326,Dosage
3693,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,CYP3A4,"CYP3A4*1, CYP3A4*2, CYP3A4*3, CYP3A4*4, CYP3A4*5, CYP3A4*6, CYP3A4*7, CYP3A4*8, CYP3A4*9, CYP3A4*10, CYP3A4*11, CYP3A4*12, CYP3A4*13, CYP3A4*14, CYP3A4*15, CYP3A4*16, CYP3A4*17, CYP3A4*18, CYP3A4*19, CYP3A4*20, CYP3A4*21, CYP3A4*22, CYP3A4*23, CYP3A4*24, CYP3A4*26, CYP3A4*28, CYP3A4*29, CYP3A4*30, CYP3A4*31, CYP3A4*32, CYP3A4*33, CYP3A4*34",Metabolism/PK
3694,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,,rs62368105,Efficacy
3695,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,,rs6973474,Efficacy
3696,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,,rs13169373,Efficacy
3697,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,,rs7205113,Efficacy
3698,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,ADAMTSL2,rs756770,Efficacy
3699,pharmgkb,naltrexone,5360515.0,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,ADH1C,rs698,Efficacy
3700,pharmgkb,naltrexone,5360515.0,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,ADH1B,rs2066702,Efficacy
3701,pharmgkb,naltrexone,5360515.0,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,ALDH2,rs671,Efficacy
3702,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,OPRM1,rs1799971,Dosage
3703,pharmgkb,naltrexone,5360515.0,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,AKR1C4,rs17134592,Metabolism/PK
3704,pharmgkb,naltrexone,5360515.0,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,AKR1C4,rs3829125,Metabolism/PK
3705,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,OPRK1,rs997917,Toxicity
3706,pharmgkb,opioids,,,OPRK1,rs997917,Toxicity
3707,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,EYA1,rs12678747,Toxicity
3708,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,"CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*24, CYP2A6*25, CYP2A6*26, CYP2A6*27, CYP2A6*28, CYP2A6*35, CYP2A6*46",Toxicity
3709,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs72549435,Metabolism/PK
3710,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs199515342,Metabolism/PK
3711,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs571335587,Metabolism/PK
3712,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs61605570,Metabolism/PK
3713,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs768416963,Metabolism/PK
3714,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs1302192284,Metabolism/PK
3715,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs111869995,Metabolism/PK
3716,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs137904044,Metabolism/PK
3717,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs114558780,Metabolism/PK
3718,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs200554095,Metabolism/PK
3719,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs772964366,Metabolism/PK
3720,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs758479488,Metabolism/PK
3721,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs145157460,Metabolism/PK
3722,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs148693084,Metabolism/PK
3723,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs1303839356,Metabolism/PK
3724,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs778019189,Metabolism/PK
3725,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs374515279,Metabolism/PK
3726,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs777098658,Metabolism/PK
3727,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs145308399,Metabolism/PK
3728,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,rs5031016,Metabolism/PK
3729,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,OPRD1,rs678849,Efficacy
3730,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,FAAH,rs324420,Toxicity
3731,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,OPRM1,rs1799971,Toxicity
3732,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,OPRM1,rs1799971,Dosage
3733,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CYP3A5,"CYP3A5*1, CYP3A5*3, CYP3A5*6",Metabolism/PK
3734,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,rs3745274,Dosage
3735,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,OPRM1,rs10485058,Efficacy
3736,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,DAO,rs55944529,Metabolism/PK
3737,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,DAO,rs55944529,Dosage
3738,pharmgkb,abiraterone,132971.0,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O,SRD5A2,rs523349,Efficacy
3739,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,ABCG2,rs2231142,Other
3740,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,ABCG2,rs2231142,Metabolism/PK
3741,pharmgkb,fluvastatin,1548972.0,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,ABCG2,rs2231142,Metabolism/PK
3742,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801133,Metabolism/PK
3743,pharmgkb,folic acid,6037.0,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,MTHFR,rs1801133,Metabolism/PK
3744,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801133,Efficacy
3745,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801133,Efficacy
3746,pharmgkb,sacubitril,,,CES1,rs71647871,Metabolism/PK
3747,pharmgkb,sulfamethoxazole / trimethoprim,358641.0,,HLA-B,HLA-B*07:02,Toxicity
3748,pharmgkb,sulfamethoxazole / trimethoprim,358641.0,,HLA-C,HLA-C*07:02,Toxicity
3749,pharmgkb,sulfamethoxazole / trimethoprim,358641.0,,GSTM1,"GSTM1 non-null, GSTM1 null",Toxicity
3750,pharmgkb,sulfamethoxazole / trimethoprim,358641.0,,NAT2,rs1799931,Toxicity
3751,pharmgkb,sulfamethoxazole / trimethoprim,358641.0,,NAT2,rs1799930,Toxicity
3752,pharmgkb,hmg coa reductase inhibitors,,,,rs13210472,Toxicity
3753,pharmgkb,Glucarpidase,,,"INSRR,NTRK1",rs10908521,Toxicity
3754,pharmgkb,Glucarpidase,,,,rs1353327,Toxicity
3755,pharmgkb,Glucarpidase,,,,rs9345389,Toxicity
3756,pharmgkb,Glucarpidase,,,GATA3,rs3824662,Toxicity
3757,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,CYP1A2,"CYP1A2*1A, CYP1A2*1C, CYP1A2*1F",Toxicity
3758,pharmgkb,quetiapine,5002.0,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,CYP3A4,"CYP3A4*1, CYP3A4*3",Metabolism/PK
3759,pharmgkb,alprazolam,2118.0,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CYP3A4,"CYP3A4*1, CYP3A4*22",Toxicity
3760,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP3A5,"CYP3A5*1, CYP3A5*3",Toxicity
3761,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP3A4,"CYP3A4*1, CYP3A4*8, CYP3A4*20, CYP3A4*22",Toxicity
3762,pharmgkb,diclofenac,3033.0,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*8, CYP2C9*13, CYP2C9*36, CYP2C9*37, CYP2C9*38, CYP2C9*39, CYP2C9*40, CYP2C9*42, CYP2C9*43, CYP2C9*44, CYP2C9*45, CYP2C9*46, CYP2C9*47, CYP2C9*48, CYP2C9*50, CYP2C9*52, CYP2C9*53, CYP2C9*54, CYP2C9*55, CYP2C9*59, CYP2C9*60, CYP2C9*62",Metabolism/PK
3763,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,KIF6,rs20455,Efficacy
3764,pharmgkb,acetaminophen,1983.0,CC(=O)NC1=CC=C(C=C1)O,HLA-DQB1,HLA-DQB1*02:02,Toxicity
3765,pharmgkb,opioids,,,,rs2952768,Efficacy
3766,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,,rs2952768,Dosage
3767,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,TPMT,"TPMT*1, TPMT*21, TPMT*33, TPMT*34",Toxicity
3768,pharmgkb,thioguanine,2723601.0,C1=NC2=C(N1)C(=S)N=C(N2)N,TPMT,"TPMT*1, TPMT*21, TPMT*33, TPMT*34",Toxicity
3769,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,TPMT,"TPMT*1, TPMT*21, TPMT*33, TPMT*34",Dosage
3770,pharmgkb,thioguanine,2723601.0,C1=NC2=C(N1)C(=S)N=C(N2)N,TPMT,"TPMT*1, TPMT*21, TPMT*33, TPMT*34",Dosage
3771,pharmgkb,thioguanine,2723601.0,C1=NC2=C(N1)C(=S)N=C(N2)N,TPMT,"TPMT*1, TPMT*19, TPMT*20, TPMT*21, TPMT*22, TPMT*30, TPMT*32, TPMT*33, TPMT*34",Metabolism/PK
3772,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,TPMT,"TPMT*1, TPMT*21, TPMT*24, TPMT*25, TPMT*32, TPMT*33, TPMT*34, TPMT*37",Metabolism/PK
3773,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,CYP1A2,"CYP1A2*1A, CYP1A2*1F",Metabolism/PK
3774,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC4,rs3742106,Metabolism/PK
3775,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC4,rs1751034,Metabolism/PK
3776,pharmgkb,tenofovir disoproxil fumarate,6398764.0,,ABCC10,rs9349256,Toxicity
3777,pharmgkb,tenofovir disoproxil fumarate,6398764.0,,ABCC4,rs3742106,Toxicity
3778,pharmgkb,digoxin,30322.0,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,NOS1AP,rs10494366,Toxicity
3779,pharmgkb,highly active antiretroviral therapy (haart),,,ABCB1,rs1045642,Efficacy
3780,pharmgkb,sulfamethoxazole / trimethoprim,358641.0,,NAT2,"NAT2*4, NAT2*5A, NAT2*5B, NAT2*6A, NAT2*6B, NAT2*7A, NAT2*7B, NAT2*14A, NAT2*14B",Toxicity
3781,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,AHRR,rs2292596,Efficacy
3782,pharmgkb,phenytoin,1775.0,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,CYP2C9,"CYP2C9*1, CYP2C9*3",Toxicity
3783,pharmgkb,ketoprofen,3825.0,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2",Toxicity
3784,pharmgkb,ketoprofen,3825.0,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,CYP2C9,"CYP2C9*1, CYP2C9*3",Efficacy
3785,pharmgkb,methoxsalen,4114.0,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,CYP2A6,"CYP2A6*1, CYP2A6*15, CYP2A6*21, CYP2A6*22",Metabolism/PK
3786,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,"CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*46",Dosage
3787,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,"CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*9, CYP2A6*12",Toxicity
3788,pharmgkb,hydralazine,3637.0,C1=CC=C2C(=C1)C=NN=C2NN,NAT2,"NAT2*4, NAT2*5D, NAT2*6B, NAT2*7A, NAT2*12A, NAT2*13A, NAT2*14A",Efficacy
3789,pharmgkb,tegafur,5386.0,,CYP2A6,"CYP2A6*1, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*11, CYP2A6*18, CYP2A6*19, CYP2A6*46",Metabolism/PK
3790,pharmgkb,letrozole,3902.0,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,CYP2A6,"CYP2A6*1, CYP2A6*2, CYP2A6*4, CYP2A6*7, CYP2A6*9, CYP2A6*12, CYP2A6*17, CYP2A6*20, CYP2A6*23, CYP2A6*35, CYP2A6*46",Metabolism/PK
3791,pharmgkb,coumarin,,,CYP2A6,"CYP2A6*1, CYP2A6*4, CYP2A6*5, CYP2A6*6, CYP2A6*7, CYP2A6*9, CYP2A6*10, CYP2A6*12, CYP2A6*17, CYP2A6*18, CYP2A6*19, CYP2A6*20",Metabolism/PK
3792,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,CYP2A6,"CYP2A6*1, CYP2A6*1x2, CYP2A6*2",Toxicity
3793,pharmgkb,buprenorphine / naloxone,,,UGT2B7,rs7662029,Metabolism/PK
3794,pharmgkb,buprenorphine / naloxone,,,UGT2B7,rs7439366,Metabolism/PK
3795,pharmgkb,tramadol,33741.0,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,ABCB1,rs1045642,Toxicity
3796,pharmgkb,nifedipine,4485.0,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,CYP3A4,"CYP3A4*1, CYP3A4*17",Metabolism/PK
3797,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,N6AMT1,rs2254638,Efficacy
3798,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,P2RY12,rs2046934,Efficacy
3799,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PTGS1,rs1330344,Efficacy
3800,pharmgkb,nimodipine,4497.0,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,CACNA1C,rs2239050,Efficacy
3801,pharmgkb,Beta Blocking Agents,,,ADRA2C,rs61767072,Efficacy
3802,pharmgkb,Beta Blocking Agents,,,GRK5,rs10787959,Efficacy
3803,pharmgkb,Beta Blocking Agents,,,GRK5,rs3740563,Efficacy
3804,pharmgkb,Beta Blocking Agents,,,GRK5,rs11198893,Efficacy
3805,pharmgkb,Beta Blocking Agents,,,GRK5,rs4752292,Efficacy
3806,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,TNF,rs1800629,Toxicity
3807,pharmgkb,Glucarpidase,,,SLCO1B1,rs4149056,Toxicity
3808,pharmgkb,Glucarpidase,,,ABCC4,rs7317112,Toxicity
3809,pharmgkb,alprazolam,2118.0,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,CYP3A4,"CYP3A4*1, CYP3A4*22",Efficacy
3810,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,CYP3A4,rs2740574,Efficacy
3811,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,CYP2C9,rs1934969,Other
3812,pharmgkb,"sulfonamides, urea derivatives",,,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Efficacy
3813,pharmgkb,clozapine,2818.0,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,HLA-DRB1,HLA-DRB1*04:02,Toxicity
3814,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-DRB1,HLA-DRB1*03:01,Toxicity
3815,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,PIK3R5,rs444904,Toxicity
3816,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,EGFR,rs917881,Toxicity
3817,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,VEGFB,rs12366035,Toxicity
3818,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,EPAS1,rs4035887,Toxicity
3819,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,KDR,rs4864950,Toxicity
3820,pharmgkb,regorafenib,,,KDR,rs4864950,Toxicity
3821,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,,rs10958704,Toxicity
3822,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,EPAS1,rs1868089,Toxicity
3823,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,PRKCE,rs11125039,Toxicity
3824,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,ADAMTS18,rs1346563,Toxicity
3825,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,EGFR,rs2330951,Toxicity
3826,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,MAP2K6,rs11651488,Toxicity
3827,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,CDH13,rs17682789,Toxicity
3828,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,WWOX,rs9927200,Toxicity
3829,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,EGFR,rs917881,Toxicity
3830,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,MAP2K6,rs12948059,Toxicity
3831,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,,rs315498,Toxicity
3832,pharmgkb,sorafenib,216239.0,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,EPAS1,rs9973653,Toxicity
3833,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,CAMK1D,rs10737062,Efficacy
3834,pharmgkb,losartan,3961.0,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,CAMK1D,rs10752271,Efficacy
3835,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,IL10,rs1800871,Metabolism/PK
3836,pharmgkb,rivaroxaban,9875401.0,,ABCB1,rs1045642,Metabolism/PK
3837,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,CYP3A4,rs2242480,Toxicity
3838,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,CYP3A4,rs2242480,Dosage
3839,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,CYP3A4,rs2242480,Efficacy
3840,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,CYP3A4,rs2242480,Metabolism/PK
3841,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A4,rs2242480,Toxicity
3842,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CYP3A4,rs2242480,Efficacy
3843,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,rs2242480,Metabolism/PK
3844,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,"CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22",Metabolism/PK
3845,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,"FASTKD3,MTRR",rs1801394,Efficacy
3846,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,"FASTKD3,MTRR",rs1801394,Other
3847,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,GABRA2,rs279858,Other
3848,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,"FASTKD3,MTRR",rs2307116,Other
3849,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,KCNK3,rs1275988,Other
3850,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,"CYP2E1,DUX1",rs2031920,Other
3851,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,CYP2E1,rs3813867,Other
3852,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,KCNK2,rs6686529,Efficacy
3853,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,GRIN2B,rs1806201,Other
3854,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,"FASTKD3,MTRR",rs3733784,Efficacy
3855,pharmgkb,sevoflurane,5206.0,C(OC(C(F)(F)F)C(F)(F)F)F,"FASTKD3,MTRR",rs2307116,Efficacy
3856,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*39:01,Toxicity
3857,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,"HLA-B*15:18, HLA-B*40:01",Toxicity
3858,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,HLA-C,HLA-C*06:02,Efficacy
3859,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-DQB1,HLA-DQB1*05:01,Toxicity
3860,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*15:01,Toxicity
3861,pharmgkb,minocycline,5281021.0,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)/C(=C(/N)\O)/C1=O)O)O)O)N(C)C,HLA-B,HLA-B*35:02,Toxicity
3862,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],ITPA,rs1127354,Efficacy
3863,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,CES1,rs2244613,Toxicity
3864,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CALM1,rs12885713,Efficacy
3865,pharmgkb,cyclosporine,6435893.0,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,,rs2874116,Efficacy
3866,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,TPMT,rs1142345,Toxicity
3867,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs7997012,Efficacy
3868,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,HTR2A,rs7997012,Efficacy
3869,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs6311,Toxicity
3870,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs6311,Toxicity
3871,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,HTR2A,rs6311,Toxicity
3872,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs6313,Toxicity
3873,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,HTR2A,rs6313,Toxicity
3874,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs9316233,Efficacy
3875,pharmgkb,Selective serotonin reuptake inhibitors,,,HTR2A,rs6311,Toxicity
3876,pharmgkb,fluvoxamine,3404.0,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Efficacy
3877,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,SLC6A4,rs57098334,Efficacy
3878,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Efficacy
3879,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Toxicity
3880,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,SLC6A4,rs57098334,Efficacy
3881,pharmgkb,antidepressants,,,SLC6A4,rs57098334,Toxicity
3882,pharmgkb,Selective serotonin reuptake inhibitors,,,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Toxicity
3883,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP2D6,rs1065852,Efficacy
3884,pharmgkb,vincristine,5978.0,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,CEP72,rs924607,Toxicity
3885,pharmgkb,mianserin,4184.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,CYP2D6,"CYP2D6*1, CYP2D6*5, CYP2D6*10",Metabolism/PK
3886,pharmgkb,rabeprazole,5029.0,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Efficacy
3887,pharmgkb,esomeprazole,9568614.0,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Efficacy
3888,pharmgkb,prasugrel,6918456.0,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,CYP2C19,"CYP2C19*1, CYP2C19*17",Toxicity
3889,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,ABCG2,rs2231142,Toxicity
3890,pharmgkb,Glucarpidase,,,ARID5B,rs10821936,Toxicity
3891,pharmgkb,n-desmethyltamoxifen,3032890.0,CC/C(=C(/C1=CC=CC=C1)\C2=CC=C(C=C2)OCCNC)/C3=CC=CC=C3,CYP2D6,"CYP2D6*1, CYP2D6*7, CYP2D6*9, CYP2D6*10, CYP2D6*12, CYP2D6*14, CYP2D6*17, CYP2D6*18, CYP2D6*22, CYP2D6*23, CYP2D6*24, CYP2D6*25, CYP2D6*26, CYP2D6*27, CYP2D6*28, CYP2D6*29, CYP2D6*30, CYP2D6*31, CYP2D6*32, CYP2D6*33, CYP2D6*36, CYP2D6*37, CYP2D6*40, CYP2D6*43, CYP2D6*45, CYP2D6*46, CYP2D6*47, CYP2D6*49, CYP2D6*50, CYP2D6*51, CYP2D6*52, CYP2D6*54, CYP2D6*55, CYP2D6*61, CYP2D6*62, CYP2D6*63, CYP2D6*64, CYP2D6*65, CYP2D6*70, CYP2D6*71, CYP2D6*114",Metabolism/PK
3892,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP3A5,rs776746,Other
3893,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,MTHFR,rs1801133,Toxicity
3894,pharmgkb,antiepileptics,,,ABCB1,rs2032582,Efficacy
3895,pharmgkb,cyclophosphamide,2907.0,C1CNP(=O)(OC1)N(CCCl)CCCl,XRCC1,rs25487,"Efficacy,Toxicity"
3896,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP2C8,rs11572103,Dosage
3897,pharmgkb,leflunomide,3899.0,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,CYP1A2,rs762551,Toxicity
3898,pharmgkb,antipsychotics,,,CYP1A2,rs2069514,Toxicity
3899,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,EPHX1,rs1131873,Dosage
3900,pharmgkb,lithium,28486.0,[Li+],CLOCK,rs1801260,Toxicity
3901,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,UGT1A9,rs17868320,Efficacy
3902,pharmgkb,antidepressants,,,GNB3,rs5443,Efficacy
3903,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,SCAP,rs12487736,Other
3904,pharmgkb,pravastatin,54687.0,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,SLCO1B1,rs2306283,Efficacy
3905,pharmgkb,amlodipine,2162.0,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CYP3A4,rs2740574,Efficacy
3906,pharmgkb,fenofibrate,3339.0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,FABP1,rs2241883,Efficacy
3907,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,BDNF,rs6265,Toxicity
3908,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,RRM1,rs1042858,Efficacy
3909,pharmgkb,benazepril,5362124.0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,ADRB2,rs1042713,Efficacy
3910,pharmgkb,ranibizumab,,,VEGFA,rs833069,Efficacy
3911,pharmgkb,propranolol,4946.0,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,CYP2D6,"CYP2D6*1, CYP2D6*10",Other
3912,pharmgkb,mefloquine,4046.0,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,G6PD,"G6PD A- 202A_376G, G6PD B (reference)",Toxicity
3913,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,UGT1A9,rs3832043,Toxicity
3914,pharmgkb,chloroquine,2719.0,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,G6PD,"G6PD A- 202A_376G, G6PD B (reference), G6PD Mediterranean Haplotype, G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",Toxicity
3915,pharmgkb,antiepileptics,,,ABCC2,rs3740066,Efficacy
3916,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,HTR3B,rs1176744,Toxicity
3917,pharmgkb,ranibizumab,,,VEGFA,rs699947,Efficacy
3918,pharmgkb,capecitabine,60953.0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,ADCY2,rs4702484,Efficacy
3919,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,rs776746,Toxicity
3920,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,SLCO1B1,rs4363657,Toxicity
3921,pharmgkb,carisoprodol,2576.0,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,CYP2C19,"CYP2C19*1, CYP2C19*2",Metabolism/PK
3922,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PON1,rs662,"Efficacy,Toxicity"
3923,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,P2RY12,rs6785930,"Efficacy,Toxicity"
3924,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,ABCB1,rs1045642,Efficacy
3925,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,GSTT1,"GSTT1 non-null, GSTT1 null",Toxicity
3926,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC2,rs2273697,Toxicity
3927,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,VEGFA,rs699947,Efficacy
3928,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,UGT2B7,rs7439366,Other
3929,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,rs776746,Toxicity
3930,pharmgkb,atorvastatin,60823.0,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,CETP,rs708272,"Efficacy,Toxicity"
3931,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CETP,rs708272,Efficacy
3932,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2A6,rs8192726,Other
3933,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2A6,rs28399454,Other
3934,pharmgkb,Photodynamic therapy,,,CFH,rs1061170,Efficacy
3935,pharmgkb,gefitinib,123631.0,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,ABCG2,rs2231142,Toxicity
3936,pharmgkb,antiepileptics,,,ABCB1,rs1128503,Efficacy
3937,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,UGT2B7,rs28365062,Metabolism/PK
3938,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CYP3A5,rs776746,Other
3939,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,DRD2,rs6277,Efficacy
3940,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,IMPDH1,rs2278293,Toxicity
3941,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,ABCB1,rs2032582,Efficacy
3942,pharmgkb,mycophenolate mofetil,5281078.0,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,UGT1A9,rs6714486,Efficacy
3943,pharmgkb,lithium,28486.0,[Li+],NTRK2,rs1387923,Efficacy
3944,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP3A5,rs776746,Other
3945,pharmgkb,anthracyclines and related substances,,,FMO3,rs1736557,Toxicity
3946,pharmgkb,anthracyclines and related substances,,,HNMT,rs17583889,Toxicity
3947,pharmgkb,anthracyclines and related substances,,,,rs17645700,Toxicity
3948,pharmgkb,anthracyclines and related substances,,,UGT1A6,rs4261716,Toxicity
3949,pharmgkb,anthracyclines and related substances,,,UGT1A6,rs6759892,Toxicity
3950,pharmgkb,anthracyclines and related substances,,,UGT1A6,rs17863783,Toxicity
3951,pharmgkb,anthracyclines and related substances,,,ADH7,rs729147,Toxicity
3952,pharmgkb,anthracyclines and related substances,,,SLC22A2,rs316019,Toxicity
3953,pharmgkb,anthracyclines and related substances,,,ABCB4,rs1149222,Toxicity
3954,pharmgkb,anthracyclines and related substances,,,ABCB4,rs4148808,Toxicity
3955,pharmgkb,anthracyclines and related substances,,,ABCB1,rs2235047,Toxicity
3956,pharmgkb,anthracyclines and related substances,,,SLC28A3,rs4877847,Toxicity
3957,pharmgkb,anthracyclines and related substances,,,SLC10A2,rs9514091,Toxicity
3958,pharmgkb,anthracyclines and related substances,,,SLC10A2,rs7319981,Toxicity
3959,pharmgkb,anthracyclines and related substances,,,SLC28A1,rs2290271,Toxicity
3960,pharmgkb,anthracyclines and related substances,,,ABCC1,rs4148350,Toxicity
3961,pharmgkb,anthracyclines and related substances,,,SLC28A1,rs2305364,Toxicity
3962,pharmgkb,anthracyclines and related substances,,,SPG7,rs2019604,Toxicity
3963,pharmgkb,anthracyclines and related substances,,,CYP4F2,rs2108623,Toxicity
3964,pharmgkb,anthracyclines and related substances,,,SULT2B1,rs10426377,Toxicity
3965,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,HNF4A,rs2071197,"Efficacy,Metabolism/PK"
3966,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP2C8,rs1934951,Toxicity
3967,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,ERCC2,rs13181,Toxicity
3968,pharmgkb,ustekinumab,,,TNFAIP3,rs610604,Efficacy
3969,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,ABCB1,rs1128503,Metabolism/PK
3970,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,ABCB1,rs1045642,"Dosage,Metabolism/PK"
3971,pharmgkb,antiepileptics,,,ABCC2,rs717620,Efficacy
3972,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,SLCO1B1,rs2306283,Toxicity
3973,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,ABCB1,rs1045642,Toxicity
3974,pharmgkb,tocilizumab,,,IL6R,rs4329505,Efficacy
3975,pharmgkb,sirolimus,6436030.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,CYP3A4,"CYP3A4*1, CYP3A4*22",Metabolism/PK
3976,pharmgkb,propofol,4943.0,CC(C)C1=C(C(=CC=C1)C(C)C)O,CYP2B6,rs2279343,Metabolism/PK
3977,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,P2RY12,rs2046934,Efficacy
3978,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,IL10,rs1800896,Metabolism/PK
3979,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,CYP3A4,rs35599367,Efficacy
3980,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HNF4A,rs2071197,Metabolism/PK
3981,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs10841753,Metabolism/PK
3982,pharmgkb,lumefantrine,6437380.0,CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)/C(=C/C4=CC=C(C=C4)Cl)/C2=CC(=C1)Cl)O,CYP3A5,rs41303343,Metabolism/PK
3983,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,HLA-B,HLA-B*38:02,Toxicity
3984,pharmgkb,"Ace Inhibitors, Plain",,,KCNIP4,rs16870989,Toxicity
3985,pharmgkb,nevirapine,4463.0,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CYP2B6,rs3745274,Toxicity
3986,pharmgkb,"Ace Inhibitors, Plain",,,KCNIP4,rs7661530,Toxicity
3987,pharmgkb,"Ace Inhibitors, Plain",,,KCNIP4,rs7675300,Toxicity
3988,pharmgkb,buprenorphine,40400.0,CC(C)(C)C(C)([C@H]1C[C@@]23CC[C@]1(C4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,OPRD1,rs581111,Efficacy
3989,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,PSORS1C1,rs3815087,Toxicity
3990,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,NR1I3,rs2501873,Dosage
3991,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs2032582,"Dosage,Metabolism/PK"
3992,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs1128503,"Dosage,Metabolism/PK"
3993,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,ABCB1,rs1045642,Efficacy
3994,pharmgkb,acenocoumarol,9052.0,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(OC3=CC=CC=C3C2=O)O,GGCX,rs11676382,Dosage
3995,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,GGCX,rs12714145,Dosage
3996,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,GGCX,rs699664,Dosage
3997,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,BDNF,rs7103411,Efficacy
3998,pharmgkb,gemcitabine,60750.0,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,SLC29A3,rs780668,Efficacy
3999,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,rs7624766,Efficacy
4000,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,rs1901633,Efficacy
4001,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,rs4982133,Efficacy
4002,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,rs1703794,Efficacy
4003,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,PTPRM,rs6506569,Efficacy
4004,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,rs2650972,Efficacy
4005,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,rs6064463,Efficacy
4006,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,ABCB1,rs1045642,Dosage
4007,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,rs776746,Efficacy
4008,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs1045642,Toxicity
4009,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,AMPD1,rs17602729,"Efficacy,Toxicity"
4010,pharmgkb,Platinum compounds,,,ERCC2,rs1799793,"Efficacy,Toxicity"
4011,pharmgkb,adefovir dipivoxil,60871.0,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,SLC22A6,rs11568634,Other
4012,pharmgkb,lisinopril,5362119.0,C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O,ACE,rs1799752,Efficacy
4013,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,ABCB1,rs1045642,Metabolism/PK
4014,pharmgkb,allopurinol,2094.0,C1=C2C(=NC=NC2=O)NN1,ABCG2,rs10011796,Efficacy
4015,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,SLC6A2,rs5569,Efficacy
4016,pharmgkb,opioids,,,OPRM1,rs1799972,Toxicity
4017,pharmgkb,cocaine,5760.0,CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC,OPRM1,rs1799971,Toxicity
4018,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,OPRM1,rs1799971,Toxicity
4019,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP3A4,rs2242480,Efficacy
4020,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,COMT,rs4633,Efficacy
4021,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,COMT,rs4680,Efficacy
4022,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"ANKK1,DRD2",rs1800497,Efficacy
4023,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,ABCB1,rs1045642,Efficacy
4024,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,ABCB1,rs1045642,Dosage
4025,pharmgkb,heroin,5462328.0,CC(=O)O[C@H]1C=C[C@H]2[C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)OC(=O)C)CCN3C,OPRM1,rs1799971,Toxicity
4026,pharmgkb,Drugs For Treatment Of Tuberculosis,,,CYP2E1,rs2031920,Toxicity
4027,pharmgkb,amlodipine,2162.0,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CYP3A4,rs2246709,Efficacy
4028,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,ABCB1,rs1045642,"Dosage,Metabolism/PK"
4029,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP4F2,rs2108622,Other
4030,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Toxicity
4031,pharmgkb,simvastatin,54454.0,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,ABCB1,rs1045642,Efficacy
4032,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,UGT2B7,rs7439366,Dosage
4033,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,LRP2,rs2075252,Toxicity
4034,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,ABCB1,rs1128503,Metabolism/PK
4035,pharmgkb,efavirenz,64139.0,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,CYP2B6,rs3211371,Metabolism/PK
4036,pharmgkb,carvedilol,2585.0,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,UGT1A1,"UGT1A1*1, UGT1A1*28",Metabolism/PK
4037,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2B6,"CYP2B6*1, CYP2B6*6",Dosage
4038,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
4039,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Metabolism/PK
4040,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3",Metabolism/PK
4041,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Efficacy
4042,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,CYP2C19,"CYP2C19*1, CYP2C19*2",Efficacy
4043,pharmgkb,oxaliplatin,6857599.0,C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)O)O.[Pt+2],GSTP1,rs1695,Efficacy
4044,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,ADRA2A,rs1800544,Efficacy
4045,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,POR,rs1057868,Toxicity
4046,pharmgkb,Platinum compounds,,,ERCC1,rs3212986,Efficacy
4047,pharmgkb,clopidogrel,60606.0,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Efficacy
4048,pharmgkb,azathioprine,2265.0,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],ITPA,rs7270101,Toxicity
4049,pharmgkb,aspirin,2244.0,CC(=O)OC1=CC=CC=C1C(=O)O,ITGB3,rs5918,Efficacy
4050,pharmgkb,Tumor necrosis factor alpha (TNF-alpha) inhibitors,,,TNF,rs1799724,Efficacy
4051,pharmgkb,mercaptopurine,667490.0,C1=NC2=C(N1)C(=S)N=CN2,ITPA,rs1127354,Toxicity
4052,pharmgkb,metformin,4091.0,CN(C)C(=N)N=C(N)N,"ATM,C11orf65",rs11212617,Efficacy
4053,pharmgkb,tacrolimus,445643.0,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC,CYP3A5,"CYP3A5*1, CYP3A5*3",Toxicity
4054,pharmgkb,risperidone,5073.0,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,DRD2,rs1799978,Efficacy
4055,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*10, CYP2D6*87, CYP2D6*89, CYP2D6*90, CYP2D6*93, CYP2D6*95, CYP2D6*97, CYP2D6*98",Metabolism/PK
4056,pharmgkb,olanzapine,4585.0,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,CYP3A5,"CYP3A5*1, CYP3A5*3",Metabolism/PK
4057,pharmgkb,antiepileptics,,,ABCB1,rs1045642,Efficacy
4058,pharmgkb,naproxen,1302.0,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*29",Metabolism/PK
4059,pharmgkb,fluorouracil,3385.0,C1=C(C(=O)NC(=O)N1)F,DPYD,rs3918290,Efficacy
4060,pharmgkb,ivacaftor,16220172.0,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CFTR,rs113993960,Efficacy
4061,pharmgkb,tenofovir,464205.0,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,ABCC2,rs8187710,Toxicity
4062,pharmgkb,ethanol,702.0,CCO,OPRM1,rs1799971,Toxicity
4063,pharmgkb,sufentanil,41693.0,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,OPRM1,rs1799971,Toxicity
4064,pharmgkb,naltrexone,5360515.0,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,OPRM1,rs1799971,Efficacy
4065,pharmgkb,rosuvastatin,6439133.0,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,SLCO1B1,rs4149056,Efficacy
4066,pharmgkb,opioids,,,OPRM1,rs1799971,Toxicity
4067,pharmgkb,ibuprofen,3672.0,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,CYP2C8,"CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4",Efficacy
4068,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,COMT,rs6269,Dosage
4069,pharmgkb,everolimus,6442177.0,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,CYP3A4,"CYP3A4*1, CYP3A4*22",Metabolism/PK
4070,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,OPRM1,rs1799971,Metabolism/PK
4071,pharmgkb,pantoprazole,4679.0,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,ABCB1,rs1045642,Efficacy
4072,pharmgkb,lamotrigine,3878.0,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,UGT2B7,rs28365063,Metabolism/PK
4073,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",Toxicity
4074,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP2D6,"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*10, CYP2D6*17, CYP2D6*41",Toxicity
4075,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Efficacy
4076,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,CYP2C9,"CYP2C9*1, CYP2C9*2, CYP2C9*3",Efficacy
4077,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801131,Dosage
4078,pharmgkb,irinotecan,60838.0,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,UGT1A1,rs4124874,Toxicity
4079,pharmgkb,sulfamethoxazole / trimethoprim,358641.0,,G6PD,"G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like",Toxicity
4080,pharmgkb,sulfametopyrazine,9047.0,COC1=NC=CN=C1NS(=O)(=O)C2=CC=C(C=C2)N,G6PD,"G6PD B (reference), G6PD Mediterranean, Dallas, Panama, Sassari, Cagliari, Birmingham",Toxicity
4081,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC19A1,rs1051266,Efficacy
4082,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801131,Efficacy
4083,pharmgkb,cisplatin,441203.0,N.N.Cl[Pt+2]Cl,ERCC1,rs3212986,Efficacy
4084,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,"C18orf56,TYMS",rs45445694,Metabolism/PK
4085,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCB1,rs1045642,Efficacy
4086,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC19A1,rs1051266,Toxicity
4087,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,VKORC1,rs17708472,Dosage
4088,pharmgkb,oxcarbazepine,34312.0,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,HLA-B,HLA-B*15:02,Toxicity
4089,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,TYMS,rs11280056,Toxicity
4090,pharmgkb,warfarin,54678486.0,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,NQO1,rs1800566,Dosage
4091,pharmgkb,nicotine,942.0,CN1CCCC1C2=CN=CC=C2,OPRM1,rs1799971,Dosage
4092,pharmgkb,valproic acid,3121.0,CCCC(CCC)C(=O)O,UGT2B7,rs7439366,Metabolism/PK
4093,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCG2,rs2231142,Metabolism/PK
4094,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC2,rs717620,Metabolism/PK
4095,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC2,rs3740065,Metabolism/PK
4096,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLC19A1,rs1051266,Metabolism/PK
4097,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCC2,rs2273697,Toxicity
4098,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCB1,rs1128503,Toxicity
4099,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCB1,rs1045642,Efficacy
4100,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTR,rs1805087,Toxicity
4101,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,"FASTKD3,MTRR",rs1801394,Toxicity
4102,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,ABCG2,rs2231142,Toxicity
4103,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,SLCO1B1,rs11045879,Toxicity
4104,pharmgkb,methotrexate,126941.0,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,MTHFR,rs1801131,Toxicity
4105,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-B,HLA-B*58:01,Toxicity
4106,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,ABCB1,rs1128503,Dosage
4107,pharmgkb,methadone,4095.0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,ABCB1,rs1045642,Dosage
4108,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,CYP2D6,"CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*6",Efficacy
4109,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,OPRM1,rs1799971,Toxicity
4110,pharmgkb,morphine,5288826.0,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,COMT,rs4680,Toxicity
4111,pharmgkb,oxycodone,5284603.0,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,COMT,rs4680,Toxicity
4112,pharmgkb,methylphenidate,4158.0,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,COMT,rs4680,Efficacy
4113,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CYP2C19,"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17",Efficacy
4114,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,ABCB1,rs1045642,Efficacy
4115,pharmgkb,docetaxel,148124.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,ABCB1,rs1045642,Efficacy
4116,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,ABCB1,rs1045642,Toxicity
4117,pharmgkb,paclitaxel,36314.0,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CYP2C8,"CYP2C8*1, CYP2C8*2, CYP2C8*3, CYP2C8*4",Toxicity
4118,pharmgkb,Beta Blocking Agents,,,ADRB1,rs1801253,Efficacy
4119,pharmgkb,Beta Blocking Agents,,,GRK5,rs2230345,Efficacy
4120,pharmgkb,Beta Blocking Agents,,,ADRB2,rs1042713,Efficacy
4121,pharmgkb,carbamazepine,2554.0,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,HLA-A,HLA-A*02:01,Toxicity
4122,pharmgkb,fentanyl,3345.0,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,CYP3A4,"CYP3A4*1, CYP3A4*18",Dosage
4123,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,HTR2A,rs6313,Efficacy
4124,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,HTR2A,rs6311,Efficacy
4125,pharmgkb,antidepressants,,,HTR2A,rs6311,Efficacy
4126,pharmgkb,antidepressants,,,HTR2A,rs6313,Efficacy
4127,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,HTR2A,rs6313,Efficacy
4128,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,HTR2A,rs6313,Efficacy
4129,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,HTR2A,rs6311,Efficacy
4130,pharmgkb,fluvoxamine,3404.0,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,HTR2A,rs6313,Efficacy
4131,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,HTR2A,rs6313,Efficacy
4132,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,HTR2A,rs6311,Efficacy
4133,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs6313,Efficacy
4134,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs6311,Efficacy
4135,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs6311,Efficacy
4136,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs6313,Efficacy
4137,pharmgkb,venlafaxine,5656.0,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Efficacy
4138,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,HTR2A,rs7997012,Efficacy
4139,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,HTR2A,rs7997012,Efficacy
4140,pharmgkb,fluvoxamine,3404.0,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,HTR2A,rs6311,Toxicity
4141,pharmgkb,fluvoxamine,3404.0,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,HTR2A,rs6311,Efficacy
4142,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,HTR2A,rs6311,Toxicity
4143,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,HTR2A,rs6311,Toxicity
4144,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,HTR2A,rs6311,Efficacy
4145,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,HTR2A,rs6313,Toxicity
4146,pharmgkb,paroxetine,43815.0,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,HTR2A,rs7997012,Efficacy
4147,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,HTR2A,rs7997012,Efficacy
4148,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Efficacy
4149,pharmgkb,citalopram,2771.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,SLC6A4,rs25531,Efficacy
4150,pharmgkb,escitalopram,146570.0,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Efficacy
4151,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,SLC6A4,rs57098334,Efficacy
4152,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Efficacy
4153,pharmgkb,sertraline,68617.0,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Toxicity
4154,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,SLC6A4,rs25531,Efficacy
4155,pharmgkb,fluoxetine,3386.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,SLC6A4,"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)",Efficacy
4156,pharmgkb,"Ace Inhibitors, Plain",,,BDKRB2,rs1799722,Toxicity
